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The yeast Candida is a common colonizer of the human skin, as well as the oral and 
gastrointestinal mucous membranes. The genus Candida comprises more than 150 
species, with only few species being considered as opportunistic fungal pathogens. These 
latter species are able to cause candidiasis. This is a disease which includes a broad 
spectrum of infections, ranging from superficial mucosal infections to life-threatening 
invasive disease in which virtually any deep organ can be involved. Discussion of the 
clinical manifestations of candidiasis is usually facilitated by dividing candidiasis into 
mucocutaneous and invasive infection. Examples of the various disease forms are shown 
in table 1.  
 
Table 1. Examples of disease forms of candidiasis. 
 
Candida albicans has been incriminated as the primary etiologic species of 
candidiasis. The most important risk factor for developing C. albicans infection is an 
impaired host defence system. Moreover, it has been known that the nature and extent of 
the impairment of the host defence dictates the manifestation and severity of the Candida 
infection. In other words, the clinical manifestations of C. albicans infection are 
contingent upon the immune response of the host. In this chapter, the host defence 
mechanisms that participate against disseminated and invasive C. albicans infection will 
be discussed. 
 
Definitions 
For this review disseminated candidiasis denotes the haematogenous spread and 
homing of C. albicans in distant organs during candidemia. Invasive candidiasis implies 
intraperitoneal C. albicans infection, which includes both C. albicans peritonitis and 
localized C. albicans abscesses. Description of host response against mucocutaneous C. 
albicans infections, as well as the other forms of invasive C. albicans infection goes 
beyond the scope of this review. 
Mucocutaneous infection Invasive infection 
- onychomycosis - candidemia and 
- oropharyngeal candidiasis acute haematogenously disseminated candidiasis 
- chronic mucocutaneous candidiasis - chronic disseminated (hepatosplenic) candidiasis 
- Candida esophagitis - Candida pneumonia 
- intertrigo - Candida osteomyelitis 
- genital candidiasis - Candida meningitis 
 - urinary tract candidiasis 
 - Candida peritonitis 
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Host defence against disseminated candidiasis 
After damage of the first line of defence against Candida infections, which includes 
the skin and the mucosa with its normal flora offering colonization resistance, C. albicans 
is able to enter the bloodstream and to spread to other parts of the body. Here, C. albicans 
is encountered with innate as well as acquired cell-mediated immune mechanisms. 
 
Innate immune system 
Blood-borne C. albicans blastoconidia that are not cleared by circulating 
polymorphonuclear phagocytes (PMNs), monocytes, and candidacidal factors (discussed 
below), are delivered to the target organs by adherence to endothelial cells or structures 
belonging to the extracellular matrix. Adhesion of C. albicans is mediated by 
mannoprotein receptors for iC3b and fibronectin [1-3]. In undamaged endothelium, the 
primary route of endothelial monolayer traversal consists of phagocytosis of C. albicans 
blastoconidia and germ tubes by endothelial cells, a process that does not require 
opsonisation [4-8].  
After ingestion, C. albicans can escape from the endothelial cell by fusion of the 
phagosome with the abluminal plasma membrane, or damaging the endothelial cell by 
germination [5,6,8] (Fig.1). Endothelial contraction and damage expose the subendothelial 
extracellular matrix, which is normally only exposed in special anatomic locations such as 
the glomerulus. Additional Candida yeasts can adhere to the exposed subendothelial 
extracellular matrix and C. albicans binds more avidly to this structure than to 
endothelium [9,10] (Fig.1). The adherence is further enhanced by platelet aggregation on 
the exposed extracellular matrix, providing an extended surface area for adherence and the 
entrapment of Candida cells in the platelet-fibrin aggregate [11]. Platelets may also play 
an antagonistic role against Candida infection via the production of platelet microbicidal 
protein that has been shown to kill Candida blastoconidia [12-14]. 
 
The endothelial traversal of C. albicans also activates the endothelial cells. In 
response to the phagocytosis of live germinating C. albicans, endothelial cells have been 
reported to produce tumour necrosis factor-α (TNFα), interleukin (IL)-1α, IL-1β, IL-8, IL-
6, granulocyte colony stimulating factor (G-CSF) and monocyte chemoattractant protein 1 
(MCP-1). In addition, via (autocrine) effects of pro-inflammatory cytokines, endothelial 
cells respond to Candida invasion by expressing leukocyte adhesion molecules, such as E-
selectin, intercellular adhesion molecule 1 (ICAM-1), and vascular adhesion molecule 1 
(VCAM-1) [8,15-18]. With the increased expression of adhesion molecules, endothelial 
cells provide phagocytes, that express the integrin counter-receptor following chemokine-
Introduction 
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stimulation, the opportunity to firmly adhere to their surface [19,20]. The magnitude and 
composition of leukocyte influx at the site of infection is regulated by the secretion of 
chemokines, such as MIP-1α, MIP-1β, MCP-1, IL-8 or its murine counterpart KC [19]. 
Subsequent migration of phagocytes upon a gradient of chemokines, released by various 
cell types, initiates a local inflammatory reaction. Pro-inflammatory cytokines released by 
macrophages, PMNs and NK-cells (discussed below) enhance their own function as well 
as the function of each other in anticandidal host response (Fig. 1).  
 
Once Candida cells have passed the endothelium, traversal of the extracellular matrix 
has to ensue before tissue parenchyma can be infiltrated. During this process they are 
encountered by phagocytic cells. 
 
Phagocytic cells 
Phagocytes, i.e., PMNs and mononuclear phagocytes are essential components of the 
innate immune resistance. The contribution of PMNs and mononuclear phagocytes to 
innate resistance against disseminated candidiasis has been assessed in several in vivo 
experiments. Studies in which mice were rendered severely granulocytopenic have 
established that PMNs play a crucial role in host defence against disseminated candidiasis, 
as evidenced by an increased outgrowth of Candida blastoconidia from the organs and 
decreased survival rates compared to immunocompetent mice [21-25].  
With respect to the role of macrophages in disseminated candidiasis however, 
evidence has been produced that both supports and refutes the importance of macrophages 
in host resistance against C. albicans. Selective elimination of macrophages from mice by 
liposomes containing dichloromethylene diphosphonate cleared C. albicans more slowly 
from the bloodstream and showed a significantly impaired survival of experimental 
disseminated candidiasis [26]. In agreement with these observations, depletion of 
macrophages with carrageenan, a cytotoxic agent for macrophages [27], significantly 
increased the number of Candida colony forming units (cfu) in the organs 24 h after 
intravenous injection of C. albicans into severe combined immunodeficiency (SCID) mice 
[28]. In contrast, monocytopenia in mice induced by etoposide did not have a detrimental 
influence on the course of disseminated candidiasis and confirmed that PMNs rather than 
macrophages play a dominant role in the early host response against systemic Candida 
infection [21].  
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Fig. 1. Cytokines are major orchestrators of the complex interplay between innate and acquired 
cell-mediated immunity against Candida albicans infection (φ: macrophage). 
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The contribution of PMNs and macrophages to host defence against C. albicans has 
been determined by assessing their capacity to internalise and kill Candida blastoconidia 
in vitro. Although these studies have yielded divergent results due to a number of 
substantial methodological variations, it can be concluded that both PMNs and 
macrophages ingest and kill internalised Candida blastoconidia [29-37], with PMNs 
showing a more potent capacity than macrophages to kill Candida blastoconidia 
intracellularly [29,33,38]. One explanation for the divergent results may be that resident 
macrophages require priming, for instance with interferon-γ (IFNγ), to activate their 
killing mechanisms [32,36,37,39]. Intracellular killing of Candida blastoconidia by PMNs 
in vitro is augmented by TNFα [34,40], IFNγ [29,34,41-43], and G-CSF (Fig.1) [44,45].  
Because growth of C. albicans is polymorphic, i.e. it exits both as yeast and 
filamentous (pseudohyphal and hyphal) growth forms, phagocyte action against Candida 
hyphal morphologies is also of importance. Both PMNs and monocytes have been shown 
to kill large uningestible hyphal growth forms of Candida extracellularly [46].  
Whereas the presence of fresh serum, which provides complement for opsonisation of 
Candida cells, is required for optimal phagocytosis [30,31,47-49], monocyte or PMN-
mediated damage of C. albicans hyphae occurs both in the absence of serum and in the 
presence of heat-inactivated serum, indicating that for this process complement is not 
essential [46,50,51]. Furthermore, similar to the PMN-mediated intracellular killing of 
Candida blastoconidia, the extracellular antifungal activity of PMNs against C. albicans 
hyphal forms is enhanced by IFNγ, G-CSF and TNFα (Fig.1) [52,53]. 
 
Phagocytes kill C. albicans intracellularly or extracellularly by means of both 
oxidative and non-oxidative candidacidal mechanisms. Oxidative mechanisms of PMNs 
and monocytes can be divided into myeloperoxidase (MPO)-dependent and MPO-
independent reactions (Table 2) [50,51,54-59].  
During the transition of monocytes into macrophages, myeloperoxidase is lost, as a 
result of which macrophages are unable to oxidise a halide in the presence of hydrogen 
peroxide and to create a strong oxidant such as hypochlorous acid (HOCL). Instead, nitric 
oxide (NO) is produced by activated macrophages, which together with MPO-independent 
superoxide (O2-) generation by phagocyte NADPH oxidase gives rise to the formation of 
another strong oxidant, peroxinitrate (ONOO-). It has been shown that ONOO- exerts the 
candidacidal activity of activated macrophages [60]. Because ONOO- kills C. albicans 
blastoconidia in vitro and NO does not, it has been suggested that the enhanced resistance 
of mice to systemic candidiasis attributed to macrophage derived NO-production [61-63] 
is in fact mediated by ONOO- [60].  
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Non-oxidative candidacidal mechanisms of PMNs include granule-derived 
antimicrobial peptides such as lysozyme [50,54], calprotectin [64], lactoferrin [65], 
azurocidin [66], human β-defensin 3 [67], and cathelicidin LL-37 [68]. Macrophage non-
oxidative C. albicans killing has been shown with lysosomal extracts from rabbit alveolar 
macrophages that contained the defensins microbicidal cationic protein-1 and 2 [69]. 
 
Table 2. Intra- and extracellular killing mechanisms of C. albicans by phagocytes. 
 
 
NK-cells 
Natural killer (NK) cells are large granular lymphocytes that arise from the same 
progenitor cell as T lymphocytes during differentiation. In contrast with T-cells, which 
require MHC class I expression by target cells to initiate lysis, NK cells preferentially kill 
cells lacking MHC class I expression [70]. NK-cells bind to C. albicans and one of the 
surface structures of NK-cells that mediates adhesion to C. albicans has been shown to be 
β2-integrin CD11b/CD18 [71]. Interleukin (IL)-2 activated natural killer cells (LAK) cells 
bind more extensively to Candida germ tubes than NK cells, but both are unable to kill or 
inhibit germ tube or hyphal growth forms of C. albicans [72-74]. These data suggest that 
NK-cells do not have an important direct anticandidal effect. Furthermore, NK-depleted 
SCID mice did not show an enhanced susceptibility to candidiasis induced by i.p. C. 
albicans administration [75]. However, NK-cells are activated by C. albicans [76], and 
human LAK-cells respond to live or heat-killed C. albicans germ tubes with an increased 
expression of TNF-α, GM-CSF, and IFN-γ mRNA [73]. Hence, NK-cells are suggested to 
play a role in anticandidal host defence through activation of phagocytes. Indeed, evidence 
has been provided that NK cells are the main inducers of phagocytic activity of splenic 
macrophages and that they mediate the protection against systemic C. albicans infection 
[77]. 
Mechanism   Phagocytes involved 
Oxidative MPO-dependent   PMNs, monocytes 
 MPO-independent   PMNs, macrophages 
 MPO-independent ONOO- Macrophages 
Non-oxidative NO 
}
 Macrophages 
 Antimicrobial peptides   PMNs, macrophages 
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Soluble factors 
Complement and mannose binding lectin 
The complement system is a group of heat-labile proteins which can be activated in a 
cascade fashion to provide a humoral defence against various micro-organisms. 
Complement activation is initiated via several pathways that all converge at a single point, 
the third complement component (C3).  
The role of complement in candidiasis is evidenced by several observations. First, C. 
albicans activates the complement cascade via both the classical (antibody-antigen) and 
alternative pathway (cell surface material with repeating chemical structure) and shows 
binding of C3 fragments [78,79]. Second, the presence of C3 promotes the ingestion of C. 
albicans by phagocytes and is prevented by anti-C3 [49]. Third, C5-deficient mice show 
an increased amount of Candida cfu in their organs and an increased mortality in 
disseminated candidiasis, probably due to lack of C5a, an important leukocyte 
chemoattractant [80].  
Moreover, the classical pathway of the complement cascade can also be activated by 
mannose binding lectin (MBL). MBL is another important serum protein of innate 
immunity that is synthesized by the liver. MBL is able to recognize and bind to multiple 
sugar ligands expressed on the surface of microbes, such as mannose on the surface of C. 
albicans [81,82]. It has been shown that MBL-initiated complement activation may play 
an important role in anticandidal host defence of previously unexposed and non-immune 
hosts [81]. However, others have found no differences in the survival rates and fungal 
burdens of wild-type and MBL-A-deficient mice, indicating that MBL-A does not 
substantially contribute to host resistance against disseminated candidiasis [83]. Likewise, 
we were not able to find a role for MBL in Candida-induced cytokine production, and the 
MBL genotype of patients with candidemia did not differ from that of healthy individuals 
(C. van der Graaf et al., manuscript in preparation). 
 
Lipoproteins 
Major lipoprotein classes in plasma, such as very low density lipoproteins (VLDL), 
low density lipoproteins (LDL), and high density lipoproteins (HDL) are able to detoxify 
lipopolysaccharide (LPS) [84,85]. The LPS-neutralising activity is mediated by both lipid-
endotoxin and protein-endotoxin interactions. The lipid A domain of LPS is masked either 
by insertion of this domain in the phospholipid leaflet that covers the surface of 
lipopoproteins, or it is bound and sheltered by the hydrophobic structures of 
apolipoproteins [84,86-88]. In addition, Apolipoprotein E (ApoE) directs LPS away from 
cytokine producing Kupffer cells to parenchymal liver cells [89], thus reducing 
cytokinemia.  
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Whereas hyperlipidemia and the presence of ApoE protect against LPS-induced 
lethality and Gram-negative bacterial infection [87,90-93], hyperlipidemia renders mice 
susceptible to disseminated candidiasis [94]. Infusion of reconstituted HDL into human 
volunteers resulted in increased C. albicans growth in the plasma of these subjects [95]. It 
is hypothesized that the excess of lipoproteins influences the growth of C. albicans 
blastoconidia either by serving as a nutrient [95-97], or by binding and inactivating plasma 
candidacidal factors, such as sphingosine [98], the calprotectin complex [64], or platelet 
microbicidal protein [12,13]. Whether ApoE plays an immunomodulatory role in the 
putative neutralisation of candidacidal factors by lipoproteins has yet to be established.  
 
Acquired immunity 
From the aforementioned data it has become apparent that professional phagocytes 
such as PMNs and macrophages play a crucial role in the innate immune defence against 
disseminated candidiasis. The innate immune system however, does not operate 
individually and isolated from acquired immunity. Phagocytes also serve afferent as well 
as efferent functions in the acquired immunity against infections by Candida albicans, as 
will be outlined in the following paragraphs.  
 
Humoral immunity 
The role of anti-Candida antibodies in host defence against disseminated candidiasis 
has remained an issue of debate since the finding that yeast-immunised mice showed 
resistance to disseminated candidiasis, which correlated with high anti-C. albicans 
antibody titres in their sera [99,100]. Since then, facts arguing in favour of, as well as facts 
militating against a protective function have accumulated [101-103].  
Vaccination of mice with a liposomal mannan preparation of Candida albicans 
induced the production of antibodies that protect against disseminated candidiasis [104]. 
Protection was conferred by immunoglobulin M monoclonal antibody (MAb) B6.1 
specific for a C. albicans cell surface β-1,2-mannotriose, or the IgG3 isotype of MAb C3.1 
which is specific for the same B6.1 epitope on the yeast cell surface. Mice treated with 
Mab's had significantly reduced amounts of Candida cfu in their kidneys and extended 
survival times [104,105]. The mode of action appeared to be through activation of the 
classical complement pathway, and enhanced killing of C. albicans blastoconidia by 
neutrophils, which only takes place in the presence of complement [31,106,107]. 
In contrast, B-cell defective CBA/N or SCID mice deficient in both T and B cells are 
as resistant to systemic Candida infections as immunocompetent mice are [28,108,109].  
Taken together, these data suggest that humoral immunity does not play a crucial role in 
the defence against disseminated candidiasis, but antibodies may aid innate host resistance 
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against disseminated C. albicans infection. However, recently, a new mechanism through 
which antibodies may contribute to protective immunity has been provided [110]. 
Candida opsonizing antibodies were required for modulating the interaction of Candida 
and dendritic cells, in that opsonizing antibodies increased phagocytosis of Candida yeast 
through CR3 and IL-10 production by dendritic cells [110-112]. These events are 
important for T regulatory cell induction and generation of memory anticandidal 
immunity, as will be discussed below. 
 
Cell-mediated immunity 
Whereas some controversy exists with respect to the contribution of the humoral 
immune response to anticandidal host defence, the role of T-cell mediated immunity in 
host defence against disseminated candidiasis has been largely established. T-cell 
mediated immunity has been studied in several experimental models. Of these models, T-
cell mediated immunity against acute disseminated candidiasis in naïve mice (animals that 
encounter the antigen for the first time, i.e. primary infection) and T-cell mediated 
immunity against reinfection of mice that were vaccinated with a systemic infection using 
agerminative yeast cells of a Candida variant strain will be discussed. 
 
After invasion of the host by C. albicans, activation of professional phagocytes is the 
main defence mechanism. Efficient activation of PMNs and macrophages depends on a 
CD4+ T helper (Th) 1 response, mainly IFN-γ.  
Indeed, in the past, a correlation has been shown between the susceptibility of mice to 
C. albicans infection and the type of Th cytokine pattern that is produced. Resistance to 
primary systemic C. albicans infection is associated with a Th1 response, represented by 
the production of cytokines such as IFN-γ and IL-2. IL-12, mainly produced by 
macrophages, primes naïve T cells for IFN-γ production [113]. IFN-γ sustains the Th1 
response, suppresses the induction of a Th2 response, and enhances phagocyte fungicidal 
effector function (Fig.1).  
In contrast, susceptibility of mice to primary systemic C. albicans infection is 
associated with a Th2 response, characterized by the presence of anti-inflammatory 
cytokines such as IL-10 and IL-4 [114-119]. IL-10 and IL-4 sustain a Th2 response, 
suppress the induction of a Th1 response and down-regulate phagocyte candidacidal 
activity [120,121] (Fig.1). Furthermore, neutralization of IL-4 or IL-10 during primary 
systemic C. albicans infection has been shown to induce the development of protective 
Th1 responses. These Th1 responses positively influenced the course of primary infection 
and rendered susceptible mice resistant to primary C. albicans infection [116,118-120].  
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Next to T helper cells, the CD4+ T cell population also constitutes CD4+ T regulatory 
cells [122]. Different subsets of T regulatory cells have been described. Each subset may 
differ in the mode of generation and mechanism of action, although evidence for 
similarities between the different T regulatory subsets have been shown [122-124]. There 
are substantial data that regulatory T cells, specialized in controlling self-reactive T-cells, 
play a critical role in immune regulation. Therefore, it is suggested that immune responses 
driven by Th1 and Th2 cells are also influenced by T regulatory cells which are 
characterized by the production of IL-4, IL-10 and transforming growth factor-β (TGF-β) 
[122-124]. These cytokines are able to induce a Th2 polarization [16,116,125-130]. Their 
presence might explain why neutralization of IL-4 and IL-10 in primary systemic C. 
albicans infection enhances resistance of mice [116,118-120]. Moreover, mice deficient in 
T-cells, such as those found in CBA/N, SCID, and athymic mice are as resistant, or even 
more resistant to acute disseminated C. albicans infections as immunocompetent mice are 
[28,108,109,131-134]. The most likely explanation for these observations is that by 
depleting T-cells, T regulatory cells are depleted as well. By doing so, naïve mice are 
deprived of an early production of IL-4 and IL-10 directing the differentiation of naïve 
CD4+ T-cells into Th2 cells. Therefore, depletion of T regulatory cells during primary 
systemic C. albicans infection is suggested to be beneficial to host response.  
However, it has to be taken into account that, after elimination of C. albicans, the pro-
inflammatory reaction required in the early phase of the host response needs to be 
dampened, which is mediated through Th2 and T-regulatory cells. 
 
Whereas early depletion of T regulatory cells in primary systemic C. albicans 
infection is suggested to be beneficial, T-regulatory cell depletion can be detrimental to T-
cell mediated immunity of vaccinated mice that receive a second systemic C. albicans 
challenge. Indeed, although IL-4, IL-10, and TGF-β inhibit Th1 activation in the inductive 
phase of primary infection, all have been shown to be required for maintaining a long-
lasting Th1 immunity to the fungus and protect against reinfection [118,121,135,136]. 
Also, the induction of a Th1 response required the combined effects of different cytokines, 
including IFN-γ [137], IL-12 [138], and TNF-α [139]. Thus, a finely regulated balance of 
Th1 and Th2 cytokines, rather than the absence of opposing Th2 cytokines, appears to be 
necessary for an optimal development and maintenance of Th1 responses in mice with a 
protracted C. albicans infection. 
After systemic vaccination of mice with a low virulent C. albicans strain, T regulatory 
cells producing IL-10, IL-4 and TGF-β were indeed expanded in the mesenteric lymph 
nodes and thymuses of these mice and these mice were protected against reinfection [140]. 
Mice deficient in B7-2 or CD28 were not able to resist C. albicans reinfection and did not 
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show T regulatory cell expansion. This indicates that expansion of T regulatory cells 
required a costimulatory signal via engagement of CD28 by B7-2 which is expressed on 
antigen presenting cells. Moreover, T regulatory cells expanded in IL-4-deficient mice, but 
not in mice treated with anti-IL-10 Mab [140]. It appears that local levels of B7-2 
expression, as well as IL-10 production for instance by dendritic cells, are both required 
for the generation of T regulatory cells during long-lasting C. albicans infection and T 
regulatory cells are an essential component of the memory-protective immunity against C. 
albicans. 
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Host defence against invasive candidiasis 
Since colonization of the gastrointestinal tract with C. albicans is common, 
gastrointestinal perforation or surgery may be complicated by intraperitoneal Candida 
infection and formation of Candida abscesses. Invasive candidiasis that involves the 
abdominal cavity is as important as disseminated candidiasis and is responsible for 
considerable morbidity and high mortality rates [141-143]. 
 
Formation of Candida abscesses  
Experimental studies have shown that, following peritoneal contamination, microbes 
are efficiently cleared within minutes via translymphatic absorption and subsequently 
exposed to systemic defence mechanisms [144,145]. Local resident peritoneal 
macrophages are the predominating phagocytic population and represent the first line of 
defence, and these are also cleared by the lymphatic system [146]. Because this clearance 
of invading micro-organisms is very efficient, the complex process of abscess formation in 
response to gastrointestinal perforation or following peritonitis induced by an 
experimental intraperitoneal microbial challenge occurs only when potentiating agents are 
present, such as autoclaved cecal contents (ACC) or bran [147,148]. These potentiating 
substances mechanically obstruct the lymphatics and serve as a niche for microbes to 
escape from phagocytosis. Furthermore, ACC and bran are opsonized [148,149], thus 
depleting the microenvironment of complement and subsequently inhibiting the 
opsonisation and intracellular killing of the invading microbial agent. With the influx of 
plasma proteins into the peritoneal cavity, which is normally a net fibrinolytic 
environment, fibrinogen is introduced as well, and fibrin is deposited after the release of 
procoagulant activity by activated macrophages [150]. The release of cytokines, 
chemokines (discussed above), other inflammatory mediators released by macrophages 
and mast cells, as well as activation of the alternative complement pathway by C. albicans 
[78] leads to recruitment and accumulation of PMNs at the site of infection.  
Fibre and fibrin cloths provide a sequestered environment in which proliferation of C. 
albicans can prevail, and which impairs migration of phagocytes. These events together 
with fibroblast growth, collagen production, and the accumulation of monocytes and their 
subsequent transition into tissue macrophages are fundamental to the development of 
intra-abdominal abscess formation. 
 
Functional activity of abscess-derived neutrophils 
Abscess formation could presumably isolate the infecting Candida cells and prevent 
them from causing further damage to the host, provided that the organisms are kept within 
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the abscess cavity and killed. However, the cellular contents of abscesses consist primarily 
of viable and disintegrating PMNs but the killing function of PMNs is significantly 
suppressed within abscesses [151,152]. Bearing the last finding in mind, it is questionable 
whether abscess formation would be beneficial to the host. Fortunately, upon disruption or 
death of PMNs, cytoplasmic granules are released which contain an abundant amount of 
the protein calprotectin [153,154]. After lysis of PMNs, the calcium/zinc binding 
calprotectin accumulates in abscess fluids and competes for zinc with C. albicans which 
requires zinc for its growth [155-158]. The anticandidal activity of calprotectin is of a 
static nature and keeps Candida growth in an extended lag phase, an effect similar to that 
seen with zinc-deprived micro-organisms [159]. Furthermore, lysates of PMNs are able to 
prevent the formation of long, multicellular Candida hyphal forms and this might prevent 
Candida cells from penetrating the limits of the abscess cavity and disseminating into the 
surrounding tissue [154].  
 
Immunomodulatory activity of amphotericin B 
The polyene antifungal agent amphotericin B derives its beneficial effect mainly from 
direct candidacidal action. In addition, amphotericin B reportedly enhances host defence 
mechanisms against Candida infection. It has been shown that amphotericin B increases 
the oxidative burst of PMNs and macrophages [160-162]. Amphotericin B also stimulates 
the production of pro-inflammatory cytokines by mononuclear cells, such as TNF and IL-
1β [163-167], and this amphotericin B-induced production seems to be mediated by Toll-
like receptor 2 and CD14 [168]. As described above, pro-inflammatory cytokines such as 
TNF, IL-1β and IFNγ augment phagocytic effector functions. Therefore, next to 
accumulation of amphotericin B in phagocytes, it is likely that the amphotericin B-
enhanced candidacidal functions of macrophages are mediated by the production of pro-
inflammatory cytokines [169-174]. Furthermore, in vivo, amphotericin B did not increase 
survival of mice deficient for the IFNγ-receptor that were intravenously infected with 
Candida albicans, whereas a positive effect on survival was observed in 
immunocompetent mice. These results suggest an immunomodulatory effect of 
amphotericin B that is mediated through an IFNγ-dependent mechanism [175].  
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Outline of the thesis 
The aim of the present thesis is to obtain further insight into anticandidal host defence 
mechanisms against disseminated and invasive candidiasis. The contribution of PMNs and 
macrophages to host defence against C. albicans is usually determined by assessing their 
capacity to internalize and kill Candida blastoconidia in microbiological test systems. Due 
to a number of substantial methodological variations, these systems have yielded 
divergent results. In order to adequately and accurately define the phagocytosis and 
intracellular killing of Candida blastoconidia by murine exudate peritoneal macrophages 
and exudate peritoneal PMNs, several microbiological test systems are compared. This 
comparison has brought about a further refined laboratory method (Chapter 2).  Both C. 
albicans blastoconidia and (pseudo)hyphae are present within lesions and the ability of C. 
albicans to undergo phenotypic switching between both growth forms is associated with 
virulence. Therefore, to further characterize the PMN-mediated host response against C. 
albicans, investigation of the extracellular antihyphal activity of PMNs, in addition to 
determination of the intracellular capacity of phagocytes to kill internalised Candida 
blastoconidia, is also required. To this purpose, a previously described colorimetric dye 
assay for assessment of pseudohyphal viability was optimized. The development of the 
assay and the influence of various pro-inflammatory cytokines on anti-pseudohyphal 
activity of PMNs are described in Chapter 3.  
Exogenous administration of pro-inflammatory cytokines or administration of 
antibodies directed against pro-inflammatory cytokines has been shown to influence 
anticandidal host defence. However, the mechanisms through which pro-inflammatory 
cytokines exert their effects, especially in physiologic amounts, remain to be established. 
Therefore, we assessed the influence of the endogenous pro-inflammatory cytokines IL-1, 
IL-18 and IL-12 in disseminated candidiasis. The role of these cytokines was studied mice 
in which the genes encoding for these cytokines had been disrupted. The influence of 
endogenous IL-1 in disseminated candidiasis is described in Chapter 4, and the influence 
of endogenous IL-18 and IL-12 in disseminated candidiasis is described in Chapter 5. 
Other factors, such as lipoproteins have also been shown to modulate host defence against 
candidiasis. In Chapter 6, the immunomodulating activity of hyperlipoproteinemia and 
apolipoprotein E in disseminated candidiasis was further investigated.  
Candida albicans has also been shown to cause invasive candidiasis, i.e. C. albicans 
peritonitis and formation of C. albicans abscesses. There is some evidence that the risk of 
invasive candidiasis is increased with the systemic use of monoclonal antibodies against 
TNF for treatment of patients with an inflammatory bowel disease. The mechanisms 
through which neutralization of endogenous TNF increases the susceptibility to invasive 
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candidiasis are incompletely understood. Therefore, the significance of endogenous TNF 
and LT to the process of intra-abdominal Candida abscess formation and the subsequent 
clearance of the yeast was investigated in TNF/LT-deficient mice. The results are 
described in Chapter 7. In general, abscesses are difficult to treat with antimicrobial drugs 
only. Combinations of antifungal agents or the simultaneous administration of an 
immunomodulating substance that enhances host resistance, such as G-CSF, is suggested 
to yield better treatment results. The results of the investigation into the efficacy of 
combination therapy with an antifungal agent and recombinant murine G-CSF of intra-
abdominal Candida abscesses is presented in Chapter 8.  
The antifungal agent amphotericin B has both a direct antifungal effect and the ability 
to modulate host defence mechanisms via influencing pro-inflammatory cytokine 
production. The latter phenomenon is associated with side-effects such as fever and chills. 
The capacity of amphotericin B to modulate pro-and anti-inflammatory cytokine balance 
by peripheral blood mononuclear cells was determined and the results are described in 
Chapter 9. 
 
Chapter 10: summary and discussion 
Chapter 11: samenvatting en discussie 
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Abstract 
Polymorphonuclear neutrophils and mononuclear phagocytes represent an important 
first line and effector function in the control of Candida infections. Their relative 
contribution to host defence is frequently assessed by means of microbiological assays. 
However, reported results are divergent and might well be associated with study design-
related issues. In the present study we compared frequently used microbiological 
candidacidal assays, in purpose to determine the most adequate method for assessment of 
phagocytosis and intracellular killing.  
We concluded that microbiological assays using yeast-phagocyte suspensions are 
inappropriate for the assessment of intracellular killing of Candida blastoconidia by 
murine macrophages, due to adherence or clumping of cells. In contrast, an adherent 
monolayer of phagocytes can be applied as a single microbiological assay to 
independently study the process of phagocytosis and intracellular killing, by exudate 
peritoneal macrophages as well as exudate peritoneal PMN. 
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Introduction 
Experimental models evaluating host defence against Candida albicans have shown 
that both innate resistance and acquired cell-mediated immunity are involved in anti-
Candida response [1,16,19]. Essential components of both arms of the immune defence 
against infections by Candida albicans are phagocytic cells, i.e., polymorphonuclear 
neutrophils (PMN) and mononuclear phagocytes [9,15,20]. 
The precise contribution of phagocytes to host defence is usually assessed by 
determining phagocytosis and killing of Candida blastoconidia by means of the classical 
microbiological method of plate counting. However, divergent results are reported by 
investigators using these microbiological assays. To a large extent, the reported 
differences may be due to a number of substantial methodological variations. First, studies 
that have applied peritoneal phagocyte populations have used different eliciting agents, 
resulting in divergent cell populations [5,15,20]. Second, the microbiological method used 
has either been based on incubation of cells in suspension under slow rotation, using 
differential centrifugation to determine the amount of phagocytised Candida blastoconidia 
[11,13,14], or a monolayer of adherent cells [3,17,18]. Furthermore, it remained 
questionable whether assays based on the enumeration of Candida cells are not biased by 
clumping or adherence of cells resulting in erroneous conclusions regarding both the 
number of phagocytised and killed Candida blastoconidia. 
In the present study we compared various frequently used microbiological 
candidacidal assays, to determine the most adequate method for assessment of 
phagocytosis and intracellular killing of Candida blastoconidia by murine peritoneal 
phagocytes. 
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Materials and methods 
Mice 
Specific pathogen-free CBA and C57Bl/6 female mice were used. Animals were 
housed under standard laboratory conditions and fed sterilised laboratory chow (Hope 
Farms, Woerden, The Netherlands) and water ad libitum. 
 
Reagents 
Sabouraud dextrose broth containing neopeptone 10 g x l -1 and dextrose 20 g x l -1 
was obtained from Difco. Modified eagle’s medium (MEM), RPMI 1640 (RPMI), both 
obtained from Gibco Life technologies, Paisley, Scotland, and RPMI 1640 Dutch 
modification with 20mM Hepes, without glutamine (RPMI-dm) purchased from ICN 
Biomedicals GmbH, Eschwege, Germany were supplemented with 1 % garamycin, 1 % 
glutamine and 1 % pyruvate. 
 
Candida blastoconidia 
Candida albicans (strain UC 820 or ATCC 10261) and C. parapsilosis (a clinical 
isolate from a patient with candidemia) were inoculated into 100 ml of Sabouraud broth 
and cultured for 24 h at 37°C. After three washes with sterile pyrogen-free PBS by 
centrifugation at 1500 g, the number of Candida blastoconidia was counted using a Bürker 
counting chamber. Candida blastoconidia were resuspended in culture medium, as 
indicated in the results section, and diluted to a final concentration of 1 x 105 blastoconidia 
/ ml medium. 
 
Opsonins 
For opsonisation of C.albicans, serum prepared from pooled blood of mice was used 
and stored in 1,5 ml aliquots at –80 ºC. The percentage of serum varied per experiment as 
described below. 
 
Recruitment of phagocytes 
Peritoneal phagocytes were harvested by rinsing the peritoneal cavity with 4 ml of 
sterile ice-cold PBS containing 50 units / ml heparin and collected in separate sterile tubes. 
Exudate peritoneal granulocytes or exudate peritoneal macrophages were obtained 4 or 72 
h after intraperitoneal (i.p.) injection of 1 ml of 10% proteose peptone (Difco Laboratories, 
Detroit, Michigan, USA), respectively. Exudate peritoneal lavage fluid was washed twice 
in sterile saline (1800 rpm, 10 min, 4 °C). The phagocytes were resuspended in culture 
medium, counted in a Bürker counting chamber, and diluted to a final concentration of 5 x 
    Chapter 2 
     
39 
106 cells / ml of culture medium. The percentages of PMN, macrophages and lymphocytes 
were determined in Giemsa-stained cytocentrifuge preparations.  
 
Comparison of assays for the "over all" killing of Candida blastoconidia by murine 
resident peritoneal macrophages  
To assess the "over all" process of phagocytosis and killing, the non-ingested 
blastoconidia were not removed during the assay. Four types of assays of "over all" killing 
were compared. In all assays, resident murine peritoneal macrophages and Candida 
blastoconidia (effector to target ratio (E:T), 250:1) were incubated in RPMI-1640 medium 
with 10% fresh normal mouse serum at 37°C. After incubation of the macrophages with 
C. albicans UC820 or C. parapsilosis, the cell suspensions were collected. Serial tenfold 
dilutions were prepared and aliquots (100 µl) were spread in duplicate on Sabouraud 
dextrose agar plates. The numbers of CFU were counted after 24 h (C. albicans) or 48 h 
(C. parapsilosis) of incubation at 37°C.  
 
1. Adherent Cell Method.  
Peritoneal macrophages were allowed to adhere for 2 hours in 96-wells microtiter 
plates (Nunc, Roskilde, Denmark) before the addition of Candida blastoconidia. At 
various time points of incubation, cells were removed and lysed by scraping and 5 washes 
with distilled water containing 0.01% bovine serum albumin and 0.01% Tween-80 (lysis 
medium). 
 
2. Suspension Sampling Method.  
A 2 ml suspension of macrophages and Candida was incubated in silicone-coated 10 
ml-glass tubes under rotation (4 rpm). At various time points of incubation, the suspension 
was vortexed, a 100 µl sample was taken, the cells were lysed with lysis medium, and 
plated on agar.  
 
3. Small Tube Method.  
To prevent variation over time by repeated sampling the suspension using the previous 
method, the Small Tube method applies a separate tube for each time point. Aliquots of 
200 µl of macrophage/Candida suspension were incubated under rotation in small 
silicone-coated 1 ml-glass tubes, and at given times the entire contents of the tubes were 
lysed with lysis medium, and plated on agar. In order to assess whether Candida and 
macrophages were completely removed from the tubes, the tubes were subsequently 
washed 5 times with lysis medium by vortexing vigorously and the washout fluid was 
cultured separately. 
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4. Centrifugation Method.  
In an attempt to circumvent adherence of cells to the tube, 200 µl of 
macrophage/Candida suspension was incubated under rotation in small silicone-coated 1 
ml-glass tubes as described above. After incubation, the contents of the tube were spun 
down by centrifugation (5 min, 1500 x g) and the contents were collected. The tube was 
washed thrice with lysis medium by vortexing vigorously and the washout was pooled 
with the contents of the tube before plating on Sabouraud agar. 
 
Phagocytosis and intracellular killing of C. albicans  
To study the processes of phagocytosis and intracellular killing independently in a 
single assay, we applied the Adherent Monolayer Method, a modification of previously 
described assays [3,5]. 
Phagocytic cell suspensions were obtained from C57Bl/6 mice as described above, 
and resuspended in RPMI-dm containing 5 % heat-inactivated foetal calf serum (FCS). To 
create a monolayer of phagocytes, 5 x 105 cells in 100 µl of RPMI-dm were dispensed into 
the wells of a 96-well flat bottom plate (Costar, Corning BV, the Netherlands) and 
incubated at 37 °C in air and 5 % CO2. Granulocytes were allowed to adhere for 0.5 h and 
macrophages for 2 h before gently washing the monolayers with culture medium to 
remove non-adherent cells. The percentage of adherence was calculated as (1 – (number of 
non-adherent cells / 5 x 105)) x 100. Subsequently, the cells were incubated with 1 x 104 
CFU C. albicans ATCC 10261, which were opsonised for 45 min at 24 ºC in MEM 
containing 2,5 % mouse serum (E:T ratio, approximately 50:1). After 15 min, supernatants 
were aspirated and monolayers were washed gently with MEM to remove uningested 
micro-organisms. The supernatant and well washings, containing the non-phagocytized 
Candida blastoconidia, were combined and plated in serial dilutions on Sabouraud agar 
plates. The percentage of phagocytized micro-organisms was defined as (1 – (number of 
uningested CFU/ CFU at the start of incubation)) x 100.  
Killing of C. albicans by phagocytes was assessed in the same monolayers. After 
removal of the non-phagocytized Candida blastoconidia, 200 µl of culture medium, 
consisting of Sabouraud in MEM (50 % v/v), was added to the monolayers. After 3 h of 
incubation at 37 °C in air and 5 % CO2, the wells were gently scraped with a plastic 
paddle and washed with 200 µl distilled H2O to achieve lysis of phagocytes. This 
procedure was repeated three times, after which the pooled washes were adjusted to a final 
volume of 1 ml with distilled water. Microscopic examination of the culture plates showed 
that there was a complete removal of phagocytes. To quantify the number of viable 
intracellular Candida blastoconidia, tenfold dilutions of each sample were spread on 
Sabouraud agar plates and incubated at 37 °C for 24 h. The percentage of yeast killed by 
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the phagocytes was determined as follows: (1 – (CFU after incubation/ number of 
phagocytized CFU)) x 100. Phagocyte-free incubations of blastoconidia were included as 
a control for yeast viability. 
 
Statistical analysis 
The results were analysed by the Mann Whitney U test. The numbers of samples are 
stated in the figure legends. The level of significance was set at p < 0.05. 
 
Results 
Comparison of assays for the “over all” killing of Candida blastoconidia by murine 
resident peritoneal macrophages  
As shown in figure 1A, the number of C. albicans rose to slightly above the initial 
number at the start of incubation when assessed with the Adherent Cell Method, as has 
also been described previously [3,10]. The results obtained with the Centrifugation 
Method were similar, indicating that adherent cells and cells in suspension do not differ in 
respect to their inability to kill ingested C. albicans blastoconidia.  
In contrast, the Suspension Sampling Method and the Small Tube Method suggested 
that the macrophages were able to kill over 80 % of the C. albicans blastoconidia in a 4.5 
h period of time (Fig. 1a). However, when C. albicans blastoconidia were cultured in the 
absence of cells (Fig. 1b), similar differences between the various assays were observed, 
indicating that other factors than the killing capacity of the macrophages were responsible 
for these findings.  
When the tubes were washed out vigorously after termination of the Small Tube 
Method, it was demonstrated that large numbers of CFU had remained adhered to the wall 
of the tubes, and this proportion rapidly rose with time. When these numbers were added 
to the numbers of CFU obtained during the assay, the totals indicated that no net killing of 
C. albicans had taken place (Fig. 1c). Similarly, when the numbers of CFU obtained from 
the Small Tube Method in the absence of macrophages (Fig. 1b) were added to the 
washout fluid counts from this assay, the total equalled the numbers of Candida obtained 
with microtiter plates, or the Centrifugation Method (data not shown), indicating that the 
majority of the blastoconidia had remained adhered to the wall of the silicone-coated 
tubes. When C. parapsilosis was used as the test organism, the Adherent Cell (Fig. 1d) 
and Centrifugation Methods (data not shown) showed that macrophages killed 48-52 % of 
the organisms in 4 hours. Again, the numbers of CFU recovered from the Small Tube 
Method and from the washout fluid of the emptied tubes had to be added up to reflect the 
net killing of C. parapsilosis (Fig. 1d). 
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Figure 1. Over all killing of Candida blastoconidia by resident peritoneal macrophages 
according to different methods. (a) Numbers of C.albicans recovered after incubation with 
phagocytes according to the adherent (♦), centrifugation (●), suspension sampling (■), and 
small tube assay (▲). (b) Numbers of C.albicans obtained after incubation in RPMI-1640 
without phagocytes. ((c) and (d) are depicted on the next page) 
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Figure 1. (c) Numbers of C.albicans incubated in the presence of resident peritoneal 
macrophages recovered from the small tube assay before (▲) and after (●) vigorous 
washing of the tubes, as well as the total of both (). (d) Numbers of C. parapsilosis 
recovered after incubation with phagocytes according to the adherent assay (♦), and the 
small tube assay before (▲) and after (●) vigorously washing the tubes. Data are given as 
the mean ± SD of 3 separate experiments, with 4 samples per time point each.  
c. Recovery from  tubes
0
1000
2000
3000
0 1 2 3 4 5time (h)
small tube assay
recovery from tubes
totals
d. C. parapsilosis  killing
0
1000
2000
3000
0 1 2 3 4 5time (h)
adherent assay
small tube assay
recovery from tubes
N
um
be
r o
f C
FU
 
N
um
be
r o
f C
FU
 
Phagocytosis and intracellular killing of C. albicans blastoconidia 
     
44 
Phagocytosis and killing: Adherent Monolayer Method 
Since the data, obtained from the Adherent Cell Method, confirmed the inability of 
resident peritoneal macrophages to kill C. albicans blastoconidia as was shown previously 
[4,10], we investigated the capacity of proteose peptone elicited peritoneal macrophages 
and PMN to ingest and kill C. albicans blastoconidia. The constitution of the exudate 
peritoneal cell populations is depicted in table 1.  
 
Table 1. Differential counts of intraperitoneal cell populations (% ± SD). Numbers were obtained 
from 8 mice at each time point in 2 separate experiments.  
 
The average number of macrophages that adhered to the microtiter plates during 2 h of 
incubation at 37 °C, was in agreement with the data previously shown by Brummer and 
colleagues [3]. After 0.5 h of incubation, the amount of cells in the PMN monolayer 
exceeded the maximum adherence percentage of macrophages after 2 h of incubation (Fig. 
2a). A time course conducted to determine PMN adherence showed that incubation for 
more than 30 min. did not substantially increase the number of adherent PMN (data not 
shown).  
Both exudate peritoneal cell populations, PMN and exudate macrophages, were able 
to internalise and kill C. albicans blastoconidia. The capacity of exudate macrophages to 
ingest C. albicans blastoconidia significantly surpassed the ability of PMN (p < 0.005, 
Fig. 2b), whereas PMN showed significantly higher killing percentages compared with 
macrophages (p < 0.05, Fig. 2c). 
To assess whether the established intracellular killing could be explained by decreased 
viability of C. albicans blastoconidia, Candida growth from phagocyte-free wells was 
quantified after 3 h of incubation. The numbers of CFU recovered from wells containing 
C. albicans alone were 150 % increased compared with baseline counts (data not shown). 
Microscopic evaluation of the wells showed no hyphal forms. 
Peritoneal cell population Macrophages PMNs Lymphocytes 
Resident 90 ± 6 1 ± 1 9 ± 5 
Exudate after 4 hours 29 ± 10 65 ± 11 6 ± 3 
Exudate after 72 hours 84 ± 6 5 ± 4 11 ± 4 
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Figure 2. Adherence, phagocytosis and killing of C. albicans blastoconidia by exudate 
peritoneal phagocytes according to the adherent monolayer method.  
 
 
 
(a) Percentage of proteose 
peptone-elicited PMN and 
macrophages, that adhered to 
microtiter plates at 37 °C in 0.5 
h (PMN) or 2 h (macrophages).  
 
 
 
 
 
 
(b) Percentage of Candida 
blastoconidia of the initial 
inoculum that was ingested by 
exudate peritoneal phagocytes 
after 15 min of phagocytosis (# 
p < 0.005).  
 
 
 
 
 
 
(c) Percentage of phagocytized 
Candida blastoconidia that was 
killed by exudate peritoneal 
phagocytes after incubation at 
37 °C for 3 h. Data are 
expressed as mean ± SD of at 
least 8 samples in 1-3 separate 
experiments (* p < 0.05).  
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Discussion 
Our results demonstrate that the process of phagocytosis and intracellular killing can 
independently be assessed by means of the Adherent Monolayer Method. Granulocytes are 
able to kill Candida yeast cells by internalisation and fusion of the phagosome with a 
lysosome within the cytoplasm, or pseudohyphae, and presumably also blastoconidia, by 
attachment and degranulation of the fungicidal content into the immediate 
microenvironment [6,7]. Therefore, it can not be assessed whether the observed killing by 
granulocytes in ‘over all killing’ assays is a result of intracellular or extracellular killing 
mechanisms. Furthermore, these assays measure ingestion and intracellular killing 
simultaneously, and apparent differences in "killing" of Candida may actually be due to 
differences in phagocytosis. To prevent a misinterpretation of the killing capacity due to 
these pitfalls, a system with adherent phagocytes is required, so that the supernatant 
containing the uningested yeast cells can be collected, thus assessing phagocytosis and 
intracellular killing independently. 
 
We found that all Candida CFU that appeared to have been killed in the Suspension 
Sampling Method and the Small Tube Method could be recovered as viable organisms 
adhering to the tube, either by repeated washes or by centrifugation. The results obtained 
with C. parapsilosis illustrate that, whereas the killing of various Candida species by 
murine macrophages may differ (this study; [4,10]), the methodological issues of 
adherence or clumping of cells may be similar for different strains. 
Using an assay with adherent cells in tissue culture plates, we have found that resident 
murine peritoneal macrophages are unable to kill ingested C. albicans in vitro. These 
findings are compatible with earlier reports that used adherent resident peritoneal 
macrophages in a microbiological assay [3,10]. However, researchers applying other 
assays have found divergent results [2,17]. 
 
Using the Adherent Monolayer Method, we have demonstrated that exudate peritoneal 
macrophages as well as peritoneal granulocytes were able to ingest and kill C. albicans 
blastoconidia. PMN showed significantly higher killing percentages compared with 
exudate macrophages, which is supported by other studies comparing candidacidal 
functions of phagocytes from different origin [2,10,21]. However, the killing percentages 
per phagocyte population may vary due to the various types of assays, mouse or Candida 
strains, or eliciting agents used. PMN elicited by injection of proteose peptone display 
significantly greater candidacidal activity than those elicited by thioglycollate [1]. Brewer 
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thioglycollate-elicited peritoneal macrophages showed an impaired killing capacity 
compared with other kinds of thioglycollate [12]. 
 
Incubations of phagocyte-free C.albicans suspensions showed that the observed 
killing by adherent peritoneal phagocytes could not be explained by loss of yeast viability. 
Microscopic evaluation of the wells showed no hyphal growth or residual cells after 
repeated well washings. Contaminating macrophages present in the peritoneal exudate 
granulocytes, obtained 4 h after injection of proteose peptone, were not likely to be 
responsible for the observed killing of C.albicans blastoconidia, since resident peritoneal 
macrophages were not able to kill C. albicans blastoconidia. 
Another source of ample confusion is the definition of intracellular killing. Some 
authors express the number of yeast killed as (1 - (CFU after incubation / CFU of Candida 
cultured without cells)) x 100 [14]. By comparing the growth of intracellular C. albicans 
with the growth rate of Candida in the absence of cells, these authors actually describe the 
difference between the intra- and extracellular milieu. Even if the Candida replicates intra 
-and extracellularly, any retardation of the intracellular outgrowth is interpreted as killing, 
as long as the growth rate of the intracellular yeast cells is slower than that of the 
extracellular control. It may be more appropriate to describe this phenomenon as 
inhibition of intracellular outgrowth rather than killing [8]. Thus, the percentage killing of 
C. albicans should be defined as (1 - (CFU after incubation / CFU recovered at the start of 
incubation or numbers of CFU phagocytized)) x 100 [10]. 
 
In conclusion, comparing data from microbiological in vitro studies on the 
phagocytosis and killing of C. albicans blastoconidia by phagocytes is hampered by 
divergent methodologies. The results of some studies may be equivocal, and the reported 
differences may for a large part be due to the various assay conditions and methods that 
have been used in determining phagocyte candidacidal activity. 
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Abstract 
For quantitative assessment of polymorphonuclear granulocyte (PMN)-mediated 
pseudohyphal damage, an improved tetrazolium (2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide; XTT) dye assay was developed. The 
modified assay proved to be a reliable indicator of viable pseudohyphal inoculum sizes. In 
addition, the influence of various endogenous pro-inflammatory cytokines on the capacity 
of PMN to damage C. albicans pseudohyphae was investigated. PMN obtained from mice 
in which the genes encoding for tumour necrosis factor-α /lymphotoxin-α (TNF/LT), 
interferon-γ (IFNγ), interleukin (IL)-1α, or IL-1β were disrupted, showed a significantly 
reduced pseudohyphal damage capacity in comparison with control PMN. The reduction 
amounted 25 % for TNF-/-LT-/-, 11 % for IFNγ-/-, 21 % for IL-1α-/-, and 34 % for IL-1α-/-β-
/- PMN. In contrast, deficiency of IL-12 or IL-18 did not result in a diminished capacity to 
damage pseudohyphae and the capacity of PMN to damage Candida pseudohyphae was 
even slightly increased by 10 % in IL-18-/- mice. These data demonstrate the importance of 
endogenous pro-inflammatory cytokines to antihyphal activity of PMN, the main effector 
cells against disseminated candidiasis by virtue of their capacity to kill both Candida 
blastoconidia and pseudohyphae. 
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Introduction 
Candidiasis is an infectious complication in patients with various immunodeficiencies, 
of which neutropenia is recognized as the most important risk factor. Although the 
incidence of species other than C. albicans as a cause of invasive candidiasis is increasing, 
C. albicans remains the most common causative species [12]. C. albicans is a dimorphic 
yeast growing as blastoconidia or pseudohyphae, and both forms are present within lesions 
[19]. Polymorphonuclear granulocytes (PMN) are the predominant effector cells in host 
defence against both growth forms of C. albicans [2,3,28,31].  
The contribution of PMN to host response against C. albicans is usually assessed by 
determination of the capacity to ingest and kill Candida blastoconidia. Whereas in vitro 
studies have shown that pro-inflammatory cytokines, such as tumour necrosis factor-α 
(TNF) or interferon-γ (IFNγ), enhance PMN anticandidal activity against Candida 
blastoconidia [7,8,21], few data are available regarding the immunomodulatory effect of 
pro-inflammatory cytokines on antihyphal activity of PMN. Moreover, although both C. 
albicans morphologies are found in lesions, the transition from a budding to a filamentous 
form is considered to be a virulence factor [17,22]. Therefore, further characterization of 
PMN-mediated host response against C. albicans warrants investigation of extracellular 
antihyphal activity of PMN in addition to determination of their intracellular capacity to 
kill phagocytized Candida blastoconidia.  
The viability of pseudohyphae can be assessed using a colorimetric dye assay, which 
is based on the conversion of 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide (XTT) to an orange water-soluble formazan by fungal mitochondrial 
dehydrogenases in the presence of an electron-acceptor. This previously described 
tetrazolium dye assay [9,10,20] was further optimized to study the influence of 
endogenous pro-inflammatory cytokines on C. albicans antihyphal activity of PMN 
lacking the genes encoding for TNF/Lymphotoxin-α (LT), IFNγ, interleukin (IL) -12, IL-
18, IL-1α, or IL-1β. 
 
Materials and methods 
Animals 
TNF-/-LT-/- mice on a mixed 129/sv-C57BL/6 background in which the genes 
encoding for TNF-α and LT-α were replaced by a neo cassette (pMCI NeopA, Stratagene) 
and their wild-type littermates were used [1]. The DNA fragment encoding for IL-1α in 
C57Bl/6 mice was replaced by the lacZ-pA-PGK-hph-pH cassette in IL-1α-deficient (IL-
1α-/-) and IL-1α/β double deficient (IL-1α-/-β-/-) mice, and the genes encoding for IL-1β 
were replaced by the lacZ-pA-PGK-neo-pH cassette in IL-1β-deficient (IL-1β-/-) and IL-
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1α-/-β-/- mice. The IL-1-deficient mice were kindly provided by Dr. Y. Iwakura (Tokyo, 
Japan) [11]. Homozygous IL-18-deficient (IL-18-/-) mice were generated by disruption of 
the IL-18 gene and the insertion of the MC-1-neo poly(A) gene, and these mice were 
kindly provided by Dr. S. Akira (Osaka, Japan) [25]. IL-12-deficient (IL-12 p40-/-) 
chimeric mice on a C57Bl/6 background in which the IL-12 p40 gene was replaced by the 
insertion of the PGK-neo gene [18], and IFN-γ-deficient (IFNγ-/-, B6.129S7-Ifngtm1Ts) 
were purchased from Jackson Laboratory (Bar Harbor, ME). C57Bl/6 mice were used as 
control mice for the IL-1, IL-18, IL-12 p40 and IFN-γ-deficient animals. All deficient and 
control mice were age-matched and were allowed to accustom to laboratory conditions for 
one week before experimental use at the Central Animal Laboratory and the Laboratory 
for Experimental Rheumatology of the Nijmegen University. The animals were housed 
under specific pathogen-free conditions and were fed standard laboratory food (Hope 
Farms, Woerden, the Netherlands), and water ad libitum. The ethics committee on animal 
experiments of the Catholic University Nijmegen had approved the experiments. 
 
Candida albicans 
C. albicans (strain UC820) was inoculated into 100 ml of Sabouraud broth and 
cultured for 24 h at 37°C. After three washes with pyrogen-free saline by centrifugation at 
1500 x g, the number of yeast cells was counted in a haemocytometer; occasional strings 
of two or more yeast were counted as one cfu of C. albicans. Pyrogen-free saline was used 
to dilute the suspension to the appropriate concentration. The viability of the yeast was at 
least 98 %, as determined by plating serial dilutions on Sabouraud dextrose agar plates. 
 
Assessment of PMN-mediated pseudohyphal damage 
Exudate peritoneal PMN from mice were elicited by an i.p. injection of 10 % proteose 
peptone, as described earlier [13]. PMN were collected in sterile tubes by washing the 
peritoneal cavity with 4ml ice-cold PBS containing 50 U/ml heparin, 4h after injection of 
proteose peptone. The cells were centrifuged (2250 x g), counted in a Bürker counting 
chamber, and resuspended in RPMI 1640 without phenol red and L-glutamine (RPMI-wp; 
ICN Biomedicals, Eschwege, Germany). The percentage of PMN was determined in 
Giemsa-stained cytospin preparations. 
PMN-mediated damage of Candida pseudohyphae was determined by a modification 
of the XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide; 
Sigma Chemical, St. Louis, MO) dye assay, as described elsewhere [30]. Candida 
blastoconidia grown on Sabouraud agar plates were collected with a swab and suspended 
at a final concentration of 1 x 106 cfu/ml in RPMI 1640 Dutch modification (with 20mM 
Hepes, without glutamine; ICN Biomedicals). The pH of the suspension was adjusted to 
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6.4 using hydrochloric acid. Pseudohyphae were obtained by incubating 10 ml of the 
suspension at 37ºC for 24h. After incubation, the pseudohyphae were centrifuged (550 x 
g) and resuspended in RPMI-wp. 160 µl aliquots containing a pseudohyphal inoculum size 
that originated from 1 x 105 blastoconidia (henceforth referred to as 1 x 105 
pseudohyphae) were then dispensed into a 24-well flat bottom plate (Costar, Corning, the 
Netherlands). 200 µl aliquots of the PMN suspension (8 x 105 PMN) were added to the 
wells containing pseudohyphae at a final E:T ratio of 8:1, in the presence of 10 % fresh 
serum (40 µl) obtained from the corresponding control mice. Control wells contained 
pseudohyphae or PMN only. After incubation for 2h, 800 µl of sterile distilled H20 was 
added to the wells and the plate was rocked at room temperature to achieve lysis of PMN. 
After 15 min., 800 µl sterile saline containing XTT, and the electron-coupling agent 
coenzyme Q0 (2,3-dimethoxy-5-methyl-1,4-benzoquinone; Sigma) were added to each 
well at a final concentration of 400 µg/ml XTT and 50 µg/ml coenzyme Q0. After 1h of 
incubation at 37ºC, the plate was centrifuged (770 x g) to deposit cells and cellular debris, 
and 150 µl of the supernatant of each well was transferred to a well of a 96-well microtiter 
plate. The absorbance of each well was measured in a spectrophotometer at 450 nm. The 
percentage of pseudohyphal damage was defined as 1– ((A450 hyphae + PMN – A450 
PMN) / A450 hyphae) x 100.  
 
Statistical analysis 
The differences between 2 groups were analyzed by the Mann-Whitney U test. For 
these comparisons the level of significance was set at p < 0.05. For comparison of 3 or 
more groups, the data were analyzed using the Kruskal-Wallis one-way ANOVA. For 
post-test comparisons, the Bonferroni t method was used. To ascertain reproducibility, the 
experiments were performed at least twice, and the data represent the cumulative results of 
all experiments performed. 
 
Results 
Modification of the tetrazolium dye assay 
In initial experiments in our laboratory using the tetrazolium dye assay, as described 
by Gaviria et al [9,10], or Meshulam et al [20], variability in assay outcome was observed. 
Several circumstances appeared to contribute to the observed variability. First, 
microscopic evaluation showed that pseudohyphae did not firmly attach to the bottom of 
the wells and could easily be removed during well washes, despite cautious aspiration of 
the supernatant. In order to obtain a better correlation between the number of undamaged 
pseudohyphae and amount of formazan products, the subsequent experimental steps were 
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performed without supernatant aspirations, thus excluding experimental bias due to hyphal 
loss. Second, it appeared that organic material (cells or cellular debris) interfered with 
accurate assessment of absorbance. Hence, prior to the transfer of well aliquots into 
corresponding wells of microtiter plates, the plates containing the cultures had to be 
centrifuged to spin down cells. In addition, since in our assay the plates were not rocked, 
centrifugation guaranteed homogenous distribution of formazan products throughout the 
supernatant, instead of mainly concentrating around hyphae at the bottom of the wells 
when centrifugation was not performed, as was observed macroscopically. Third, since the 
XTT conversion is not terminated during the course of the experiment, outcome variability 
was observed due to small variations in incubation time of the wells. Therefore, the 
addition, removal or transfer of well contents was performed according to a strict time 
schedule per well. After having obviated the aforementioned experimental biases, the 
assay described in the section materials and methods was tested for its ability to reliably 
indicate pseudohyphal inoculum size. To this purpose, it was assessed whether a linear 
relationship existed between increasing inoculum sizes of pseudohyphae that were 
exposed to 400 µg/ml XTT with 50 µg/ml coenzyme Q and the extinction. Indeed, the 
linearity of the relationship between formazan production with increasing amounts of 
pseudohyphae showed that the XTT assay was a reliable indicator of pseudohyphal 
inoculum size (Fig.1). 
Figure 1. Relationship between the amount of formazan produced by increasing 
pseudohyphal inoculum sizes and the absorbance of light with a wavelength of 450 nm. The 
reduction of 400 µg/ml XTT in the presence of 50 µg/ml coenzyme Q by different inoculum sizes 
was measured in duplicate. Symbols represent the means. Linear regression was used to generate 
the regression lines of which the dotted lines delineate the 95% confidence intervals. 
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PMN-mediated pseudohyphal damage 
The influence of endogenous pro-inflammatory cytokines on C. albicans antihyphal 
activity of PMN lacking the genes encoding for TNF/LT, IFNγ, IL-12, IL-18, IL-1α, or 
IL-1β, was studied. 
The relative capacity of PMN from TNF-/-LT-/- mice to damage of C. albicans 
pseudohyphae was significantly reduced by 25% compared to that of PMN from 
TNF+/+LT+/+ mice (Fig. 2; p < 0. 001). Likewise, IFNγ-/- PMN had a significantly impaired 
capacity to damage pseudohyphae relative to that of IFNγ+/+ PMN (Fig 2; p < 0.005).  
Figure 2. Extracellular pseudohyphal damage of TNF-/-LT-/- and IFNγ-/- PMN relative to control 
PMN. C. albicans pseudohyphae were incubated in the presence of PMN for 2h. Horizontal bars 
indicate the means. Kruskal-Wallis one-way ANOVA,  
a p < 0.001 vs. TNF+/+LT+/+ PMN 
b p < 0.005 vs. IFN+/+ PMN. 
 
Analogous to TNF and IFNγ, IL-1α is important for extracellular damage of Candida 
pseudohyphae, as was shown by the significantly reduced capacity to damage 
pseudohyphae of PMN from IL-1α-/- mice or IL-1α-/-β-/- mice compared to that of PMN 
from IL-1α+/+β+/+ mice (Fig. 3; p < 0.001). Deficiency of both IL-1β and IL-α showed a 
tendency to further impair PMN antipseudohyphal resistance compared to IL-1α 
deficiency alone. Deficiency of IL-1β alone did not diminish the capacity of PMN to 
damage C. albicans pseudohyphae. 
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Figure 3. Extracellular 
pseudohyphal damage of 
IL-1 deficient PMN 
relative to IL-1α+/+β+/+ 
controls. C. albicans 
pseudohyphae were 
incubated in the presence 
of PMN for 2h. 
Horizontal bars indicate 
the means. Kruskal-Wallis 
one-way ANOVA, a p < 
0.001 vs. IL-1α+/+β+/+ 
PMN. 
 
 
 
 
Disruption of the genes encoding for IL-12 did not significantly affect PMN capacity 
to damage pseudohyphae compared to control PMN (C57Bl/6; Fig. 4; p > 0.05). In 
contrast to the diminished or unaltered PMN-mediated damage of Candida pseudohyphae 
in absence of the other pro-inflammatory cytokines tested, lack of endogenous IL-18 
slightly but significantly increased the capacity to damage pseudohyphae compared to 
control PMN (C57Bl/6; Fig. 4; p < 0.01). 
 
 
 
Figure 4. Extracellular pseudohyphal 
damage of IL-12 p40-/- and IL-18-/- 
PMN relative to C57Bl/6 controls. C. 
albicans pseudohyphae were incubated 
in the presence of PMN for 2h. 
Horizontal bars indicate the means. 
Kruskal-Wallis one-way ANOVA 
a p < 0.01 vs. C57Bl/6 PMN. 
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Discussion 
Our experiments have further defined conditions for reproducible quantification of 
PMN-mediated damage of Candida pseudohyphae. The findings in the present study 
indicate that the modified tetrazolium dye assay is a reliable indicator of pseudohyphal 
inoculum size, and this is the first study to investigate the influence of several endogenous 
pro-inflammatory cytokines on anticandidal PMN activity against C. albicans 
pseudohyphae. It was shown that PMN-mediated damage of Candida pseudohyphae, the 
predominating growth form in invasive lesions of candidiasis, is significantly reduced in 
absence of endogenous TNF/LT, IFNγ, or IL-1α, whereas the PMN-mediated damage 
appeared to be unaltered or even slightly improved in mice deficient for endogenous IL-12 
and IL-18, respectively. 
 
Candida albicans is able to switch between yeast and filamentous growth, a strategy 
that may contribute to its pathogenicity in several ways. Disruption of genes essential for 
hyphal growth locks C. albicans in the yeast form, and these mutants had a reduced 
virulence in a mouse model [14]. Hyphal growth of C. albicans not only enables the 
pathogen to invade tissue cells; it has also been shown to enable it to escape from 
macrophages by piercing their cell membrane, thus avoiding destruction [17,22,29]. In 
addition to effects that are the direct consequence of differences in morphology of 
Candida, antigens and other properties may not be identical in blastoconidia and hyphae. 
Indeed, heat-killed and viable hyphae elicited different immunological responses from 
human monocytes compared with blastoconidia, as indicated by a reduced production of 
IL-12 and the chemokines MIP-1α, MIP-1β, IL-8 and MCP-1 in response to hyphae 
[16,26], which is detrimental to mounting a protective host response against C. albicans. 
PMN are the main effector cells against C. albicans by virtue of their capacity to kill 
Candida cells irrespective of their morphology. Priming of PMN with exogenous TNF or 
IFNγ has been shown to enhance the blastoconidia-induced respiratory burst and 
degranulation of PMN, and to increase PMN candidacidal activity against blastoconidia 
[7,8,13,24]. However, the possible application of immunotherapy requires insight into the 
influence of pro-inflammatory cytokines on PMN-mediated damage of Candida hyphal 
morphologies, in addition to their influence on PMN phagocytosis and intracellular killing 
of blastoconidia which is usually assessed. Hence, we investigated the influence of 
endogenous pro-inflammatory cytokines on C. albicans antihyphal activity of PMN. Our 
present data indicate that lack of endogenous TNF/LT or IFNγ significantly impaired 
PMN-mediated damage of C. albicans hyphae. This is in line with findings showing that 
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PMN pre-treated with exogenous recombinant TNF or IFNγ displayed an augmented 
fungicidal activity against C. albicans hyphae [4,9,23].  
 
Since IL-12 is an important stimulant for the synthesis of IFNγ by lymphocytes and 
NK-cells [18,27], we also assessed the capacity of IL-12p40-/- PMN to damage 
pseudohyphae. However, unlike IFNγ-/- PMN, IL-12p40-/- PMN only showed a tendency 
towards diminished capacity to damage Candida pseudohyphae. Several mechanisms 
might explain this observation. First, this indicates that, in this model, the synthesis of 
IFNγ is not entirely dependent on IL-12.  Second, the direct effect of IL-12 on antihyphal 
activity of PMN appeared to be limited.  
The fact that IL-18 is also known to be a costimulator for IFNγ production [6], and 
that human neutrophils can be activated by IL-18 resulting in increased neutrophil 
granulation and respiratory burst [15], suggests that PMN from IL-18-/- mice might have 
an impaired antihyphal activity. However, unexpectedly, IL-18-/- PMN showed a slightly, 
but significantly increased capacity to damage C. albicans pseudohyphae compared to 
control PMN, although the magnitude of the effect is small and may be irrelevant in vivo. 
The mechanisms through which IL-18 exerted this effect are not clear as yet.  
 
Like deprivation of endogenous IL-18, absence of IL-1β alone did not have a 
detrimental effect on PMN capacity to damage pseudohyphae. In contrast, absence of IL-
1α alone significantly reduced the capacity of PMN to damage Candida pseudohyphae, 
and deprivation of both IL-1 molecules resulted in the strongest reduction. This suggests 
that both IL-1α and IL-1β beneficially influence PMN antihyphal response, with IL-1α 
inducing the strongest effect. The most likely explanation for this observation is the 
difference in amount of IL-1α and IL-1β produced in mice. Approximately 90% of IL-1 
production in mice consists of IL-1α and the remaining 10% of IL-1β (Netea et al, 
unpublished observations). In addition, the stronger effect of IL-1α than IL-1β on PMN 
antihyphal response may also be due to the different affinity of the IL-1R type I and IL-1R 
type II for the IL-1 molecules [5]. In absence of IL-1α, most IL-1β probably binds to the 
IL-1R type II that has a high affinity for IL-1β but lacks a signal transducing cytoplasmic 
domain making it a functionally negative receptor. Subsequently, the resulting small 
amounts of IL-1β that do bind to the IL-1RI may not be enough to induce a positive effect 
on PMN capacity to damage Candida pseudohyphae.  
 
The current study suggests that neutralization of pro-inflammatory cytokines could 
have detrimental effects on host response against C. albicans infection in which PMN play 
an essential role. In view of the expanding anti-inflammatory cytokine strategies in 
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humans, these exploring animal studies offer further insight into the clinical implications 
for the proposed use of these therapeutic options. 
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Abstract 
The effect of endogenous IL-1α and IL-1β on disseminated C. albicans infection was 
investigated in mice deficient in the genes encoding for IL-1α (IL-1α-/-), IL-1β (IL-1β-/-), 
or both IL-1α and IL-1β (IL-1α-/-β-/-). Both IL-1α and IL-1β were involved in the 
anticandidal host defense as shown by the significantly increased susceptibility of IL-1α-/- 
mice (59 % mortality)  and IL-1β-/- mice (62 % mortality) versus control mice (28 % 
mortality; p < 0.05) to disseminated candidiasis. Moreover, mortality was even further 
increased in double-knockout IL-1α-/-β-/ mice (71 %; p < 0.001). Outgrowth of Candida in 
the kidneys was significantly increased in IL-1-deficient mice compared to 
immunocompetent mice. However, the mechanisms of host defense triggered by IL-1α 
and IL-1β differed. IL-1β-/- mice showed a decreased recruitment of granulocytes to the 
site of infection and generation of superoxide production. IL-1α-/- mice had a reduced 
capacity to damage Candida pseudohyphae extracellularly. Protective Th1 responses were 
deficient in both IL-1α-/- and IL-1β-/- mice, as assessed by production of interferon-γ in 
response to heat-killed C. albicans blastoconidia by splenic lymphocytes. In conclusion, 
whereas the modes of action differ, both IL-1α and IL-1β are essential for mounting a 
protective host response against invasive C. albicans infection. 
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Introduction 
Interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) are pro-inflammatory 
cytokines that exert similar biological activities after interaction with the IL-1 type I 
receptor (IL-1RI) and the IL-1R accessory protein [5]. Exogenous recombinant human IL-
1α or IL-1β have been administered in disseminated murine candidiasis and these studies 
have clearly indicated a protective role for IL-1 in disseminated C. albicans infection 
[8,20]. The mechanisms for this beneficial effect have only partly been elucidated. It has 
been excluded that IL-1 has a direct antifungal effect, and the protective effect of IL-1 in 
host defence against C. albicans did not depend on the presence of granulocytes or 
humoral factors, such as acute phase proteins [8,20]. To characterize the role of 
endogenous IL-1α and IL-1β in disseminated candidiasis and to gain further insight into 
the mechanisms through which both IL-1 molecules confer protection against infection 
with C. albicans, mice in which the genes encoding for IL-1α (IL-1α-/-), IL-1β (IL-1β-/-), 
or both (IL-1α-/-β-/-) had been disrupted were used. The IL-1-deficient mice and their 
immunocompetent littermates were subjected to experimental C. albicans infection.  
 
Materials and methods 
Animals 
The DNA fragment encoding for IL-1α was replaced by the lacZ-pA-PGK-hph-pH 
cassette in IL-1α-/- and IL-1α-/-β-/- mice, and the genes encoding for IL-1β were replaced 
by the lacZ-pA-PGK-neo-pH cassette in IL-1β-/- and IL-1α-/-β-/- mice on a C57Bl/6 
background [6]. As control mice for the IL-1-deficient animals, age matched C57Bl/6 
mice were used (IL-1α+/+β+/+ mice). The mice were allowed to accustom to laboratory 
conditions for one week before experimental use. The animals were housed under specific 
pathogen-free conditions and were fed standard laboratory chow (Hope Farms, Woerden, 
the Netherlands) and water ad libitum. The ethics committee on animal experiments of the 
Catholic University Nijmegen had approved the experiments. 
 
Candida albicans 
C. albicans (strains UC820 and ATCC 10261) was inoculated into 100 ml of 
Sabouraud broth and cultured for 24h at 37 °C. After three washes with pyrogen-free 
saline by centrifugation at 1500 x g, the number of yeast cells was counted in a 
haemocytometer; occasional strings of two or more yeast were counted as one cfu of C. 
albicans. Pyrogen-free saline was used to dilute the suspension to the appropriate 
concentration. The viability of the yeast was at least 98 %, as determined by plating serial 
dilutions on Sabouraud dextrose agar plates. 
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Infection model 
Mice received an intravenous injection of 100 µl pyrogen-free PBS containing 1 x 105 
live C. albicans UC820 blastoconidia into the retroorbital plexus. Survival was assessed 
daily for 21 days. For measurement of circulating granulocytes, cytokine concentrations 
and quantification of fungal outgrowth, subgroups of 5 mice were bled from the 
retroorbital plexus on day 1, 3 or 7 of infection, and blood was collected in EDTA tubes. 
The kidneys were removed aseptically, weighed, and homogenized in sterile saline in a 
tissue grinder. Serial dilutions of the homogenates were plated on Sabouraud dextrose agar 
plates, as described elsewhere [8]. After incubation at 37°C for 48h, the numbers of cfu 
were counted and the results were expressed as log cfu per kidneys. For histology, kidneys 
obtained from subgroups of mice were fixed in buffered formaldehyde (4 %). Paraffin-
embedded sections were stained with periodic acid-Schiff, or hematoxylin-eosin, and 
examined microscopically.  
To investigate whether the role of endogenous IL-1α, and IL-1β in a model of 
disseminated candidiasis is mediated by polymorphonuclear neutrophils (PMN), 
subgroups of deficient and wild-type mice were rendered granulocytopenic by 
pretreatment with cyclophosphamide (Bristol-Myers Squibb, Weesp, The Netherlands), as 
described previously [8]. Cyclophosphamide 150 mg/kg was administered s.c. 4 days 
before infection, followed by 100 mg/kg 1 day before infection, as well as on day 2 after 
i.v. injection of 100 µl pyrogen-free PBS containing 1 x 104 viable C. albicans UC820. To 
compensate for the hyperuricemia-induced TNF production in cyclophosphamide treated 
mice, mice received sodium bicarbonate by gastric installation at 100 mg/kg b.i.d. daily, 
starting on day -4 until the end of the experiment [15]. Daily differential counts in 
peripheral blood smears confirmed that granulocytes remained < 100 x 106/L throughout 
the infection (data not shown). Outgrowth of Candida in the kidneys on day 1 or 3 of 
infection was determined as described above 
 
Recruitment 
The recruitment of PMN to the site of infection was determined after injection of 107 
cfu heat-killed C. albicans into the peritoneal cavity of uninfected subgroups of mice. 
Four hours after the injection of the heat-killed yeast, the mice were killed by CO2 
asphyxia and the peritoneal cavities were rinsed with ice-cold PBS containing 50 U/ml 
heparin. After centrifugation of the peritoneal exudate, the cells were counted in a 
haemocytometer, and the percentage of PMN was assessed in Giemsa-stained 
cytocentrifuge preparations. 
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Superoxide production 
Superoxide production was studied in a luminol-enhanced peroxidase-catalyzed 
chemiluminescence assay [9]. Exudate peritoneal PMN of IL-1α-/-, IL-1β-/-, and IL-
1α+/+β+/+ mice were collected 4 h after i.p. injection of 10 % proteose peptone. PMN were 
suspended at 2 x 106 cells/ml HBSS without phenol red (Life Technologies, Paisley, 
Scotland) supplemented with 0.25 % human serum albumin (Behringwerke, Marburg, 
Germany). Cells (2 x 105/well) were incubated in 96-well microtiter plates (Costar) with 
50 µM luminol, 4.5 U/ml horseradish peroxidase (Sigma), and stimulated with Candida 
blastoconidia and phorbol 12-myristate 13-acetate (PMA; 50 ng/ml). Chemiluminescence 
was measured on a Victor2 1420 multilabel counter (Wallac, Turku, Finland) at room 
temperature. Chemiluminescence was expressed as the total amount of superoxide 
produced in 35 min by integrating the area under the curve per PMN. 
 
Phagocytosis and intracellular killing of C. albicans 
Exudate peritoneal phagocytes from groups of five mice were elicited by an i.p. 
injection of 10 % proteose peptone. Phagocytes were collected in sterile tubes by washing 
the peritoneal cavity with 4ml ice-cold PBS containing 50 U/ml heparin 4h (PMN) or 72h 
(macrophages) after injection. The cells were centrifuged (2250 x g), counted in a Bürker 
counting chamber and resuspended in RPMI-dm supplemented with 5 % heat-inactivated 
foetal calf serum.  
The processes of phagocytosis and intracellular killing were studied in an adherent 
monolayer of phagocytes, as described previously [23]. Briefly, phagocytes were allowed 
to adhere for 0.5h (PMN), or 2h (macrophages) before gently washing the monolayers 
with culture medium to remove non-adherent cells. Subsequently, the cells were incubated 
with 1 x 104 cfu C. albicans ATCC 10261, which were opsonized for 45 min at 24 ºC in 
Modified Eagle’s medium (Gibco Life technologies, Paisley, Scotland; MEM), containing 
2,5 % fresh mouse serum (E:T ratio, 40:1). After 15 min, supernatants were aspirated and 
monolayers were gently washed with MEM to remove uningested blastoconidia. The 
supernatant and well washings, containing the non-ingested Candida blastoconidia, were 
combined and plated in serial dilutions on Sabouraud agar plates. The percentage of 
phagocytized blastoconidia was defined as (1 – (number of uningested cfu/cfu at the start 
of incubation)) x 100.  
Killing of C. albicans by PMN was assessed in the same monolayers. After removal 
of the non-phagocytized Candida blastoconidia, 200 µl of culture medium, consisting of 
Sabouraud in MEM (50 % v/v), was added to the monolayers. After 3h of incubation at 37 
°C and 5 % CO2, the wells were gently scraped with a plastic paddle and washed with 200 
µl distilled H2O to achieve lysis of PMN. This procedure was repeated to a final volume of 
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1ml. Microscopic examination of the culture plates showed that there was a complete 
removal of phagocytes. The number viable intracellular Candida blastoconidia was 
quantified as described above. The percentage of yeast killed by the phagocytes was 
determined as follows: (1 – (cfu after incubation/ number of phagocytized cfu)) x 100. 
Phagocyte-free incubations of blastoconidia were included as a control for yeast viability. 
 
Assessment of PMN-mediated pseudohyphal damage 
The PMN-mediated damage of Candida pseudohyphae was determined by a 
modification of the XTT dye assay, as described previously [22]. Candida blastoconidia 
(strain UC820) grown on Sabouraud agar plates were collected with a swab and suspended 
at a final concentration of 1 x106 cfu/ml in RPMI 1640 Dutch modification (with 20mM 
Hepes, without glutamine, ICN Biomedicals GmbH, Eschwege, Germany) supplemented 
with 1 % gentamicin, 1 % L-glutamine and 1 % pyruvate, henceforth to be called RPMI-
dm. The pH of the suspension was adjusted to 6.4 using hydrochloric acid. Pseudohyphae 
were obtained by incubating 10 ml of the suspension at 37 ºC for 24h. After incubation, 
the pseudohyphae were centrifuged (550 x g) and resuspended in RPMI 1640 without 
phenol red and L-glutamine (RPMI-wp; ICN Biomedicals, Eschwege, Germany). 200µl 
aliquots of a suspension containing 1 x 105 pseudohyphae were dispensed into a 24-well 
flat bottom plate (Costar, Corning, the Netherlands). PMN were elicited by an i.p. 
injection of 10 % proteose peptone. After 4h, cells were collected and resuspended in 200 
µl RPMI-wp, and added to the wells containing pseudohyphae at a final E:T ratio of 8:1, 
in the presence of 10 % fresh IL-1α+/+β+/+ serum. Control wells contained pseudohyphae 
or PMN only. After incubation for 2h, 800 µl of sterile H20 was added to the wells and the 
plate was rocked at room temperature to achieve lysis of PMN. After 15 min., 800 µl 
sterile saline containing XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide; Sigma Chemical, St. Louis, MO) and coenzyme Q0 (2,3-dimethoxy-5-
methyl-1,4-benzoquinone; Sigma) was added to each well at a final concentration of 400 
µg/ml XTT and 50 µg/ml coenzyme Q0. After 1h of incubation at 37 ºC, the plate was 
centrifuged (770 x g) and 150 µl of the supernatant of each well was transferred to a well 
of a 96-well microtiter plate. The absorbance of each well was measured in a 
spectrophotometer at 450 nm. The percentage of fungal damage was defined as 1– ((A450 
hyphae + PMN – A450 PMN) / A450 hyphae) x 100. 
 
Stimulation of peritoneal macrophages 
Resident peritoneal macrophages were obtained by rinsing the peritoneal cavity 
aseptically with ice-cold PBS containing 50 U/ml heparin. After centrifugation for 10 min, 
1800 rpm, at 4ºC, the cells were resuspended in RPMI-dm and 105 cells/well were added 
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to round bottom 96-wells microtiter plate (Costar Corporation, Cambridge, MA). The cells 
were stimulated with heat-killed C.albicans (UC 820) blastoconidia (107) or 
pseudohyphae (106). The supernatants were collected after 24 h of incubation and stored at 
-80 ºC until cytokine determination. For measurement of cell-associated IL-1α, 200 µl 
RPMI 1640 was added to the remaining macrophages that were subsequently disrupted by 
three freeze-thaw cycles. The cell lysates were stored at -80 ºC until assay. 
 
Stimulation of splenic lymphocytes 
Spleens were removed 14 days after an i.v. injection of 1 x 104 C. albicans. Spleen 
cells were obtained by gently squeezing spleens in a sterile 200 µm filter chamber. 
Microscopic examination of Giemsa stained cytospin preparations showed that 
splenocytes consisted for 95 % of lymphocytes, 2 % monocytes and 3 % granulocytes. 
Splenocytes were washed and resuspended in RPMI-dm, counted in a Bürker counting 
chamber, and the number was adjusted to 5 x 106/ml. 1 ml of the cell suspension was 
stimulated with 1 x 107 heat-killed Candida albicans UC820 blastoconidia (E:T ratio, 
2:1). Measurement of IFNγ and IL-10 concentrations was performed in supernatants 
collected after 48h of incubation at 37 °C in 5 % CO2 in 24-well plates (Greiner, Alphen 
a/d Rijn, The Netherlands).  
 
Cytokine assays 
The concentrations of TNFα were determined using specific radioimmunoassays as 
described previously [14]. The detection limit was 40 pg/ml for TNFα, and 20 pg/ml for 
IL-1α and IL-1β. IL-10, IFNγ and IL-6 concentrations were determined by a commercially 
available ELISA kit (Biosource, Europe), according to the guidelines of the manufacturer. 
The detection limits were 8, 15.6, or 150 pg/ml, respectively. Murine KC, macrophage 
inhibitory protein (MIP)-2, and monocyte chemotactic protein-1 (MCP-1) concentrations 
were measured by commercial ELISA kits, according to the instructions of the 
manufacturer (R&D Systems). 
 
Statistical analysis  
Values were expressed as means ± standard deviation (sd) or, in case of logarithmic 
data, as means and the 95 % confidence intervals. Since 3 groups or more were compared, 
the data were analyzed using the Kruskal-Wallis one-way ANOVA. For post-test 
comparisons, the Bonferroni t method was applied. The data represent the average results 
of all experiments performed. 
 
IL-1 in disseminated candidiasis 
     
72 
Results 
Disseminated candidiasis in nonneutropenic mice 
Whereas 72 % of the IL-1α+/+β+/+ mice survived the i.v. infection of 1 x 105 cfu C. 
albicans, only 41 % of IL-1α-/-, and 38 % of IL-1β-/- mice did (p < 0.05; Fig. 1). Moreover, 
survival was even further impaired in mice lacking both IL-1α and IL-1β and the 
difference was significant compared with IL-1α+/+β+/+ mice (p < 0.001) or IL-1α-/- mice (p 
< 0.05; Fig. 1). 
 
Figure 1. The survival of IL-1-deficient mice after an i.v. injection of 1 x 105 C. albicans cfu. 
Survival of IL-1α-/- or IL-1β-/- mice was significantly impaired compared with IL-1α+/+β+/+ mice (p 
< 0.05). IL-1α-/-β-/- mice showed a significantly impaired survival compared with IL-1α+/+β+/+ mice 
(p < 0.001), or with IL-1α-/- mice (p < 0.05). The data are the cumulative results of experiments 
performed in quadruplicate for at least 25 mice per group.  
 
Since the kidneys are the main target organs in disseminated candidiasis [7,8], 
outgrowth of C. albicans in the kidneys was determined. Seven days after i.v. injection of 
1 x 105 C. albicans blastoconidia, outgrowth of C. albicans was increased 51-fold in IL-
1α-/- mice (p < 0.01), 3-fold in IL-1β-/- (p > 0.05), and 125-fold in IL-1α-/-β-/- (p<0.001; 
Fig. 2) compared with IL-1α+/+β+/+ mice. At this point in time, the number of Candida cfu 
in the kidneys from IL-1α-/- mice was significantly higher than in those of IL-1β-/- mice (p 
< 0.05; Fig. 2). To determine the difference in outgrowth between IL-1α-/- and IL-1β-/- 
mice on a later point in time during infection, subgroups of IL-1α-/-, IL-1β-/-, or IL-
1α+/+β+/+ mice received an i.v. injection of 5 x 104 C. albicans cfu. On day 14 of infection, 
no difference between the number of Candida cfu recovered from the kidneys of IL-1α-/- 
(6.03 log cfu; 95%CI, 5.50, 6.57) or IL-1β-/- mice (6.10 log cfu; 95%CI, 5.44, 6.77) was 
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observed, and outgrowth in both groups was 10-fold increased compared with IL-1α+/+β+/+ 
mice (4.25 log cfu; 95%CI, 2.54, 5.96; p < 0.05). 
 
 
Figure 2. Outgrowth of C. albicans in the kidneys on day 7 of infection. Data represent the 
cumulative results of two experiments, and are expressed as the mean and 95% confidence interval 
for 5-10 mice per group. a p < 0.001 vs. IL-1α+/+β+/+ mice; b p < 0.01 vs. IL-1β-/- mice; c p < 0.01 
vs. IL-1α+/+β+/+ mice; d p < 0.05 vs. IL-1β-/- mice. 
 
Circulating cytokine concentrations 
Determination of the circulating concentrations of TNFα, IFNγ, IL-10, and IL-6 in 
blood obtained from mice on day 7 of infection revealed no differences between groups. 
All data were around the detection limit (data not shown).  
 
Histopathological examination. 
Seven days after an i.v. injection of 1 x 105 C. albicans blastoconidia, the 
inflammatory lesions in the kidneys of IL-1α+/+β+/+ mice were healing, as evidenced by the 
presence of scar tissue with few PMN and fibroblasts (Fig. 3D). In the kidneys of IL-1β-/- 
and IL-1α-/-β-/- mice, a granulomatous response was observed without the presence of 
yeast cells (Fig. 3B and C). In IL-1α-/- mice however, a large amount of C. albicans 
blastoconidia and pseudohyphae had accumulated in the collecting ducts, surrounded by 
PMN and lymphocytes (Fig. 3A). 
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Figure 3 (for colour printing, see cover). Histopathology of the kidneys after an i.v. injection of 
1 x 105 cfu C. albicans on day 7 of infection (x 400; periodic acid-Schiff stained sections). (A) In 
the collecting duct of IL-1α-/- mice a large number of C. albicans blastoconidia and pseudohyphae 
were observed surrounded by granulocytes and lymphocytes. In the kidney of IL-1β-/- (B), as well 
as in that of IL-1α-/-β-/- mice (C) a granulomatous response with foreign body giant cells was 
observed. (D) The kidneys of IL-1α+/+β+/+ show scar tissue with fibroblasts and granulocytes in 
healing tissue. 
 
Macrophage function and cytokine production. 
Macrophage recruitment was determined by harvesting peritoneal exudate cells 72h 
after an i.p. injection of 107 cfu heat-killed C. albicans. No differences in the numbers of 
macrophages that were recruited into the peritoneal cavity were observed compared with 
control mice (IL-1α+/+β+/+, 1.01 ± 0.12 x 109; IL-1α-/-, 1.10 ± 0.02 x 109; IL-1β-/-, 0.96 ± 
0.19 x 109; IL-1α-/-β-/- 1.18 ± 0.15 x 109). IL-1 neither influenced the capacity of exudate 
peritoneal macrophages to phagocytize C. albicans blastoconidia (IL-1α+/+β+/+, 41 ± 5%; 
IL-1α-/-, 50 ± 4%; IL-1β-/-, 56 ± 3%; IL-1α-/-β-/- 41 ± 16%107 cfu heat-killed C. albicans), 
nor their capacity to damage Candida pseudohyphae (data not shown).  
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IL-1-deficient resident peritoneal macrophages were stimulated in vitro with heat-
killed C. albicans blastoconidia or pseudohyphae. Since stimulation with heat-killed 
blastoconidia or pseudohyphae yielded similar results, the differences between the groups 
were assessed using the cumulative results of both stimuli. IL-1-deficient macrophages 
showed a significantly impaired production of the chemokine KC compared with IL-
1α+/+β+/+ macrophages (p < 0.05; Table 1). The difference in IL-6 production was 
significant for IL-1α-/- or IL-1α-/-β-/- compared with IL-1α+/+β+/+ macrophages (p < 0.05; 
Table 1).  
 
Table 1. In vitro cytokine and chemokine production capacity of resident peritoneal macrophages 
stimulated with heat-killed C. albicans. 
Data are obtained from one experiment and expressed as means ± sd of at least 8 mice per group. 
*p<0.05 v.s. IL-1α+/+β+/+ mice  
 
Stimulation of splenic lymphocytes 
To assess whether IL-1 induces a T helper type 1 (Th1) or a Th2-type immune 
response, 5 x 106 splenic lymphocytes obtained on day 14 of infection from IL-1α+/+β+/+ 
mice and IL-1-deficient mice were stimulated with 1 x 107 heat killed C. albicans cfu in-
vitro. Whereas IL-1α+/+β+/+ lymphocytes produced IFNγ (47.4 ± 30.7 pg/ml), no IFNγ 
production was detected by IL-1-deficient lymphocytes (< 15.6 pg/ml; p < 0.05). Both IL-
1α+/+β+/+ and IL-1α-/- lymphocytes produced IL-10 (respectively, 32.3 ± 8.8 pg/ml and 30.8 
± 12.2 pg/ml), whereas IL-1β-/- as well as IL-1α-/-β-/- lymphocytes did not (< 8 pg/ml; p < 
0.05 vs IL-1α+/+β+/+ or IL-1α-/- lymphocytes). Data are 107 cfu heat-killed C. albicans 
expressed as means ± sd for at least 4 mice per group. 
 
Circulating numbers of PMN and PMN recruitment 
The influence of IL-1 on the circulating numbers of PMN is depicted in table 2. The 
mean numbers of peripheral blood PMN were similar for all groups on day 7 of infection 
(data not shown). The numbers of PMN collected 4 h after an i.p. injection of 107 cfu heat-
killed C. albicans indicate that IL-1β itself is more important for the recruitment of PMN 
Strain  TNFα (ng/ml) IL-6 (pg/ml) MCP-1 (pg/ml) Mip-2 (pg/ml) KC (pg/ml) 
IL-1α+/+β+/+  0.98 ± 0.71 959 ± 466 87 ± 45 2772 ± 2190 1881 ± 830 
IL-1α-/-  0.92 ± 0.39 257 ± 177* 40 ± 1 2605 ± 1550 407 ± 188* 
IL-1β-/-  0.60 ± 0.29 373 ± 242 50 ± 22 2331 ± 1690 203 ± 258* 
IL-1α-/-β-/-  0.85 ± 0.40 195 ± 132*  1485 ± 638 284 ± 276* 
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to the site of infection than IL-1α, and may partly explain the higher numbers of 
circulating PMN observed during the early days of infection in IL-1β-/- and IL-1α-/-β-/- 
mice compared with IL-1α-/- and IL-1α+/+β+/+mice (Table 2). 
 
Table 2. Number of circulating PMN prior to, or on day 3 of an infection with Candida 
blastoconidia (105 i.v.), and recruitment of PMN 4h after injection of heat-killed Candida 
blastoconidia (107 i.p.). The i.p. PMN recruitment is represented as the percentage of the total 
numbers of peritoneal exudate cells, as well as the absolute numbers of PMN. 
Data are obtained from 1 experiment and expressed as means ± sd of at least 3 mice per group.      
ap < 0.005; bp < 0.01 vs. control or IL-1α-/- mice. 
 
Disseminated candidiasis in neutropenic mice 
To assess whether the protective effect of IL-1 is mediated through PMN, mice were 
repeatedly injected with cyclophosphamide to induce a profound and sustained 
granulocytopenia. At all time points tested, the largest quantity of C. albicans was 
recovered from the kidneys of IL-1α-/-β-/- mice, and the difference was significant 
compared with IL-1α+/+β+/+ mice on day 3 of infection (5.23 log cfu; 95%CI, 4.85, 5.60 vs. 
3.64 log cfu; 95%CI, 3.13, 4.14; p < 0.01). Outgrowth in the kidneys of IL-1α-/- mice (4.27 
log cfu; 95%CI, 2.96, 5.58) was similar to that in the kidneys of IL-1 β-/- mice (4.13 log 
cfu; 95%CI, 3.47, 4.78; data are the cumulative results of experiments performed twice for 
at least 6 mice per group).  
 
Anticandidal response of PMN against C. albicans blastoconidia and pseudohyphae 
To further characterize the influence of endogenous IL-1α and IL-1β on the activity of 
PMN against C. albicans, the fungicidal capacity of PMN was determined in vitro against 
both growth forms of C. albicans. Whereas PMN from IL-1α-/- only showed a tendency to 
reduced superoxide production (58.3 ± 15.4 x 103 counts), IL-β-/- PMN produced 
significantly less superoxide than control PMN did (30.6 ± 15.9 x 103 counts vs. 71.5 ± 
10.5 x 103 counts; p < 0.01). However, this observation was not accompanied by an 
altered capacity of IL-1-deficient PMN to phagocytize or kill internalized C. albicans 
  number of circulating PMN (x 109/l)  i.p. PMN recruitment 
Strain  prior to infection day 3 of infection  (%) (x 106) 
IL-1α+/+β+/+  0.89 ± 0.31  0.84 ± 0.71   63 ± 13  5.81 ± 3.26 
IL-1α-/-  0.42 ± 0.10 0.86 ± 0.30   54 ± 6  5.56 ± 1.62 
IL-1β-/-  1.38 ± 0.47 3.20 ± 0.99   37 ± 12a  1.85 ± 0.84b 
IL-1α-/-β-/-  0.67 ± 0.35 2.95 ± 0.52   39 ± 8a  3.21 ± 0.70 
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blastoconidia (data not shown). In contrast, IL-1 modulated the capacity of PMN to 
damage C. albicans pseudohyphae extracellularly (Fig. 4). Pseudohyphal damage by PMN 
from IL-1α-/- or IL-1α-/-β-/- mice was significantly less compared to that by PMN from IL-
1α+/+β+/+ or IL-1β-/- mice (Fig. 4; p < 0.001). Deficiency of both IL-1β and IL-α showed a 
tendency to further impair PMN antipseudohyphal resistance compared to IL-1α 
deficiency alone. Deficiency of IL-1β alone did not diminish the capacity of PMN to 
damage C. albicans pseudohyphae. 
 
Figure 4. Percentage of exudate PMN-mediated pseudohyphal damage. 1 x 105 pseudohyphae 
were incubated in the presence of 8 x 105 PMN for 2h. Data are the cumulative results of two 
separate experiments. Horizontal bars indicate the means. a p < 0.001 vs. IL-1α+/+β+/+ or IL-1β-/- 
mice.  
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Discussion 
The results of the present study indicate that deficiency of endogenous IL-1 has 
deleterious effects on outcome of disseminated C. albicans infection. IL-1-deficient mice 
showed an increased mortality that was associated with an increased outgrowth of C. 
albicans in the kidneys. Presence of IL-1β proved to be important for recruitment of 
granulocytes to the site of infection and generation of superoxide production. IL-1α was 
essential for the capacity of granulocytes to damage Candida pseudohyphae and both IL-
1α and IL-1β were elementary for the induction of protective Th1 responses.  
 
One of the mechanisms through which IL-1 has been suggested to confer protection 
against infection is the enhancement of granulopoiesis and the influx of PMN to the site of 
infection. Although IL-1α-/- mice had 50 % fewer circulating granulocytes compared to 
controls at the time of infection, their number in the circulation on day 3 of infection and 
the recruitment of PMN to the site of infection did not differ from that of control mice. In 
IL-1β-/- mice however, a trend towards an increased number of circulating granulocytes 
during infection was observed and this coincided with a significantly decreased migration 
of PMN to the site of infection. On the one hand, this indicates that both endogenous IL-
1α and IL-1β are, either directly, or indirectly through induction of colony-stimulating 
factors, important for granulopoiesis and this is in keeping with earlier findings showing 
that exogenous administration of IL-1α or IL-1β induced peripheral blood granulocytosis 
[1,13]. On the other hand, although exogenous administration of either IL-1 molecule has 
been reported to induce PMN accumulation [4,18], our data of PMN recruitment in 
response to heat-killed C. albicans suggest an important role for endogenous IL-1β and 
not IL-1α in early PMN influx, an observation that was further corroborated by 
histopathological examination of the kidneys on day 3 of C. albicans infection, revealing 
PMN infiltration in IL-1α-/- mice whereas hardly any PMN were detected in IL-1β-/- mice 
(data not shown). In addition, PMN recruitment in IL-1-deficient mice may be further 
impaired due to decreased production of neutrophil chemoattractants. Therefore, 
production by macrophages of members of the CXC chemokine subfamily, such as MIP-2 
and KC was determined. Only the production of KC by IL-1-deficient macrophages was 
significantly reduced, thus contributing to impaired granulocyte recruitment in IL-1β-/- 
mice. Transcription of the genes encoding for MIP-2 and KC is induced through signals 
mediated by Toll-like receptor 4 [16], and IL-1 has been shown to selectively stabilize KC 
mRNA [17]. Hence, it is hypothesized that the normal production of MIP-2 in contrast to 
the 80 % reduced production of KC by IL-1-deficient macrophages is due to the selective 
effect of IL-1 on KC mRNA. 
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The effect of endogenous IL-1 on PMN function has not been investigated before. The 
results of the present study have indicated that IL-1 affects PMN function and that the 
modes of action differ for IL-1α and IL-1β. Whereas IL-1α-/- PMN showed a decreased 
capacity to damage C. albicans pseudohyphae, IL-1β-/- PMN had an impaired superoxide 
production. In addition, production of IL-6 that has been shown to stimulate PMN 
function [3,19], was diminished in IL-1α-/- mice. The impaired IL-6 production in IL-1α-/- 
mice may thus further diminish PMN function and anticandidal defence.  
To test whether IL-1 exerts its beneficial effect mainly through PMN recruitment and 
function, the differences in outgrowth between the groups as observed in non-
granulocytopenic mice, should disappear in granulocytopenic mice. However, the 
observed differences persisted, indicating that the effect of endogenous IL-1 is at least in 
part mediated through other mechanisms than modulation of PMN recruitment and 
function, which is in line with previous findings [8,20].  
 
Macrophages are effector cells in anticandidal defence as well [2,21]. Although IL-1-
deficient macrophages that were stimulated in vitro with heat-killed C. albicans responded 
with diminished IL-6 and KC production, macrophage recruitment and phagocytosis were 
not altered in IL-1-deficient mice. This is in line with previous research showing normal 
phagocytosis and NO production by IL-1-deficient macrophages [12,25]. However, 
activation of phagocyte functions strongly depends on the presence of the Th1 cytokine, 
interferon-γ [10,24]. Production of interferon-γ was virtually absent in IL-1-deficient 
lymphocytes, indicating that phagocyte activation and subsequent clearance of Candida 
cells will be impaired during infection. In addition, transition of macrophages to 
functionally inactive foreign body giant cells (FBGCs) is favoured in the presence of Th2 
cytokines [11]. Therefore, the FBGCs that were observed in the kidneys of IL-1-deficient 
mice confirm the presence of an anti-inflammatory Th2 response, which is detrimental to 
anticandidal host defence.  
 
In conclusion, the results of the present study further clarified the mechanisms through 
which IL-1 enhances host resistance to disseminated candidiasis. Although a functional 
difference between IL-1α and IL-1β was observed, both IL-1α and IL-1β have been shown 
to be essential to anticandidal host defence. 
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Abstract 
IFN-γ plays a crucial role in the defence against infection with Candida albicans. 
Since IL-18 and IL-12 are strong stimuli of IFN-γ production, we investigated whether 
endogenous IL-18 and IL-12 are involved in the host defence during disseminated 
candidiasis. IL-18 knockout (IL-18-/-) mice, but not IL-12-/- mice, displayed an increased 
mortality due to C. albicans infection, accompanied by a decreased clearance of the yeasts 
from the kidneys late during the course of infection. Histopathology of the organs, 
combined with phagocyte recruitment experiments, showed a decreased influx of 
monocytes at the sites of Candida infection, mainly in the IL-18-/- mice. Whereas 
production of the chemokine KC was decreased in both IL-18-/- and IL-12-/- mice, MIP-2 
production was deficient only in IL-18-/- animals, which may explain the differences in 
phagocyte recruitment. In addition, although IFN-γ production capacity, as a parameter of 
the Th1-protective immunity, was reduced by 65 to 80% in the IL-12-/- mice, this defect 
was even more pronounced in the IL-18-/- mice (85 to 95% downmodulation). In 
conclusion, the anticandidal effects of endogenous IL-18 are mediated late during the 
infection by assuring a proper IFN-γ response and promoting the infiltration of the site of 
infection by monocytes.  
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Introduction 
Acute disseminated candidiasis is a life-threatening disease which occurs 
predominantly in immunocompromized patients. Despite development of new antifungal 
drugs, mortality associated with disseminated candidiasis remains high [2], and additional 
therapies directed towards the augmentation of host defence mechanisms would be a 
rational approach. A better understanding of the mechanisms responsible for the defence 
against an invasive Candida infection is therefore needed, in order to develop strategies 
aimed to enforce the anticandidal actions of the immune system. 
Candida albicans or mannoproteins derived from the yeast cell wall induce IFN-γ 
production by human mononuclear cells, and IFN-γ is a key cytokine for defence to 
candidiasis [15]. In vitro studies have demonstrated stimulatory effects of IFN-γ on the 
phagocytosis and killing of C. albicans by neutrophils and macrophages [5,22], whereas 
the central role of endogenous IFN-γ in the resistance against systemic candidiasis has 
been demonstrated in knock-out mice deficient in IFN-γ which are highly susceptible to C. 
albicans infection [1,18]. Moreover, administration of recombinant IFN-γ to wild-type 
mice infected with C. albicans improves the outcome of the infection [15]. 
Interleukin-18 (IL-18) and IL-12 are costimuli for IFN-γ production in the context of 
microbial stimulation [29,31]. When endogenous IL-18 is neutralized by administration of 
antibodies to IL-18 [7], there is little, if any, IFN-γ production after challenge with 
endotoxin. We have recently demonstrated that both endogenous IL-18 and IL-12 are 
involved in the production of IFN-γ production in human whole blood stimulated with C. 
albicans [28]. Administration of recombinant IL-18 restores anti-candidal defence in 
caspase-1-deficient mice, and challenge with IL-12 may have either protective or 
deleterious effects during systemic candidiasis [18]. It is therefore apparent that IL-18 and 
IL-12 are important for the modulation of the host defence against disseminated 
candidiasis, but a clear characterization of their respective effects is still missing. 
The aim of the present study was to investigate whether endogenous IL-18 and IL-12 
are involved in host defence against Candida infection. We have assessed susceptibility to 
a systemic C. albicans infection in IL-18 knockout (IL-18-/-) and IL-12-/- mice, and 
investigated the defence mechanisms responsible for the anti-Candida defence in these 
mice. 
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Materials and methods 
Animals  
Homozygous IL-18-/- mice on a C57BL/6 background were a kind gift from Dr. S. 
Akira (Osaka, Japan) [33]. The IL-18-/- knockout mice were initial on a C57BL/6J×Sv129 
background, and they were backcrossed for six generations into a C57BL/6J background. 
Homozygous IL-12-/- mice on a C57BL/6 background were obtained from Jackson Labs 
[21]. Specific pathogen-free knockout mice and age and weight-matched C57BL/6 control 
mice (20-25 g, 6 to 8 weeks old) were used. Mice were fed sterilized laboratory chow 
(Hope Farms, Woerden, The Netherlands) and water ad libitum. 
 
Candida albicans infection model  
C. albicans UC 820, a clinical isolate well-described earlier [19] has been used in all 
experiments. Mice were injected intravenously with C. albicans (between 1 and 5 x 105 
colony forming units (CFU)/mouse) in a 100-µl volume of sterile pyrogen-free phosphate-
buffered saline (PBS), as indicated. Survival was assessed daily for 30 days in groups of at 
least 20 animals per group. At the end of the observation period, the surviving mice were 
anesthetized with ether and killed by cervical dislocation. In addition, subgroups of 5 
animals were killed on days 1, 3, 7 or 14 of infection, and blood was collected on EDTA 
for plasma cytokine concentration measurements. To assess the outgrowth of the micro-
organisms, the liver, spleen and left kidneys of the sacrificed animals were removed 
aseptically, weighed, and homogenized in sterile saline in a tissue grinder. The number of 
viable Candida cells in the tissues was determined by plating serial dilutions on 
Sabouraud dextrose agar plates as previously described [16]. The CFU were counted after 
24 h of incubation at 37°C, and expressed as log CFU/g tissue. From the same animals, the 
right kidneys were fixed in formalin (4%), embedded in paraffin, and serial sections were 
examined microscopically after staining with a combination of periodic acid Schiff (PAS) 
and hematoxylin-eosin (HE). 
 
Cytokine production capacity  
Uninfected IL-18-/-, IL-12-/- mice and wild-type controls were killed and resident 
peritoneal macrophages were harvested by injecting 4 ml of sterile PBS containing 0.38% 
sodium citrate [15]. After centrifugation and washing, the cells were resuspended in RPMI 
1640 containing 1 mM pyruvate, 2 mM L-glutamine, 100 µg/ml gentamicin and 2% fresh 
mouse plasma (culture medium). Cells were cultured in 96-well microtiter plates (Costar, 
Corning, The Netherlands) at 105 cells/well, in a final volume of 200 µl. The cells were 
stimulated with heat-killed (1 h, 100°C) C. albicans, either blastospores or hyphae, at a 
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concentration of 107 micro-organisms/ml. After 24 h of incubation at 37°C, the plates 
were centrifuged (500 x g, 10 min), and the supernatant was collected and stored at -80°C 
until cytokine assays were performed. 
For the assessment of IFN-γ and IL-10 production capacity, splenic lymphocytes were 
stimulated in vitro with heat-killed Candida. Spleen cells were obtained by gently 
squeezing spleens in a sterile 200-µm filter chamber. Microscopic examination of Giemsa 
stained cytospin preparations showed that these cells consisted for 95 % of lymphocytes, 2 
% monocytes and 3 % granulocytes. The cells were washed and resuspended in RPMI-dm, 
counted in a Bürker counting chamber, and the number was adjusted to 5 x 106/ml. 1 ml of 
the cell suspension was stimulated with 1 x 107 heat-killed C. albicans UC820 
blastoconidia (E:T ratio, 2:1). Measurement of IFN-γ and IL-10 concentrations was 
performed in supernatants collected after 48 h of incubation at 37°C in 5 % CO2 in 24-
well plates (Greiner, Alphen a/d Rijn, The Netherlands). 
In an additional experiment we have assessed the local cytokine levels in the kidneys 
of the infected mice by homogenization of the organs in 3 ml of sterile PBS. TNF, IFN-γ, 
IL-1β andIL-6 concentrations in the homogenates were measured as described below. 
 
Cytokine assays 
IL-1α, IL-1β and TNF-α were determined by specific radioimmunoassays (detection 
limit 20 pg/ml), as previously described [25]. IFN-γ concentrations were measured by a 
commercial ELISA (Biosource, Camarillo, CA; detection limit 16 pg/ml), according to the 
instructions of the manufacturer. MIP-2 and KC concentrations were measured by a 
commercial ELISA (R&D Systems, Abingdon, GB; detection limit 24 pg/ml), according 
to the instructions of the manufacturer. 
 
Extracellular killing of C. albicans hyphae by neutrophils (PMN)  
The PMN-mediated damage of Candida hyphae was determined by a modification of 
the XTT dye assay, which was previously described by Gaviria et al. [9]. Candida 
blastoconidia (strain UC820) grown on Sabouraud agar plates were collected with a swab 
and suspended at a final concentration of 1 x 106 cfu/ml in RPMI 1640 Dutch modification 
(with 20 mM Hepes, without glutamine, ICN Biomedicals, Eschwege, Germany) 
supplemented with 1 % gentamicin, 1 % L-glutamine and 1 % pyruvate. The pH of the 
suspension was adjusted to 6.4 using hydrochloric acid. Hyphae were obtained by 
incubating 10 ml of the suspension at 37°C for 24 h. After incubation, the hyphae were 
centrifuged (1800 rpm, 10 min) and resuspended in RPMI 1640 without phenol red and L-
glutamine (RPMI-wp; ICN). Aliquots (160 µl) of a suspension containing 1 x 105 hyphae 
were dispensed into a 24-well flat-bottom plate (Costar). PMN were elicited by an i.p. 
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injection of 10 % proteose peptone. After 4 h, cells were collected and resuspended in 
RPMI, the number of PMN was determined in Giemsa stained cytospin preparations and 8 
x 105 PMN (200 µl) were added to the wells containing hyphae at a final E:T ratio of 8:1, 
in the presence of 10 % fresh mouse serum. Control wells contained either hyphae or 
PMN only. After incubation for 2 h, 800 µl of sterile H2O was added to the wells and the 
plate was rocked at room temperature to achieve lysis of PMN. After 15 min., 800 µl 
sterile saline-solution containing XTT [2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide; Sigma Chemical, St. Louis, MO] and coenzyme Q0 (2,3-
dimethoxy-5-methyl-1,4-benzoquinone; Sigma) were added to each well at a final 
concentration of 400 µg/ml XTT and 50 µg/ml coenzyme Q0. After 1 h of incubation at 
37°C, the plate was centrifuged (1800 rpm, 10 min) and 150 µl of the supernatant of each 
well was transferred to a well of a 96-well microtiter plate. The absorbance of each well 
was measured in a spectrophotometer at 450 nm. The percentage of fungal damage was 
defined as [1-((A450 hyphae + PMN - A450 PMN)/E450 hyphae)] x 100. 
 
Phagocytosis and intracellular killing of C. albicans blastoconidia by PMN and 
macrophages  
Exudate peritoneal macrophages from groups of five control, IL-12-/- and IL-18-/- mice 
were elicited by an i.p. injection of 10 % proteose peptone. Phagocytes were collected in 
sterile tubes by washing the peritoneal cavity with 4 ml ice-cold PBS containing 50 U/ml 
heparin 72 h after injection. The cells were centrifuged (10 min; 3600 rpm; 2250 x g), 
counted in a Bürker counting chamber and resuspended in RPMI supplemented with 5 % 
heat-inactivated foetal calf serum. 
The processes of phagocytosis and intracellular killing were studied in an adherent 
monolayer of phagocytes, as described [34]. To create a monolayer of macrophages, 5 x 
105 cells in 100 µl of RPMI-dm were dispensed into the wells of a 96-well flat-bottom 
plate (Costar) and incubated at 37°C and 5 % CO2. Macrophages were allowed to adhere 
or 2 h before gently washing the monolayers with culture medium to remove nonadherent 
cells. The percentage of adherence was calculated as [1-(number of nonadherent 
cells/5×105)] x 100. Subsequently, the cells were incubated with 1 x 104 CFU C. albicans, 
which were opsonised with 2.5 % fresh mouse serum (E:T ratio, 40:1) in modified Eagle's 
medium (Gibco Life technologies, Paisley, Scotland; MEM), for 45 min at 24 °C. After 
15-min incubation, supernatants were aspirated and monolayers were gently washed with 
MEM to remove uningested blastoconidia. The supernatant and well washings, containing 
the non-ingested Candida blastoconidia, were combined and plated in serial dilutions on 
Sabouraud agar plates. The percentage of phagocytized blastoconidia was defined as [1-
(number of uningested CFU/CFU at the start of incubation)] x 100. 
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Killing of C. albicans by macrophages was assessed in the same monolayers. After 
removal of the non-phagocytized Candida blastoconidia, 200 µl of culture medium, 
consisting of Sabouraud in MEM (50 % v/v), was added to the monolayers. After 4 h of 
incubation at 37°C and 5 % CO2, the wells were gently scraped with a plastic paddle and 
washed with 200 µl distilled H2O to achieve lysis of macrophages. This procedure was 
repeated three times, after which the pooled washes were adjusted to a final volume of 
1 ml with distilled water. Microscopic examination of the culture plates showed that there 
was a complete removal of phagocytes. To quantify the number of viable intracellular 
Candida blastoconidia, tenfold dilutions of each sample were spread on Sabouraud agar 
plates and incubated at 37°C for 24 h. The percentage of yeast killed by the macrophages 
was determined as follows: [1-(CFU after incubation/number of phagocytized CFU)] x 
100. Macrophage-free incubations of blastoconidia were included as a control for yeast 
viability. 
 
Superoxide production 
PMN from IL-18-/-, IL-12-/- and control mice were collected 4 h after intraperitoneal 
injection of proteose peptone as described above. Luminol-enhanced chemiluminescence 
of proteose-peptone-elicited PMN was measured on a Victor 1420 multilabel counter 
(Wallac, Turku, Finland) at 20°C using white 96-well microplates (Costar Corporation, 
Cambridge, MA), as previously described [20]. Each well contained 2 x 105 cells, 50 µM 
luminol, 4.5 U/ml horseradish peroxidase (HRP) and 50 ng/ml phorbol 12-myristate 13-
acetate (PMA) in 200 µl of Hank's balanced salt solution without phenol red (Gibco Life 
Technologies) supplemented with 0.25 % human albumin (Behringwerke, Marburg, 
Germany). Reactions were started by adding PMA. Each experiment was performed in 
duplicate. HRP was added to the system in order to overcome peroxidase deficiency 
extracellularly. In previous experiments we found that the addition of extra peroxidase did 
not affect superoxide production (measured as reduction of cytochrome c) of human 
neutrophils stimulated with PMA, but increased luminol-enhanced chemiluminescence 
three- to fourfold. Hence, solely the detection of superoxide is enhanced in the presence of 
extra peroxidase. The chemiluminescence was expressed as the total amount of superoxide 
produced during the assay period by integrating the area under the curve (in mV.s) per 
PMN. 
 
NO production  
Resident peritoneal macrophages were collected as described above. Cells were 
counted and adjusted to 5 x 106/ml, and stimulated with heat-killed C. albicans (107 micro-
organisms/ml) and IFN-γ (100 U/ml) for 24 h at 37°C. Nitrite concentration in the 
IL-12 and IL-18 in disseminated candidiasis 
     
90 
supernatants of cells from IL-18-/-, IL-12-/- and control mice was determined by the Griess 
reaction [4]. 
 
Recruitment of neutrophils and monocytes  
To investigate the recruitment of PMN and monocytes at the site of Candida infection, 
groups of 5 IL-18-/-, IL-12-/- mice and wild-type controls were injected intraperitoneally 
with 107 heat-killed C. albicans micro-organism. At 0 h (before Candida) and after 4 h 
(for neutrophils) and 72 h (for monocytes), peritoneal cells were collected in sterile saline 
containing 0.38 % sodium citrate, and the total cell number was counted in a 
hemacytometer. The percentage and the absolute numbers of neutrophils and monocytes 
were determined in Giemsa-stained cytocentrifuge preparations. 
 
Statistical analysis  
The differences between groups were analyzed by Mann-Whitney U-test, and where 
appropriate by Kruskal-Wallis ANOVA test. Survival curves were analyzed by the 
Kaplan-Meyer log-rank test. The level of significance between groups was set at p<0.05. 
All experiments were performed at least twice, and the data are presented as cumulative 
results of all experiments performed. 
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Results 
Candida albicans infection model 
After an infection with 5 x 105 CFU of C. albicans, 100 % mortality was observed in 
all three groups, and the mean survival time did not differ between control, IL-12-/- and IL-
18-/- mice (not shown). However, when mice were infected with 2.5 x 105 CFU C. 
albicans, a significantly greater mortality was recorded in the IL-18-/- mice (80 %) 
compared with IL-12-/- (50 %) and control (40 %) mice (Fig. 1). In a model of infection of 
the mice with 1 x 105 CFU C. albicans, there was no mortality recorded in either of the 
groups.  
 
 
 
 
Figure 1. Survival of IL-18-/- and IL-12-/- after infection with C. albicans. Control mice (●), IL-18-
/- mice (∆) and IL-12-/- mice (○) were infected i.v. with 2.5 x 105 CFU Candida/mouse, and 
survival was assessed daily. IL-18-/- mice were significantly more susceptible to disseminated 
candidiasis compared with wild-type or IL-12-/- mice (ten mice/group, p < 0.05, log-rank test). 
 
In further experiments, 1 x 105 CFU C. albicans/mouse was used, in order to avoid the 
bias induced by differential mortality at various time points in the three groups. After 
injection, the outgrowth of the yeasts in the kidneys was 2 to 5-fold higher than that in the 
brain, and 100-fold higher than that in the liver, which is in agreement with the notion that 
the kidneys are the target organ for C. albicans outgrowth in murine candidiasis (Fig. 2). 
IL-18-/- mice had an increased load of C. albicans in the kidneys on day 7 and 14, but not 
on day 1 and 3 post-infection, compared to IL-12-/- and control mice (Fig. 2A). In contrast, 
no difference between Candida growth in the brains (Fig. 2B) or livers (not shown) of 
IL12-/-, IL-18-/- and control mice was apparent. Similar results were obtained in duplicate 
experiments with ten mice/group. 
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Figure 2. Growth of C. albicans in the organs. Outgrowth of C. albicans in the kidneys (A) and 
brain (B) of control mice (open bars), IL-12-/- mice (hatched bars) and IL-18-/- mice (dotted bars) 
after i.v. infection with 1 x 105 CFU Candida/mouse. Data represent the mean ± SD for two 
experiments with a total of ten mice/group. Significant differences between wild-type and 
knockout mice are indicated (*p < 0.05). 
 
Histopathology of the kidneys of control mice showed small PMN infiltrates on day 1, 
3 and neutrophil/monocyte infiltrates on day 7 of infection with 1 x 105 CFU Candida, 
with controlled growth of very small numbers of yeasts, without hyphal formation (Fig. 
3). In contrast, the small neutrophil infiltrates present on day 1 and 3 after infection in the 
kidneys of the IL-12-/-, but particularly of IL-18-/- mice, were accompanied by the presence 
of extensive growth of Candida, which in the IL-18-/- mice had formed hyphae and 
pseudohyphae. On day 7, despite the presence of large granulocyte infiltrates of PMN, 
Candida was present in large numbers in the centers of the infiltrates in the kidneys of IL-
12-/- and IL-18-/- mice (Fig. 3). There was relative paucity of monocytes in the infiltrates of 
IL-18-/- mice on day 7, compared with controls.  
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Figure 3 (for coulour printing, see cover). Histopathology of the kidneys in the Candida-
infected mice. In control mice (A), small PMN infiltrates can be seen on day 1 and 
neutrophil/monocyte infiltrates on day 7 after infection, with controlled growth of very small 
numbers of yeasts, without hyphal formation. In contrast, the small neutrophil infiltrates present on 
day 1 after infection in the kidneys of the IL-12-/- (B), but particularly of IL-18-/- mice (C), are 
accompanied by the presence of Candida growth, which had formed hyphae and pseudohyphae. 
On day 7, despite the presence of large granulocyte infiltrates, Candida is present in large numbers 
in the centres of the infiltrates in the kidneys of IL-12-/- and IL-18-/- mice. Periodic acid Schiff 
(PAS) combined with hematoxylin-eosin (HE) staining. Original magnification 800x. 
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Cytokine production capacity 
Resident peritoneal macrophages from control, IL-12-/- and IL-18-/- mice were 
stimulated with 107 heat-killed C. albicans blastoconidia or hyphae in vitro for 24 h. The 
production of TNF by macrophages from the three mouse strains was similar in response 
to Candida stimulation (Fig. 4). IL-1α and KC release after C. albicans stimulation with 
both blastoconidia and hyphae was impaired in both IL-12-/- and IL-18-/- mice (Fig. 4). In 
contrast, MIP-2 production differed: macrophages of IL-18-/-, but not of IL-12-/-, exhibited 
an impaired production of MIP-2 upon stimulation with Candida blastoconidia (Fig. 4). 
Stimulation of MIP-2 by Candida hyphae was similar in the three mouse strains tested. 
 
 
 
 
Figure 4. Cytokine production. Resident peritoneal macrophages from control (open bars), IL-12-/- 
(hatched bars) and IL-18-/- (dotted bars) mice stimulated in vitro with either heat-killed C. albicans 
blastoconidia or hyphae (107 CFU/ml). Data represent the mean ± SD for two experiments (n = 
10/group). *p < 0.05 compared to control mice. 
 
Stimulation of spleen cells with C. albicans blastoconidia resulted in normal IL-10 
release by cells from IL-12-/- mice (115 ± 31 pg/ml) compared to control mice (131 ± 38 
pg/ml), whereas IL-18-/- mice released lower IL-10 amounts (63 ± 22 pg/ml, p<0.05). 
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Similar data were obtained when spleen cells were stimulated with Candida hyphae (not 
shown). Upon stimulation with both Candida hyphae and conidia, spleen cells from IL-12-
/-, but in particular IL-18-/- mice, released significantly less IFN-γ compared to control 
mice (20 to 35% of normal production in IL-12-/- mice and 5 to 15 % of normal production 
in the IL-18-/- mice; Fig. 5, p < 0.01). 
In addition, we measured local cytokine production in the kidneys of infected mice. 
Production of IFN-γ and TNF in the kidneys was below detection limit, whereas the local 
release of IL-1α and IL-1β was low and varied between 30 and 100 pg/ml (no differences 
between the knockout mice and controls).  
 
 
 
 
Figure 5. IFN-γ production after Candida albicans stimulation. Spleen cells from control (open 
bars), IL-12-/- (hatched bars) and IL-18-/- (dotted bars) mice were stimulated in vitro with either 
heat-killed C. albicans blastoconidia or hyphae (107 CFU/ml), and IFN-γ production was 
measured 48 h later. Data represent the mean ± SD for two experiments (n=10/group). *p < 0.05 
compared to control mice. 
 
Phagocytosis and killing of C. albicans 
IFN-γ has important stimulatory effects on the fungicidal activities of phagocytes. The 
defective production of IFN-γ by cells of IL12-/- and IL-18-/- was accompanied by a 
tendency for a lower capacity of neutrophils from both knockout strains to kill C. albicans 
hyphae extracellularly, compared to neutrophils from control mice (58 and 61 % in IL-18-
/- and IL-12, respectively, whereas being 73 % in wild-type mice). Similarly, the 
phagocytosis and intracellular killing of Candida blastoconidia was similar by the 
neutrophils or monocytes of the three mouse strains (not shown). 
As superoxide radicals and NO are the two main candidacidal mechanisms employed 
by the phagocytes, we next assessed their release in the IL-12-/- and IL-18-/- mice. Both IL-
12-/- and IL-18-/- neutrophils released less superoxide radicals compared to control cells: 
0.13 ± 0.04 and 0.11 ± 0.03, respectively, vs. 0.17 ± 0.04 mV.s/PMN in control mice 
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(p<0.05). In contrast, no differences between NO production in the three mouse strains 
were apparent: 33.2 ± 11.2 µg/ml in control mice, 40.2 ± 7.4 µg/ml in IL-12-/- mice and 
31.0 ± 9.8 µg/ml in IL-18-/- mice (p > 0.05). 
 
Recruitment of neutrophils and monocytes 
To investigate the recruitment of neutrophils at the site of a C. albicans infection, 
groups of control, IL-12-/- and IL-18-/- mice were injected intraperitoneally with 107 heat-
killed C. albicans micro-organisms, and exudate peritoneal neutrophils were harvested and 
counted 2 and 4 h later. The monocyte infiltration in the peritoneum was assessed 72 h 
after injection of Candida. As shown in Fig. 6, monocyte infiltration in the peritoneum 
increased 5-fold upon injection with Candida in the control and IL-12-/- mice. In contrast, 
there was only a 2.5-fold increase in the monocyte numbers in the peritoneal cavity of IL-
18-/- injected with C. albicans (p<0.05, Fig. 6). There was no difference between the 
neutrophil infiltration in the peritoneal cavity of the three mouse strains at both 2 h and 4 h 
after injection of Candida (data not shown).  
 
 
Figure 6. Recruitment of monocytes. Control mice (open bars), IL-12-/- mice (hatched bars) and 
IL-18-/- mice (dotted bars) were injected i.p. with 107 CFU Candida/mouse. 72 h later, fewer 
monocytes infiltrate the peritoneal cavity of IL-18-/- mice than of control and IL-12-/- mice. Data: 
mean ± sd for 2 experiments with 10 mice/group. *p < 0.05 
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Discussion 
In the present study, it is shown that IL-18-/- mice have an increased susceptibility to a 
systemic infection with C. albicans, manifested as increased mortality and a 10- to 25-fold 
increased fungal outgrowth in their kidneys, the target organ of disseminated candidiasis 
in mice. In contrast, IL-12-/- mice demonstrated only a marginal increase in fungal load in 
their organs. A decreased Th1-type protective immunity, as revealed by lower IFN-γ 
production, and a reduced recruitment of monocytes at the site of infection, are likely 
responsible for the blunted host response against Candida in the IL-18-/- deficient mice. 
 
Both IL-18 and IL-12 have been shown to be involved in the induction of IFN-γ by C. 
albicans [28], and IFN-γ is crucial for defence against disseminated candidiasis [1,18]. 
The results of the present study demonstrate that IL-18-/- mice have an increased 
susceptibility to C. albicans infection, and these data are sustained by the deleterious 
effects of a neutralizing anti-IL-18 antibody during systemic candidiasis [32]. In contrast, 
IL-12-/- mice had only a marginally increased outgrowth of Candida in their kidneys, 
which implies that an effective anti-candidal response can develop in the absence of IL-12. 
Our results are in line with the findings of Mencacci et al. [24], who reported that IL-12-/- 
mice are more susceptible to gastrointestinal, but not systemic Candida infection, 
underscoring the difference in pathogenesis between these two manifestations of candidal 
infection. Differences between the role of IL-18 and IL-12 have been also observed in 
other infectious models. It appears that IL-18-/-, but not IL-12-/- mice, are more susceptible 
to pneumococcal pneumonia, and this effect is mediated through differential neutrophil 
recruitment in the lungs [17]. This is in contrast with a model of experimental 
Mycobacterium tuberculosis infection, in which both functional IL-12 and IL-18 are 
necessary for the host defence, but IL-12p40-/- mice seem to be more susceptible than IL-
18-/- mice in this infectious model [13].  
 
There are marked effects of IL-18 and IL-12 in our study, and they are likely to be 
mediated at least in part by IFN-γ. Production of IFN-γ was decreased in IL-12-/- mice, and 
was even more strongly reduced in IL-18-/- mice. As IFN-γ is central to an effective anti-
candidal defence, it is likely that this decreased response in the knock-out animals is 
involved in their susceptibility to candidiasis, which is also in line with our recent studies 
demonstrating that administration of anti-IL-18 antibodies to control animals, but not IFN-
γ-/- mice, has deleterious effects during Candida infection [32]. A crucial role of IFN-γ in 
the host defence mechanisms activated by IL-18 was also reported in experimental 
infections with Cryptococcus neoformans [12], Salmonella typhimurium [23], Toxoplasma 
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gondii [3], and Pseudomonas aeruginosa [10]. These mechanisms involve release of 
oxygen radicals [8] and NO [6], the two main antifungicidal mechanisms employed by 
phagocytes. 
In addition to its role in the release of IFN-γ in the context of IL-12 co-stimulation, 
IL-18 has also pro-inflammatory effects that are independent of IFN-γ. IL-18 stimulates 
production of other pro-inflammatory cytokines and chemokines [30,27], directly induces 
expression of adhesion molecules [14], and is involved in the pathogenesis of lethal 
endotoxaemia and experimental arthritis through IFN-γ -independent pathways [11,26].  
When the production of chemokines was investigated, only monocytes from IL-18-/- 
mice, but not IL-12-/- mice, had a decreased production of MIP-2 upon stimulation with C. 
albicans blastoconidia, and this was accompanied by a defective monocyte infiltration at 
the site of infection. KC production was decreased in both IL-18-/- and IL-12-/- mice. One 
should note that MIP-2 and KC are important chemoattractants for both monocytes and 
neutrophils, and only recruitment of the former is defective in the IL-18-/- mice. It is 
therefore conceivable that production of other monocyte-specific chemokines is also 
affected in IL-18-/- mice. In contrast, the phagocytosis and intracellular killing of Candida 
blastoconidia by monocytes of IL-12-/- and IL-18-/- mice was normal. It appears therefore 
that the intrinsic anti-candidal capacities of the monocytes are intact, but late during the 
infection the IL-18-/- mice fail to mount a proper monocytic infiltrate, which precludes 
normal clearance of the infection. Recruitment of neutrophils at the site of infection did 
not differ between control and knockout mice, suggesting therefore that the mice can 
mount proper neutrophil infiltrates. 
The production of TNF by the peritoneal cells of IL-12-/- and IL-18-/- mice was 
normal. We have recently shown that synthesis of TNF is rapid and proximal to that of IL-
18, and endogenous TNF is necessary for a proper release of IL-18 during C. albicans 
infection [32]. On the other hand, other pro-inflammatory cytokines such as IL-1α are 
released later after stimulation, and its production was significantly decreased in both 
knock-out strains. In view of the fact that no difference in the TNF or IL-1α could be 
observed between IL-12-/- and IL-18-/- mice, it is unlikely that their release can explain the 
differential roles of IL-12 and IL-18 in our model of systemic candidiasis. 
In conclusion, endogenous IL-18 plays a protective role in the defence against 
disseminated infection with Candida albicans, and its effects are partly mediated by 
induction of a protective IFN-γ response, and partly through monocyte recruitment at the 
site of infection as a result of chemokine release. In turn, IL-12 has a less important role 
during invasive candidiasis in stimulating IFN-γ and chemokine release. 
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Apolipoprotein-E-deficient mice exhibit  
an increased susceptibility to  
disseminated candidiasis 
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Abstract 
The effect of hyperlipoproteinemia on systemic candidiasis was investigated by 
assessing the susceptibility of hyperlipoproteinemic apolipoprotein E deficient (ApoE -/-) 
mice to a systemic Candida albicans infection. The absence of ApoE in these mice 
resulted in an eightfold increase in plasma lipoprotein concentrations in the very low-
density lipoprotein (VLDL) fraction, as compared with levels seen in ApoE +/+ mice. 
Mortality due to candidemia was significantly higher (86%) in ApoE -/- than in ApoE +/+ 
mice (52%), and in platings of homogenized kidney material in fungal culture medium, 
ApoE -/- mice yielded significantly higher levels of Candida outgrowth than did ApoE 
+/+ mice. C. albicans grew twofold better in ApoE -/- plasma in 4 h than in ApoE +/+ 
plasma, and depletion of lipoproteins from plasma resulted in a significant seven- to 
tenfold increase in C. albicans growth. Recombinant ApoE did not directly inhibit 
Candida growth. Our data indicate that the increased susceptibility of ApoE -/- mice to C. 
albicans is due both to increased growth of blastoconidia in ApoE -/- mice in response to 
the availability of lipids as nutrients, and to the neutralization of candidacidal factors by 
lipoproteins. This study suggests that lipoproteins play a significant role in host defence 
against candidiasis. 
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Introduction 
Acute disseminated infections caused by Candida species are life-threatening diseases 
despite the availability of potent antifungal agents [21]. Patients receiving total parenteral 
nutrition (TPN) are at risk for disseminated candidiasis [6]. The growth of C. albicans is 
increased in lipid-rich formulations compared with growth levels seen  in conventional 
TPN solutions [2,14]. Low-density lipoprotein (LDL) receptor-deficient mice, which have 
elevated plasma lipoprotein concentrations, are highly susceptible to C. albicans infection, 
and the proliferation of C. albicans blastoconidia in LDL-rich plasma is increased, as 
shown by studies on outgrowth of candidal colony forming units from this material [18]. 
In addition, plasma obtained from volunteers infused with high concentrations of 
recombinant high-density lipoprotein (rHDL) promotes the growth of C. albicans 
blastoconidia [17]. 
Apolipoprotein E (ApoE) is a major structural component of several plasma 
lipoproteins, such as chylomicrons, very low density lipoproteins (VLDL), intermediate 
density lipoprotein (IDL) and high density lipoprotein (HDL); it has an important role in 
the metabolism of these plasma lipoproteins. Furthermore, there is increasing evidence 
that ApoE has a beneficial role in modulating the pro-inflammatory immune response seen 
during exposure to nonspecific stimuli [9,15,20,23], as well as during bacterial infections 
[3,4,22]. Mice deficient in ApoE showed enhanced susceptibility to both 
lipopolysaccharide (LPS) [4], and Klebsiella pneumoniae [3,4]; this effect was brought 
about via down-modulation of the pro-inflammatory cytokine response. Indeed, a 
physiological increase of ApoE has been observed in response to LPS administration, and 
exogenous ApoE protects against LPS-induced death [24]. However, it is unclear whether 
ApoE exerts a protective effect during other infections, such as candidiasis. 
In the present study, we assessed the influence of increased VLDL levels on host 
defences against disseminated candidiasis, and investigated whether this influence is 
mediated by ApoE. Mice lacking the gene encoding for ApoE (ApoE -/- mice) have 
elevated VLDL plasma concentrations. These mice and control ApoE +/+ mice were used 
in our experiments. 
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Materials and Methods 
Animals and Reagents 
For all experiments, we used homozygous apolipoprotein E-deficient mice with a 
C57Bl/6 genetic background. These mice (6-8 weeks old; 20-25 grams) were obtained 
from the Transgenic Facility of Leiden University Medical Centre, Leiden, The 
Netherlands [25]. Weight-matched C57BL/6 mice (ApoE +/+ mice) were selected as 
controls. The animals were kept under specific pathogen-free conditions and were fed 
standard laboratory chow. The experiments were approved by the ethics committee on 
animal experiments of the University Medical Centre Nijmegen. Human recombinant 
Apolipoprotein E4 was kindly provided by Dr. V.E.H. Dahlmans and Dr. L.M. Havekes 
(TNO-PG Leiden, The Netherlands). 
 
Candida albicans 
C. albicans blastoconidia (strains UC820 and ATCC 10261 [American Type Culture 
Collection, Manassas, VA, USA]), were inoculated in Sabouraud broth and cultured for 
24h at 37°C. After 10 min centrifugation at 1650 x g, pellets were dissolved in sterile 
saline, and the number of colony forming units (cfu) was counted in a Bürker counting 
chamber.  
 
Infection model 
ApoE -/- and ApoE +/+ mice were infected with C. albicans strain UC820 by 
intravenous injection of 5 x 105 blastoconidia in 100 µl of pyrogen-free phosphate-
buffered saline (PBS) into the retroorbital plexus. Survival was assessed daily for 21 days 
in groups of at least 13 animals. For measurement of circulating cytokine concentrations 
and quantification of fungal outgrowth, subgroups of 6 mice were bled from the 
retroorbital plexus on day 1, 3 and 7 of infection, and blood was collected in 
ethylenediamine tetraacetic acid (EDTA) tubes. The kidneys and liver were removed 
aseptically, weighed, and homogenized in sterile saline in a tissue grinder. Serial dilutions 
of the homogenates were plated on Sabouraud dextrose agar plates as described earlier 
[10]. After incubation at 37°C for 48h, the number of cfu was counted and the results were 
expressed as the log cfu per gram of tissue.  
 
Cytokine measurements 
Concentrations of tumour necrosis factor (TNF)-α and interleukin-1α (IL-1) in EDTA 
plasma were measured using specific radioimmunoassays (RIA) developed in our 
laboratory, as described previously [26]. 
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Recruitment of neutrophils 
To investigate the recruitment of granulocytes (PMN) at the site of Candida infection, 
groups of 6 ApoE -/- mice and ApoE +/+ mice received an intraperitoneal (i.p.) injection 
of 107 heat-killed C. albicans blastoconidia. Four hours after injection, cells were 
harvested by washing the peritoneal cavity with 4ml of ice-cold PBS, and the total number 
of cells was counted in a Bürker counting chamber. The percentage and absolute numbers 
of neutrophils were determined in Giemsa-stained cytocentrifuge preparations. 
 
Phagocytosis and intracellular killing of C. albicans 
The processes of phagocytosis and intracellular killing were studied using the 
Adherent Monolayer Method, as described [27]. Exudate-derived ‘exudate peritoneal 
granulocytes’ and ‘exudate peritoneal macrophages’ were obtained 4 or 72h after 
intraperitoneal (i.p.) injection of 1 ml of 10 % proteose peptone (Difco Laboratories, 
Detroit, MI), respectively. Peritoneal lavage cells from exudate were centrifuged (1800 
rpm, 10 min, 4°C) and washed twice in sterile saline. The phagocytes were resuspended in 
RPMI 1640, Dutch modification (with 20 mM Hepes, without glutamine; ICN 
Biomedicals, Eschwege, Germany) supplemented with 5 % heat-inactivated foetal calf 
serum (FCS) 1 % gentamicin, 1 % L-glutamine and 1 % pyruvate (RPMI-dm), counted in 
a Bürker counting chamber, and diluted to the required final concentration.  
To create a monolayer of phagocytes, 5 x 105 cells in 100 µl RPMI-dm were 
dispensed into a 96-well flat bottom plate (Costar, Corning, the Netherlands) and 
incubated at 37°C in 5 % CO2. Granulocytes were allowed to adhere for 0.5h and 
macrophages for 2h before gently the monolayers were gently washed with culture 
medium to remove non-adherent cells. The percentage of adherence was calculated as (1 – 
[number of non-adherent cells / 5 x 105]) x 100. Subsequently, the cells were incubated 
with 1 x 104 cfu C. albicans strain ATCC 10261, cells of which had been opsonised at 24 
ºC with supplemented Modified Eagle’s Medium (MEM; Gibco Life Technologies, 
Paisley, Scotland) containing 2,5 % mouse serum (effector to target [E:T] ratio, 
approximately 40:1) for 45 min. After 15 min, supernatants were aspirated and 
monolayers were washed gently with MEM to remove uningested micro-organisms. The 
supernatant and washes, containing the non-phagocytized C. albicans blastoconidia, were 
combined and plated in serial dilutions on Sabouraud agar plates. The percentage of 
phagocytized micro-organisms was defined as (1 – [number of uningested cfu/cfu at the 
start of incubation]) x 100.  
Killing of C. albicans by phagocytes was assessed in the same monolayers. After 
removal of the non-phagocytized C. albicans blastoconidia, 200 µl of culture medium, 
consisting of Sabouraud in MEM (50% v/v), was added to the monolayers. After 3h of 
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incubation at 37°C in air plus 5% CO2, the wells were gently scraped with a plastic paddle 
and washed with 200 µl distilled H2O to achieve lysis of phagocytes. This procedure was 
repeated three times, after which the pooled washes were adjusted to a final volume of 1 
ml with distilled water. Microscopic examination of the culture plates showed that there 
was a complete removal of phagocytes. To quantify the number of viable intracellular 
Candida blastoconidia, tenfold dilutions of each sample were spread on Sabouraud agar 
plates and incubated at 37°C for 24h. The percentage of yeast killed by the phagocytes 
was determined as: (1 – [cfu after incubation/ number of phagocytized cfu]) x 100. 
Phagocyte-free incubations of blastoconidia were included as a control for yeast viability. 
 
Assessment of PMN-mediated hyphal damage 
PMN-mediated damage of hyphae was determined by a modification of the XTT (2,3-
bis-[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide) dye assay 
previously described by Gaviria et al [7]. Candida blastoconidia (strain UC820) grown on 
Sabouraud agar plates were collected with a swab and suspended at a final concentration 
of 1 x106 cfu/ml in RPMI-dm. The pH of the suspension was adjusted to 6.4 using 
hydrochloric acid. Pseudohyphae (henceforth to be called hyphae) were obtained by 
incubating 10 ml of the suspension at 37ºC for 24h. After incubation, the hyphae were 
centrifuged (1800 rpm, 10 min) and resuspended in RPMI 1640 variant lacking phenol red 
and L-glutamine (RPMI-wp; ICN Biomedicals, Eschwege, Germany). 200µl aliquots of a 
suspension containing 1 x 105 hyphae were dispensed into a 24-well flat bottom plate 
(Costar, Corning, the Netherlands). PMN, obtained as described above, were resuspended 
in 200 µl RPMI-wp, and added to the wells containing hyphae at a final E:T ratio of 10:1, 
in the presence of 20 % fresh ApoE +/+ serum. Control wells contained hyphae or PMN 
only.  
After incubation for 2h, 800 µl of sterile H20 was added to the wells and the plate was 
rocked at room temperature to achieve lysis of PMN. After 15 min., 800 µl sterile saline 
containing XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide; Sigma Chemical, St. Louis, MO) and coenzyme Q0 (2,3-dimethoxy-5-
methyl-1,4-benzoquinone; Sigma) were added to each well at a final concentration of 400 
µg/ml XTT and 50 µg/ml coenzyme Q0.  
After 1h of incubation at 37ºC, the plate was centrifuged (1800 rpm, 10 min) and 100 
µl of the supernatant of each well was transferred to a well of a 96-well microtiter plate. 
The absorbance of each well was measured in a spectrophotometer at 450 nm. The 
percentage of fungal damage was defined as 1– ((A450 hyphae + PMN – A450 PMN) / A450 
hyphae) x 100. 
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Superoxide production 
To investigate whether the capacity to produce superoxide was altered in ApoE -/- 
mice, exudate peritoneal PMN were studied in a luminol-enhanced peroxidase-catalyzed 
chemiluminescence (CL) assay [13]. Exudate peritoneal PMN of 5 mice per group were 
obtained as described above and suspended at 2 x 106 cells/ml HBSS without phenol red 
(Life Technologies, Paisley, Scotland) supplemented with 0.25 % human serum albumin 
(Behringwerke, Marburg, Germany). Cells (2 x 105/well) were incubated in 96-well 
microtiter plates (Costar) with 50 µM luminol, 4.5 U/ml horseradish peroxidase (Sigma), 
and stimulated with phorbol 12-myristate 13-acetate (PMA; 50 ng/ml). 
Chemiluminescence was measured on a Victor2 1420 multilabel counter (Wallac, Turku, 
Finland) at room temperature. 
 
Isolation of lipoprotein subclasses and lipoprotein-depleted plasma 
For lipid measurement, VLDL (final cholesterol concentration 0,9 mmol/L), LDL (2.0 
mmol/L cholesterol), and HDL (0.5 mmol/L cholesterol) subclasses, were isolated from 
fresh EDTA-plasma by sequential ultracentrifugation, as described earlier [5]. The 
triglycerides, total and lipoprotein specific cholesterol concentrations were determined by 
enzymatic methods on a Hitachi 747 analyser. For in vitro experiments, the density of the 
plasma samples was adjusted to 1.18 kg/L using a solution of KBr in 0.9 % pyrogen free 
saline. The LPS-free lipoprotein fraction (containing VLDL, IDL, LDL and HDL) as well 
as the lipoprotein-depleted plasma (<0.1 mmol/L cholesterol) were isolated after 
ultracentrifugation at 38.000 rpm, and 4ºC for 25h. Lipoproteins for lipid measurements 
and in vitro assays, as well as the lipoprotein depleted-plasmas were dialyzed against 
0.05mM phosphate buffer, pH 7.4, containing 5 mM EDTA/L for 24h, with one exchange 
of the buffer.  
 
C. albicans growth in vitro 
Blood was collected from ApoE -/- and ApoE +/+ mice by cardiac puncture. Pooled 
EDTA-plasma was obtained by centrifugation at 15000 x g for 5 minutes. C. albicans 
(UC820; 2 x 103 cfu/ml) was suspended in Sabouraud broth and diluted 1:1 in ApoE -/- or 
ApoE +/+ plasma, or ApoE +/+ plasma supplemented with the lipoprotein fraction 
obtained from ApoE -/- mice (supplemented ApoE +/+ plasma).  Likewise, in comparison 
trials, Candida blastoconidia were also incubated in the presence of ApoE -/- lipoprotein-
depleted plasma, ApoE +/+ lipoprotein-depleted plasma, and the lipoprotein-depleted 
plasma obtained from supplemented ApoE +/+ plasma. As a control, Candida 
blastoconidia were grown in Sabouraud broth diluted 1:1 in PBS. Also, to assess whether 
ApoE could directly influence C. albicans growth, C. albicans blastoconidia were 
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incubated in the presence of 10, 1, or 0.1 µg/ml recombinant human ApoE4 in Sabouraud 
broth. The growth of C. albicans in the presence of the various factors was established 
after 2, 4, 8 and 24 h incubation in 96-well flat bottom plates (final volume 200 µl/well) at 
37°C in 5 % CO2. After incubation, the contents of the wells were harvested as described 
above, and serial dilutions were plated on Sabouraud agar. The colonies of C. albicans 
were enumerated after incubation at 37°C for 48h. 
 
Statistical analysis 
The Kaplan-Meyer log rank test was used to analyze survival data. Differences in 
cytokine concentrations, PMN recruitment, superoxide production, and outgrowth of 
micro-organisms in the organs or plasma were analyzed using the Mann-Whitney U-test. 
Differences in lipid concentrations were analyzed with the Students’ t-test. Differences 
between groups were considered significant at p < 0.05. 
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Results 
Cholesterol and triglyceride concentrations 
Plasma cholesterol concentrations were eight- to nine fold higher in uninfected ApoE -
/- mice than in ApoE +/+ animals (Table 1). These elevated concentrations were due to 
high cholesterol concentrations in the VLDL + IDL fraction and, to a lesser extent, 
increased LDL cholesterol concentrations. In contrast, HDL cholesterol concentrations 
were significantly lower in ApoE -/- mice than in controls. Plasma triglyceride 
concentrations were two-fold higher in ApoE -/- mice due to an elevation in the VLDL + 
IDL fraction (Table 1). The VLDL like particles of the ApoE -/- mice were cholesterol-
rich and triglyceride-poor, in contrast to VLDL from ApoE +/+ mice [4]. 
 
Table 1. Plasma and lipoprotein cholesterol and triglyceride concentrations in uninfected 
apolipoprotein E (ApoE) -/- mutant mice and ApoE +/+ control mice. 
Results are given as mean ± SD for 30 animals per group. Significant differences between ApoE 
+/+ and ApoE -/- mice are indicated as follows; a p<0.01, b p<0.001, c p<0.0001. HDL, high-density 
lipoproteins; LDL low-density lipoproteins; VLDL very low-density lipoproteins. 
 
C. albicans infection 
Death occurred after day 5 of infection in mice administered 5 x 105 C. albicans 
blastoconidia/mouse. Mortality was significantly higher in ApoE -/- mice (86%) than in 
ApoE +/+ mice (52%; p < 0.005; Fig. 1). Infection with a lower amount of C. albicans (2 
x 105 blastoconidia/mouse) led to a similar difference in mortality between ApoE -/- and 
ApoE +/+ mice (data not shown). 
To examine whether the increased mortality in Apo E -/- mice could be explained by 
an increased outgrowth of C. albicans in the organs, animals were sacrificed on day 1, 3 
and 7 after infection and the liver and kidneys were removed to assess fungal outgrowth. 
In both groups, the number of cfu recovered from the kidneys continued to increase from 
day 1 through day 7 of infection. On day 1 and 3, the outgrowth of C. albicans in the 
kidneys of ApoE -/- mice was significantly greater than in those of ApoE +/+ mice (p < 
 Cholesterol (mmol/L )  Triglycerides (mmol/L) 
 ApoE -/- ApoE +/+  ApoE -/- ApoE +/+ 
Plasma 16.14 ± 3.73 1.87 ± 0.15 c  1.13 ± 0.40 0.85 ± 0.30 b 
VLDL 10.2 ± 1.14 0.12 ± 0.03 c  0.81 ± 0.14 0.48 ± 0.16 a 
LDL 0.60 ± 0.06 0.23 ± 0.03 c  0.03 ± 0.01 0.04 ± 0.01 
HDL 0.47 ± 0.10 1.04 ± 0.10 c  0.03 ± 0.01  0.03 ± 0.01 
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0.05 and p < 0.001, respectively; Fig.2). On day 7, a similar trend was observed. No 
difference in outgrowth from the liver was observed between groups at any time (data not 
shown). Circulating cytokine concentrations were measured on day 1, 3 and . IL-1α was 
not detectable in the circulation at any time. TNFα concentrations were detectable on day 
3 of infection only. The concentration observed in ApoE -/- mice (0.25 ± 0.21 ng/ml) did 
not differ significantly from that found in ApoE +/+ mice at the same time (0.18 ± 0.18 
ng/ml; p > 0.05). 
 
Figure 1. Survival of ApoE -/- 
(dashed line) and ApoE +/+ 
(solid line) mice after i.v. 
injection of 5 x 105 cfu C. 
albicans per mouse. The 
figure shows pooled data from 
2 experiments with at least 13 
animals per group per 
experiment. p < 0.005 ApoE -
/- vs. ApoE +/+ mice. 
 
 
 
Figure. 2. Outgrowth of C. 
albicans from the kidneys of 
ApoE -/- () and ApoE +/+ 
mice (▲) assessed on day 1, 3 
or 7 after an i.v. injection of 5 
x 105 cfu of C. albicans. 
Results are pooled data of 3 
experiments with 6 animals/ 
group and presented as mean 
± SD (ap < 0.05; bp < 0.005). 
 
 
Recruitment of PMN 
To assess whether the increased outgrowth of C. albicans in the kidneys of ApoE -/- 
mice could be due to differences in the numbers of granulocytes, which are the main 
effector cells in disseminated candidiasis, the recruitment of PMN to an injection of heat-
killed C. albicans blastoconidia into the peritoneal cavity was investigated in ApoE -/- and 
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ApoE +/+ mice. No significant difference could be detected at any time between the 
numbers of PMN recovered from the peritoneal lavage fluid of the two mouse strains (at 
2h counts were 5.91 ± 1.97 x 106/ml in ApoE -/- vs. 7.70 ± 2.02 x 106/ml in ApoE +/+; at 
4h, counts were 11.98 ± 2.67 x 106/ml in ApoE -/- vs. 12.94 ± 2.31 x 106/ml in ApoE +/+ 
mice; p > 0.05). 
 
Phagocytosis and intracellular killing of C. albicans blastoconidia by murine 
phagocytes 
To characterize granulocyte function in the mouse strains, the capacity to internalize 
and kill C. albicans blastoconidia was quantified. PMN obtained from ApoE -/- mice 
phagocytosed numbers of C. albicans blastoconidia (61.3 ± 4.3 %) similar to the numbers 
taken up by PMN from ApoE +/+ mice (60.7 ± 5.7 %; p > 0.05). The number of C. 
albicans blastoconidia killed by ApoE -/- PMN (84.0 ± 4.1%) did not differ from the 
number killed by PMN of ApoE +/+ mice (82.0 ± 3.3%; p > 0.05). Exudate macrophages 
of ApoE -/- mice were able to phagocytose and kill C. albicans blastoconidia to the same 
extent as macrophages of ApoE +/+ mice did (p > 0.05; data not shown). To assess 
whether the established intracellular killing could be explained by decreased viability of 
C. albicans blastoconidia, C. albicans growth from phagocyte-free wells was quantified 
after 3 h of incubation. The numbers of cfu recovered from wells containing C. albicans 
alone remained unaltered when gauged against baseline counts (data not shown). 
Microscopic evaluation of the wells showed no hyphal growth. 
 
PMN-mediated hyphal damage 
In addition to making an assessment of the intracellular killing capacity of 
granulocytes, we also determined their extracellular killing capacity by means of a 
tetrazolium dye assay quantifying hyphal viability. The damage of C. albicans hyphae 
mediated by PMN from ApoE -/- mice (45.9 ± 4.4 %) did not differ significantly from that 
brought about by PMN from ApoE +/+ mice (46.1 ± 2.1 %; p > 0.05). 
 
Superoxide production 
The capacity to produce superoxide in response to PMA stimulation was similar for 
exudate peritoneal PMN of ApoE -/- mice (12.9 ± 0.86 x 104 cps) and ApoE +/+ mice 
(13.3 ± 2.7 x 104 cps, p > 0.05). 
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Growth of Candida albicans in various types of plasma or in the presence of ApoE4  
To determine whether the increased susceptibility of the ApoE -/- mice could, at least 
in part, be explained by the hyperlipoproteinemia of ApoE -/- mice, growth of C. albicans 
in the presence of murine plasma was assessed in vitro. At 4 h of incubation, C. albicans 
outgrowth was significantly higher in ApoE -/- plasma than in ApoE +/+ plasma (Fig. 3; p 
< 0.05). However, plasma could be seen to function in the inhibition of candidal growth 
when C. albicans counts from plasma were compared with counts from a mixture of 
Sabouraud and PBS (Fig. 3; p < 0.05). In addition, enrichment of ApoE +/+ plasma by the 
isolated circulating lipoprotein fraction from ApoE -/- mice significantly increased 
outgrowth of C. albicans in ApoE +/+ plasma (Fig. 3).  
 Plasma source  -/- +/+ +/+ -/- +/+ +/+ none 
 Lipoprotein-supplemented  - - yes - - yes - 
 Lipoprotein-depleted - - - yes yes yes - 
 
Figure 3. In vitro growth of C. albicans expressed as log cfu in Sabouraud broth supplemented 
with 50 % (v/v) various plasma sources after incubation at 37 ºC for 4 hours (solid bars), as well as 
a control mixture of PBS in Sabouraud medium (50 % v/v; open bars). Data are expressed as mean 
± SD of 4 samples obtained from 2 experiments. ‘Lipoprotein-supplemented’ stands for the 
addition of lipoproteins obtained from ApoE -/- plasma. 
a p < 0.05 compared with growth in ApoE +/+ plasma.  
b p < 0.05 lipoprotein-deleted plasma compared with non-lipoprotein-depleted plasma. 
c p < 0.05 for comparison with Sabouraud medium mixed with PBS. 
 
To determine whether this effect was caused by lipoproteins serving as nutrients or by 
the binding and inactivation of circulating candidacidal factors, growth of C. albicans was 
compared in lipoprotein-depleted plasma of ApoE -/- and ApoE +/+ mice, as well as ApoE 
+/+ plasma that had been supplemented with the ApoE -/- lipoprotein fraction before the 
depletion procedure was carried out. C. albicans growth was significantly enhanced in all 
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lipoprotein-depleted plasma samples, irrespective of the mouse strain involved. 
Supplementation of ApoE +/+ plasma with lipoproteins prior to their removal tended to 
lead to a further increase in C. albicans growth (Fig. 3). Similar results were observed 
after 8 and 24 h incubation (data not shown). This suggests that, in addition to lipids 
themselves serving as nutrients, extracellular candidacidal factors are bound to, and 
extracted together with lipoproteins during the depletion procedure.  
 To assess whether ApoE could directly inhibit C. albicans growth, blastoconidia were 
cultured in the presence of increasing amounts of recombinant human ApoE4 up to 10 
µg/ml. No inhibitory effect was detected after 4 h incubation in 10 µg/ml ApoE4 (3.29 ± 
0.06 x 106 cfu vs. 3.26 ± 0.06 x 106 cfu for control growth; p > 0.05). Similar results were 
obtained after 24 hours of incubation (data not shown). 
 
Discussion 
Our study showed that ApoE -/- mice exhibit a susceptibility to acute disseminated 
candidiasis that exceeds that of ApoE +/+ mice. Both mortality levels and outgrowth of C. 
albicans blastoconidia from kidney macerates became elevated in ApoE -/- mice. The 
observed increased susceptibility of ApoE -/- mice appears to be the result in part of an 
increased growth of C. albicans in plasma due to lipids serving as nutrients. In addition, 
the effect seen was caused in part by the neutralizing of candidacidal plasma factors by 
elevated lipoprotein levels. No parallel neutralizing effect was observed for ApoE itself.  
 
The major reason for the enhanced susceptibility of ApoE -/- mice is the significantly 
increased growth of C. albicans blastoconidia in the hyperlipidemic plasma of these mice, 
as compared to growth in plasma of ApoE +/+ mice. Our results are similar to those 
obtained in LDL receptor-deficient (LDLr -/-) mice, which were also more susceptible to 
C. albicans infection than controls [18]. It is hypothesized that the excess of lipoproteins 
influences the growth of C. albicans blastoconidia either by serving as a nutrient [2,14,17] 
or by binding and inactivating plasma candidacidal factors, such as the calprotectin 
complex [16], sphingosine [19], or platelet microbicidal protein [29]. Fresh plasma 
inhibits fungal reproduction (Fig. 3), pointing to the presence of candidacidal factors in 
plasma, as has been described earlier [1,8]. An increased amount of lipoproteins in plasma 
enhanced the outgrowth of C. albicans, as was demonstrated by the increased outgrowth 
of C. albicans blastoconidia from Apo E -/- plasma. This is in agreement with our earlier 
findings that all lipoprotein fractions enhance growth of C. albicans in vitro [17]. 
Likewise, C. albicans growth was enhanced in ApoE +/+ plasma supplemented with the 
lipoprotein fraction obtained from ApoE -/- plasma. Lipoprotein depletion of plasma 
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increased C. albicans growth even further. This suggests that candidacidal factors are 
neutralized by lipoproteins. When additional lipoproteins were added to ApoE +/+ plasma 
before the depletion procedure, C. albicans growth was further enhanced, suggesting an 
augmented neutralization of candidacidal factors.  
 
As the lipoproteins added were obtained from ApoE -/- mice and thus did not contain 
ApoE, the neutralization of candidacidal factors is not due to ApoE, and a direct 
candidacidal effect of ApoE can de excluded. In correlation with this, C. albicans growth 
was seen not to be affected by the addition of recombinant human ApoE4. Therefore, the 
reduced growth of Candida in ApoE +/+ plasma is not due to a direct effect of ApoE.  
An earlier study has shown that C. albicans grew significantly better in lipoprotein-
depleted plasma from mice lacking LDL receptors than in normal murine plasma [17]. In 
the present study, however, no significant difference in yeast outgrowth was observed in 
lipoprotein-depleted plasma from ApoE -/- and ApoE +/+ animals, a finding that 
contrasted with the significant differences seen with in non-depleted plasma samples from 
these mouse lines. In LDLr -/- mice, the major lipoprotein in the circulation is LDL, 
whereas VLDL is the main circulating lipoprotein in ApoE -/- mice. Again, this suggests 
that ApoE does not mediate the neutralizing of candidacidal factors. Lipoproteins other 
than VLDL appear to be able to bind and neutralize candidacidal factors in plasma, 
independent of ApoE availability.  
 
Although ApoE -/- mice had already significantly elevated fungal burdens in their 
kidneys on day 1 of infection, differences in mortality between the two test groups were 
only observed after 1 week of infection. As has been described previously, the early 
differences in outgrowth during disseminated candidiasis subsequently lead to differences 
in mortality. Mortality is due to kidney failure [10,12]. 
 
Plasma factors and PMN are the most important host defence components in the initial 
stage of disseminated candidiasis. The outgrowth of Listeria monocytogenes was 
increased in ApoE -/- mice during the early stage of infection, presumably due to an 
impaired granulocyte defect [22]. Moreover, granulocytes pre-incubated with lipid 
emulsions showed an impaired intracellular killing capacity of C. albicans blastoconidia 
[28]. Therefore, the possibility was investigated that neutrophil function might be 
impaired in ApoE -/- mice, enhancing their susceptibility. However, the recruitment, as 
well as intra- and extracellular killing rates of PMN from ApoE -/- mice were similar to 
those of ApoE +/+ mice. This excludes impaired granulocyte function as the cause of the 
increased susceptibility of ApoE -/- mice to acute disseminated candidiasis. 
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It has been shown that ApoE regulates cell-mediated immunity. This is evidenced by a 
decrease in the delayed-type hypersensitivity response of ApoE -/- mice [11], a 
phenomenon that may lead to impaired macrophage function at the site of infection. 
However, cell-mediated immunity does not play a significant role in the host defences to 
disseminated candidiasis [10]. Moreover, we have previously shown that the in vitro 
cytokine production capacity of ApoE -/- macrophages is not increased [4], and in the 
present study, the circulating pro-inflammatory cytokine concentrations were not 
significantly different in ApoE -/- mice from that in controls. Taken together, the results of 
the present study do not suggest a major immunomodulatory effect of ApoE mediated via 
cellular mechanisms. 
 
In conclusion, this study demonstrates that increased (ApoE-deficient) VLDL levels 
have deleterious effects on the outcome of disseminated candidiasis. In addition to lipids 
themselves serving as nutrients for C. albicans, lipoproteins neutralize serum candidacidal 
factors. Hyperlipoproteinemia is deleterious for host defence against candidiasis. 
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Abstract 
The role of endogenous tumour necrosis factor-α (TNF) and lymphotoxin-α (LT) in a 
model of intra-abdominal Candida sepsis and abscess formation was investigated. A 
significantly higher number of abscesses was observed in TNF/LT double knockout (TNF-
/-LT-/-) mice compared to wild-types (TNF+/+LT+/+). The outgrowth of Candida in 
abscesses of TNF-/-LT-/- mice was 10-fold increased on day 14, and 60-fold increased on 
day 21 of infection. The diminished host resistance was explained by an impaired 
extracellular killing capacity of granulocytes and a delayed development of a Th1 
response in TNF-/-LT-/- mice. The IL-10/IFNγ ratio as measured in the supernatants of 
stimulated splenocytes, shifted from 131 for TNF-/-LT-/- mice and 13.9 for TNF+/+LT+/+ 
mice on day 8, to 0.11 for TNF-/-LT-/- mice and 11.66 for TNF+/+LT+/+ mice on day 14 of 
infection. In conclusion, TNF and LT are critical to the stimulation of effector cells 
consequently leading to elimination of Candida from abscesses. 
Chapter 7 
  
 123
Introduction 
Tumour necrosis factor-α (TNF) and lymphotoxin-α (LT) are members of the TNF- 
superfamily [4]. Both ligands bind with similar affinity to the p55 and p75 TNF receptor, 
inducing the same biological responses [4,13]. Overproduction of TNF and the release of 
high amounts into the circulation induce a systemic inflammatory reaction resulting in 
systemic hypotension, multi organ failure, and eventually death [19]. In contrast, small 
amounts of TNF produced locally at the site of infection are important for mounting a 
proper host response to the invading micro-organism.  
The role of TNF in systemic intravascular models of bacterial infection is significantly 
different from that in localized infections. Anti-TNF antibodies offer protection against a 
lethal intravenous bacterial challenge, whereas neutralization of endogenous TNF with 
anti-TNF antibodies has deleterious effects on the outcome of localized infection such as 
experimental peritonitis [3,21]. This is in agreement with the observation that 
administration of recombinant murine TNF, and its subsequent interaction with the 
p55TNF receptor, is required to mount an adequate host defence against bacterial 
peritonitis [7,8].  
TNF and LT play a major role in host defence against disseminated candidiasis. 
Pharmacological agents and anti-TNF antibodies neutralizing endogenous TNF worsen the 
outcome of experimental disseminated candidiasis [16,20], and mice lacking the genes 
encoding for TNF and LT are highly susceptible to systemic Candida albicans infection 
[15,18]. Furthermore, evidence exists that the systemic use of monoclonal antibodies 
against TNF for treatment of patients with an inflammatory bowel disease might increase 
the risk of invasive fungal infections [25]. The mechanisms through which neutralization 
of endogenous TNF increases the susceptibility to fungal infections are incompletely 
understood. 
To investigate the role of endogenous TNF and LT in a model of deep-seated 
localized Candida infection, we induced intra-abdominal abscess formation by an 
injection of C. albicans blastoconidia and sterile faecal content into the peritoneal cavity 
of TNF/LT double knockout (TNF-/-LT-/-) mice and their wild-type (TNF+/+LT+/+) 
littermates. 
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Materials and methods 
Animals 
Female, 6-8 weeks old TNF-/-LT-/- mice on a mixed 129/sv-C57BL/6 background in 
which the genes encoding for TNF-α and LT-α were replaced by a neo cassette (pMCI 
NeopA, Stratagene) and their wild-type littermates were used [1]. The mice were allowed 
to accustom to laboratory conditions for one week before experimental use. The animals 
were housed under specific pathogen-free conditions and were fed standard laboratory 
chow (Hope Farms, Woerden, the Netherlands) and water ad libitum. The experiments 
were approved by the ethics committee on animal experiments of the University Medical 
Centre Nijmegen. 
 
Candida albicans 
C. albicans (strains UC820 and ATCC 10261) was inoculated into 100 ml of 
Sabouraud broth and cultured for 24h at 37 °C. After three washes with pyrogen-free 
saline by centrifugation at 1500 x g, the number of yeast cells was counted in a 
hemacytometer; occasional strings of two or more yeast were counted as one cfu of C. 
albicans. Pyrogen-free saline was used to dilute the suspension to the appropriate 
concentration. The viability of the yeast was at least 98 %, as determined by plating serial 
dilutions on Sabouraud dextrose agar plates. 
 
Abdominal abscess induction 
Mouse faeces were ground in a tissue grinder and suspended in 0.9 % pyrogen-free 
saline to form a 5 % w/v mixture, and sterilized in a steam autoclave (15 min, 2 bar, 120 
°C). The sterility of the preparation was confirmed by plating aliquots on blood agar 
plates. To induce abdominal abscess formation, mice received an intraperitoneal injection 
of 100 µl of sterile faecal suspension containing 5 x 105 live C. albicans cfu. Subgroups of 
animals were anesthetized with ether and bled from the retroorbital plexus on day 3, 8, 14 
or 21 for measurement of circulating TNFα, IL-1α, IL-6, IFNγ and IL-10 concentrations. 
At the same points in time, the abdominal cavity was explored for the presence and 
number of abscesses ≥ 1 mm. All abscesses ≥ 1 mm were removed, measured, rinsed with 
70 % ethanol, and subsequently with saline to remove external micro-organisms.  
 
Outgrowth of C. albicans 
To assess the outgrowth of micro-organisms, the abscesses, left kidney, and a 10 x 10 
mm sample of the peritoneum were weighed and homogenized in sterile saline in a tissue 
grinder. The number of viable Candida cells in the tissues was determined by plating 
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serial dilutions on Sabouraud dextrose agar plates, as described previously [14]. The cfu 
were counted after 24h of incubation at 37 °C, and expressed as log cfu/sample. To 
evaluate bacterial coinfection of the abscesses, aliquots were plated on blood agar. For 
histology, tissue samples were fixed in buffered formalin (4 %), and paraffin-embedded. 
Sections were stained with periodic acid-Schiff, hematoxylin-eosin or elastin von Gieson, 
and examined microscopically. 
To assess the presence and severity of diffuse peritonitis, the number of Candida 
blastoconidia present in the peritoneal cavity was determined. Subgroups of mice were 
sacrificed on day 8, 10, 12 or 14, and the peritoneal contents were harvested by washing 
the peritoneal cavity with 4 ml ice-cold PBS. After centrifugation, the pellet was 
resuspended in 600 µl sterile water containing 0.01 % BSA. The undiluted suspension was 
subsequently plated on Sabouraud dextrose agar plates and the cfu were counted, as 
described above.  
To investigate the role of polymorphonuclear neutrophils (PMN) in an abdominal 
Candida infection in TNF-/-LT-/- mice, subgroups of wild-type and deficient animals were 
rendered granulocytopenic by pre-treatment with cyclophosphamide (Bristol-Myers 
Squibb, Weesp, The Netherlands), as described previously [14]. Cyclophosphamide 150 
mg/kg was administered s.c. 4 days before infection, followed by 100 mg/kg 1 day before 
infection, as well as on day 2 and 5 after i.p. injection of 100 µl sterile faecal suspension 
containing 5 x 104 live C. albicans. Daily differential counts in peripheral blood smears 
confirmed that granulocytes remained < 100 x 106/L throughout the infection (data not 
shown). The number of abscesses and outgrowth of the micro-organisms in the tissues on 
day 8 of infection were determined, as described above. 
 
Assessment of PMN-mediated hyphal damage 
Previous research conducted by our group revealed that the capacity to phagocytize 
Candida blastoconidia by PMN from TNF-/-LT-/- mice was significantly impaired 
compared with PMN from TNF+/+LT+/+ mice, whereas their capacity to kill the ingested 
Candida was similar [18]. The PMN-mediated damage of Candida pseudohyphae 
(henceforth to be referred to as hyphae) was determined by a modification of the XTT dye 
assay, which was previously described by Gaviria et al [11]. Candida blastoconidia (strain 
UC820) grown on Sabouraud agar plates were collected with a swab and suspended at a 
final concentration of 1 x106 cfu/ml in RPMI 1640 Dutch modification (with 20mM 
Hepes, without glutamine, ICN Biomedicals GmbH, Eschwege, Germany) supplemented 
with 1 % gentamicin, 1 % L-glutamine and 1 % pyruvate, henceforth to be referred to as 
RPMI-dm. The pH of the suspension was adjusted to 6.4 using hydrochloric acid. Hyphae 
were obtained by incubating 10 ml of the suspension at 37ºC for 24h. After incubation, the 
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hyphae were centrifuged (1800 rpm, 10 min) and resuspended in RPMI 1640 without 
phenol red and L-glutamine (RPMI-wp; ICN Biomedicals, Eschwege, Germany). 160µl 
aliquots of a suspension containing 1 x 105 hyphae were dispensed into a 24-well flat 
bottom plate (Costar, Corning, the Netherlands). PMN were elicited by an i.p. injection of 
10 % proteose peptone. After 4h, cells were collected and resuspended in RPMI-wp, the 
number of PMN was determined in Giemsa stained cytospin preparations and 5 x 105 
PMN (200 µl) were added to the wells containing hyphae at a final E:T ratio of 5:1, in the 
presence of 10 % fresh TNF+/+LT+/+ serum. Control wells contained either hyphae or PMN 
only. After incubation for 2h, 800 µl of sterile H20 was added to the wells and the plate 
was rocked at room temperature to achieve lysis of PMN. After 15 min., 800 µl sterile 
saline-solution containing XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide; Sigma Chemical, St. Louis, MO) and coenzyme Q0 (2,3-
dimethoxy-5-methyl-1,4-benzoquinone; Sigma) were added to each well at a final 
concentration of 400 µg/ml XTT and 50 µg/ml coenzyme Q0. After 1h of incubation at 
37ºC, the plate was centrifuged (1800 rpm, 10 min) and 150 µl of the supernatant of each 
well was transferred to a well of a 96-well microtiter plate. The absorbance of each well 
was measured in a spectrophotometer at 450 nm. The percentage of fungal damage was 
defined as 1– ((A450 hyphae + PMN – A450 PMN) / E450 hyphae) x 100. 
 
Phagocytosis and intracellular killing of C. albicans 
Exudate peritoneal macrophages from groups of five TNF-/-LT-/- and TNF+/+LT+/+ 
mice were elicited by an i.p. injection of 10 % proteose peptone. Phagocytes were 
collected in sterile tubes by washing the peritoneal cavity with 4ml ice-cold PBS 
containing 50 U/ml heparin 72h after injection. The cells were centrifuged (10 min; 3600 
rpm; 2250 g), counted in a Bürker counting chamber and resuspended in RPMI-dm 
supplemented with 5 % heat-inactivated foetal calf serum.  
The processes of phagocytosis and intracellular killing were studied in an adherent 
monolayer of phagocytes, as described previously [24]. To create a monolayer of 
macrophages, 5 x 105 cells in 100 µl of RPMI-dm were dispensed into the wells of a 96-
well flat bottom plate (Costar, Corning BV, the Netherlands) and incubated at 37 °C and 5 
% CO2. Macrophages were allowed to adhere for 2h before gently washing the 
monolayers with culture medium to remove non-adherent cells. The percentage of 
adherence was calculated as (1 – (number of non-adherent cells / 5 x 105)) x 100. 
Subsequently, the cells were incubated with 1 x 104 cfu C. albicans ATCC 10261, which 
were opsonised for 45 min at 24 ºC in Modified Eagle’s medium (Gibco Life 
technologies, Paisley, Scotland; MEM), containing 2,5 % fresh mouse serum (E:T ratio, 
40:1). After 15 min, supernatants were aspirated and monolayers were gently washed with 
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MEM to remove uningested blastoconidia. The supernatant and well washings, containing 
the non-ingested Candida blastoconidia, were combined and plated in serial dilutions on 
Sabouraud agar plates. The percentage of phagocytized blastoconidia was defined as (1 – 
(number of uningested cfu/cfu at the start of incubation)) x 100. Killing of C. albicans by 
macrophages was assessed in the same monolayers. After removal of the non-
phagocytized Candida blastoconidia, 200 µl of culture medium, consisting of Sabouraud 
in MEM (50 % v/v), was added to the monolayers. After 3h of incubation at 37 °C and 5 
% CO2, the wells were gently scraped with a plastic paddle and washed with 200 µl 
distilled H2O to achieve lysis of macrophages. This procedure was repeated three times, 
after which the pooled washes were adjusted to a final volume of 1ml with distilled water. 
Microscopic examination of the culture plates showed that there was a complete removal 
of phagocytes. To quantify the number of viable intracellular Candida blastoconidia, 
tenfold dilutions of each sample were spread on Sabouraud agar plates and incubated at 37 
°C for 24h. The percentage of yeast killed by the macrophages was determined as follows: 
(1 – (cfu after incubation/ number of phagocytized cfu)) x 100. Macrophage-free 
incubations of blastoconidia were included as a control for yeast viability.  
 
Stimulation of splenic lymphocytes 
Spleen cells were obtained by gently squeezing spleens in a sterile 200 µm filter 
chamber. Microscopic examination of Giemsa stained cytospin preparations showed that 
splenocytes consisted for 95 % of lymphocytes, 2 % monocytes and 3 % granulocytes. 
Splenocytes were washed and resuspended in RPMI-dm, counted in a Bürker counting 
chamber, and the number was adjusted to 5 x 106/ml. 1 ml of the cell suspension was 
stimulated with 1 x 107 heat killed Candida albicans UC820 blastoconidia (E:T ratio, 2:1). 
Measurement of IFNγ and IL-10 concentrations was performed in supernatants collected 
after 48h of incubation at 37 °C in 5 % CO2 in 24-well plates (Greiner, Alphen a/d Rijn, 
The Netherlands).  
 
Cytokine assays 
The concentrations of TNFα and IL-1α were determined using specific 
radioimmunoassays as described previously [17]. The detection limit using a 100 µl 
sample was 40 pg/ml for TNFα and 20 pg/ml for IL-1α. IL-10, IFNγ and IL-6 
concentrations were determined by a commercially available ELISA kit (Biosource 
Europe), according to the guidelines of the manufacturer. The detection limits were 8, 1.5, 
or 150 pg/ml, respectively. 
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Statistical analysis 
Values were expressed as means ± sd. The differences between groups were analyzed 
by the Mann-Whitney U test. For all comparisons the level of significance was set at p < 
0.05. All experiments were performed at least twice, and the data represent the average 
results of all experiments performed. 
 
Results 
Number of abscesses 
Abdominal abscess formation was induced by the injection of 100 µl sterile faecal 
suspension containing 5 x 105 viable C. albicans blastoconidia into the peritoneal cavities 
of TNF+/+LT+/+ and TNF-/-LT-/- mice. All animals survived the acute period of infection 
and consistently developed abscesses, which became visible from day 3 of infection 
onwards. In TNF+/+LT+/+ mice, the maximum number of abscesses was reached on day 8 
of infection, after which the number gradually decreased (Fig.1). During the first week of 
infection, similar numbers of abscesses were found in TNF-/-LT-/- mice. However, as 
opposed to the number of abscesses in the immunocompetent littermates, the numbers 
continued to increase to day 21 of infection in the TNF-/-LT-/- mice (TNF-/-LT-/- vs 
TNF+/+LT+/+ mice, p < 0.0001, Fig.1). 
 
Figure 1. The number of 
intra-abdominal abscesses 
per animal. A significantly 
higher number of abscesses 
was recovered from the 
peritoneal cavity of TNF-/-
LT-/- mice (○) than of 
TNF+/+LT+/+ mice () on 
day 3 (* p < 0 .005) as well 
as on day 8 and 14 of 
infection (** p < 0.0001). 
 
Histopathology of the inflammatory lesions recovered from the abdominal cavities of 
both groups of mice, showed that a small amount of the lesions were foreign body 
granulomas rather than abscesses, consisting of faecal contents surrounded by 
macrophages without Candida cells. No significant histopathological differences between 
abscesses recovered from both groups of mice on either day 8 or 14 of infection were 
detected (Fig.2). 
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Figure 2 (for coulour printing, see cover). Histopathology of abscesses in TNF+/+LT+/+ and TNF-
/-LT-/- mice. (A) TNF+/+LT+/+ mice on day 8, a large abscess is present filled with granulocytes, 
bordered by an inflammatory response, dominated by macrophages. (B) On day 15, TNF+/+LT+/+ 
mice had increased abscess formation, with histopathological features similar to those on day 8. 
(C) On day 8, TNF-/-LT-/- mice revealed an inflammatory response to fibres and yeast cells with 
small amounts of granulocytes and an increased histiocytic response. (D) On day 15, TNF-/-LT-/- 
mice showed a more intense and expanded response with large numbers of yeast cells and giant 
cell reaction leading to granulomatous inflammation. 
 
To investigate whether the increasing number of abscesses after day 8 in TNF-/-LT-/- 
mice might be the result of local spread or due to disseminated candidiasis, the outgrowth 
of Candida cfu in the left kidney, peritoneal lavage fluid, and a standardized sample (1 
cm2) of the peritoneum was assessed. Only during the first week of infection the kidneys 
of both groups showed growth of Candida, but there was no difference between the 
groups (log cfu/kidney of controls vs. deficient mice on day 3: 2.68 ± 0.49 vs. 2.52 ± 0.50; 
day 8: 1.30 ± 1.22 vs. 0.93 ± 0.55; p > 0.05). The fungal load in the peritoneum of TNF-/- 
LT-/- mice was not significantly different compared with that of control mice (absolute 
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number of cfu/cm2 peritoneum of controls vs. deficient mice on day 3: 149 ± 110 vs. 85 ± 
35; day 8: 34 ± 29 vs. 22 ± 21; p > 0.05). On day 8 or 10 of infection, less than 25 
Candida blastoconidia were recovered from the peritoneal lavage fluid in all mice of both 
groups. No cfu were recovered from peritoneal lavage fluid, kidney, or peritoneum after 
day 8 of infection.  
 
Number of C. albicans in abdominal abscesses 
To evaluate the fungal burden in the abscesses of TNF+/+LT+/+ and TNF-/-LT-/- mice, 
all abscesses larger than 1 mm were homogenized and plated on Sabouraud dextrose agar 
plates. No other micro-organism than C. albicans was recovered from the abscesses.  
The course of the number of Candida cfu in the abscesses is depicted in Fig. 3. During 
the first week of infection, the numbers of Candida cells in the abscesses decreased over 
time. No differences were found between the fungal load in TNF+/+LT+/+ and TNF-/-LT-/- 
mice at day 3 and 8 of infection. From day 8 to 21 of infection, the outgrowth of C. 
albicans in the abscesses of TNF+/+LT+/+ mice continued to decrease, whereas the numbers 
of cfu increased after an initial reduction in TNF-/-LT-/- mice. Quantification of yeast cells 
recovered from abscesses of TNF-/-LT-/- mice revealed significantly larger amounts of 
Candida blastoconidia, compared with those of TNF+/+LT+/+ mice on day 14 and 21 of 
infection (P < 0.0001, Fig.3). 
 
Figure 3. The number of C. albicans cfu in intra-abdominal abscesses per mouse. The amount of 
Candida cfu recovered from abscesses of TNF-/-LT-/- mice (○) was significantly increased 
compared to that from abscesses of TNF+/+LT+/+ mice () on day 14 and 21 of infection **p < 
0.0001. 
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Circulating cytokine concentrations 
During the entire experiment, circulating concentrations of TNF, IL-1α, or IFN-γ 
remained below the detection limit in TNF+/+LT+/+ mice. IL-6 appeared in the circulation 
on day 3 of infection only and the amounts were similar for both groups (197 ± 75 pg/ml 
in TNF-/-LT-/- vs. 180 ± 68 pg/ml in TNF+/+LT+/+ mice; p > 0.05). In TNF-/-LT-/- mice, IL-
1α was undetectable at all time points tested. The systemic concentration of IFN-γ in TNF-
/-LT-/- mice was significantly higher compared with TNF+/+LT+/+ mice on day 21 (Table 2.; 
p < 0.05). The circulating IL-10 concentration was significantly increased in TNF-/-LT-/- 
mice compared with TNF+/+LT+/+ mice on 8, 14 and 21 of infection (Table 1; p < 0.05). 
 
Table 1. Circulating cytokine concentrations of TNF-/-LT-/- and TNF+/+LT+/+ mice at various time 
points after i.p. injection of 100µl sterile faecal suspension containing 5 x 104 viable C. albicans. 
  IL-10 (pg/ml)  IFN-γ (pg/ml) 
  TNF-/-LT-/- TNF+/+LT+/+  TNF-/-LT-/- TNF+/+LT+/+ 
day 3  47 ± 64 20 ± 25  <1.5 <1.5 
day 8  195 ± 266 * < 8  <1.5 <1.5 
day 14  49 ± 84 * < 8  2.4 ± 1.6 <1.5 
day 21  141 ± 180 * 26 ± 22  3.7 ± 2.0 * <1.5 
Data are expressed as means ± sd of 10 mice per group obtained from 3 experiments. * p < 0.05 
compared with circulating cytokine concentrations of TNF+/+LT+/+ mice. 
 
Cyclophosphamide treatment 
To investigate the role of TNF and LT on granulocytes in this model of intra-
abdominal sepsis, subgroups of TNF+/+LT+/+ and TNF-/-LT-/- mice were rendered 
granulocytopenic by cyclophosphamide treatment and were injected i.p. with 100 µl sterile 
faecal suspension containing 5 x 104 viable C. albicans blastoconidia. Enumeration of 
Candida cfu recovered from abscesses on day 8 of infection showed that the absence of 
granulocytes resulted in significantly enhanced outgrowth (Table 2). Similar to the 
findings in nongranulocytopenic mice, the abscesses of neutropenic TNF-/-LT-/- mice 
contained significantly more Candida cfu than the abscesses of neutropenic TNF+/+LT+/+ 
mice did (p < 0.05; Table 2). Granulocytopenia resulted in dissemination of the infection, 
as shown by the presence of Candida cfu in the kidneys and the standardized sample of 
the peritoneum. At these sites, the numbers of Candida blastoconidia were also 
significantly greater in TNF-/-LT-/- mice (p < 0.05; Table 2). 
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PMN-mediated hyphal damage  
Since granulocytes contributed to host defence against Candida in this intra-
abdominal model, their extracellular killing capacity was determined. The damage of C. 
albicans hyphae mediated by PMN from TNF-/-LT-/- mice was significantly less compared 
with that by PMN from TNF+/+LT+/+ mice (Fig. 4; p < 0.0001). 
 
Figure 4. Percentage of PMN-mediated hyphal damage. Exudate PMN obtained from TNF-/-LT-/- 
mice were significantly impaired in their capacity to damage C. albicans hyphae compared with 
PMN of TNF+/+LT+/+ mice (p < 0.0001). 
 
Phagocytosis and killing of Candida blastoconidia 
To assess whether the capacity of macrophages deficient for TNF and LT to ingest 
and kill Candida blastoconidia was impaired, the percentage of phagocytosis and 
intracellular killing was determined in a monolayer of macrophages. No significant 
difference was found in either the capacity to ingest Candida by TNF-/-LT-/- macrophages 
(40 ± 17 %) compared with those of TNF+/+LT+/+ mice (47 ± 16 %; p > 0.05), or to kill 
Candida by macrophages from TNF-/-LT-/- mice (82 ± 17 %) compared with TNF+/+LT+/+ 
macrophages (86 ± 8 %; p > 0.05). 
TNF+/+LT+/+ TNF-/-LT-/-
0
10
20
30
40
50
hy
ph
al
 d
am
ag
e 
(%
)
Influence of TNF on intra-abdominal C. albicans abscesses 
  
134 
Splenocyte stimulation 
To assess whether a dysbalance in Th1/Th2 cytokines may have led to an enhanced 
outgrowth of Candida blastoconidia from the abscesses of TNF-/-LT-/- mice, 5 x 106 
splenic lymphocytes obtained on day 8 or 14 of infection were stimulated with 1 x 107 
heat killed C. albicans cfu in vitro. On day 8 of infection, when the Candida load was 
similar in both groups of mice, lymphocytes of TNF-/-LT-/- mice produced hardly any 
IFNγ, whereas those of TNF+/+LT+/+ mice produced a significantly larger amount (Fig. 5a, 
p < 0.0001). No significant differences in IL-10 production were observed. The IL-
10/IFNγ ratio was 9-fold higher for TNF-/-LT-/- compared with TNF+/+LT+/+ lymphocytes 
(131 vs. 13.9). 
On day 14, when the Candida burden was significantly higher in TNF-/-LT-/- than in 
TNF+/+LT+/+ mice, the opposite effect was found. At this time point, larger amounts of 
IFNγ were produced by TNF-/-LT-/- lymphocytes (Fig. 5c, p < 0.0001), whereas the IL-10 
production was low in both mouse strains. A 100-fold higher IL-10/IFNγ ratio was found 
for TNF+/+LT+/+ lymphocytes compared with TNF-/-LT-/- lymphocytes on day 14 (11.66 vs. 
0.11). These results indicate that the development of a Th1 response is delayed in TNF-/-
LT-/- mice during intra-abdominal C. albicans abscess formation. 
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Figure 5. In-vitro cytokine production in response to heat killed Candida blastoconidia (107/ ml) 
by splenic lymphocytes obtained on day 8 (upper panel) or 14 (lower panel) of infection.* 
indicates a significant difference between TNF-/-LT-/- and TNF+/+LT+/+ mice (p < 0.0001). No 
significant difference for IL-10 production between groups was observed on either day of 
infection. Results are expressed as mean ± sem from at least 8 samples per group  
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Discussion 
The main conclusion of the present study is that TNF and LT are necessary for host 
defence against intra-abdominal Candida abscesses. Two factors contributed to the 
reduced host resistance of TNF-/-LT-/- mice. First, the granulocytes of these mice had a 
significantly reduced extracellular killing capacity for C. albicans hyphae. Secondly, the 
absence of TNF and LT in TNF-/-LT-/- mice resulted in a delayed Th1 response, as was 
shown by the significantly increased IL-10/IFNγ ratio during the first week of infection. 
This delayed Th1 response is likely to lead to a deficient stimulation of effector cells, 
resulting in a significantly increased fungal burden in the abscesses.  
The complex host response of abscess formation consists of various processes, such as 
recruitment and accumulation of granulocytes at the site of infection, deposition of fibrin, 
activation of the complement cascade and procoagulant activity, fibroblast growth, 
collagen production, and the accumulation of monocytes and their subsequent transition to 
tissue macrophages. An important function of TNF and LT is containment of the infection 
through activation of endothelial cells, resulting in expression of the vascular adhesion 
molecules, ICAM-1 and E-selectin, which are important for the recruitment of neutrophils 
and monocytes to the site of infection [6].  
Previous studies have demonstrated that knock out mice lacking TNF, LT, or the 
p55TNF receptor, as well as mice treated with anti-TNF antibodies, have an impaired host 
defence against mycobacteria [5,9], bacterial peritonitis [3,7], or abscesses with B. fragilis 
[12]. However, our data as well as those from others [5,9,10], indicate that TNF and LT 
are not essential to abscess and granuloma formation, which also occurs in the absence of 
TNF, LT, or the p55TNF receptor. In contrast, TNF and LT play a major role in the 
subsequent stage of infection, i.e. the containment and clearance of abscesses through 
necrosis and killing of micro-organisms.  
Although abscess formation was normal in TNF-/-LT-/- mice, i.e., granulocytes as well 
as macrophages accumulated at the site of infection, the question was raised whether the 
effect of TNF and LT was mediated through granulocytes in our model of intra-abdominal 
abscesses, as is the case in disseminated candidiasis [18]. Rendering mice 
granulocytopenic significantly enhanced Candida outgrowth from abscesses compared 
with non-granulocytopenic mice of the same group, and increased Candida dissemination 
and peritonitis. Likewise, it was shown that the capacity of PMN from TNF-/-LT-/- mice to 
damage C. albicans pseudohyphae was significantly impaired compared with PMN from 
TNF+/+LT+/+ mice. In addition, our group has previously shown that PMN from TNF-/-LT-/- 
mice have a significantly reduced capacity of TNF-/-LT-/- PMN to phagocytize Candida 
blastoconidia compared with PMN from TNF+/+LT+/+ mice [18]. Thus, the effector 
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function of PMN to both forms of the dimorphic yeast C. albicans is affected in TNF-/-LT-
/- mice. In addition, the differences in outgrowth between TNF-/-LT-/- and TNF+/+LT+/+ 
mice occurring late during infection persisted during granulocytopenia and therefore are 
mediated through other cells than granulocytes. At this stage of infection, macrophages 
play the most important role in anticandidal defence, both by their afferent functions such 
as antigen presentation, and as effector cells killing C. albicans [2,23]. Macrophages 
obtained from uninfected TNF-/-LT-/- mice showed a similar capacity to ingest and kill 
Candida blastoconidia to that of TNF+/+LT+/+ macrophages, indicating a normal 
candidacidal function in the absence of infection. In contrast, during infection, the 
activation of TNF-/-LT-/- macrophages is likely to be deficient due to the delayed 
development of a Th1 response. TNF is an important co-stimulus for the induction of a 
protective Th1 response, primarily by its ability to induce IFNγ production in T cells 
(Netea M.G., unpublished data), and natural killer cells [22]. TNF-/-LT-/- mice are highly 
susceptible to disseminated candidiasis due to their incapability to mount a protective 
Th1-mediated immune response [15,18]. Similarly, TNF-/-LT-/- mice with Candida 
abscesses had a delayed Th1 response as shown by the IL-10/IFNγ ratio of 131 in TNF-/-
LT-/- mice on day 8 of infection compared to a ratio of 13.9 in TNF+/+LT+/+ mice. This is 
in agreement with the delayed Th1 development observed in TNFR p55-/- mice 
accompanying the progression of granulomas in mycobacterial infection [9].  
The delayed shift to a Th1-type of cytokine production in TNF-/-LT-/- mice leading to 
high IFNγ concentrations on day 14 of infection might merely be secondary to the 
increased outgrowth in the abscesses at later stages of the infection. Eventually, TNF-/-LT-
/- mice also recovered from their infection, and on day 40 of infection hardly any abscesses 
were found (data not shown). Apparently, this response is mediated by cytokines other 
than TNF and LT (such as IL-12, IL-18, and IL-23).  
In conclusion, intra-abdominal granuloma and abscess formation in response to C. 
albicans infection requires a Th1-type cytokine response. TNF and LT have a pivotal role 
in the elimination of Candida from abscesses both by directly influencing neutrophil 
functions and indirectly by the induction of a Th1-type response.  
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Abstract 
The aim of the present study was to assess the influence of immunomodulation of host 
defence with recombinant murine granulocyte colony stimulating factor (rmG-CSF) on 
intra-abdominal abscesses caused by Candida albicans. Mice received prophylaxis or 
therapy with 1 µg of rmG-CSF/day in the presence or absence of antifungal treatment 
consisting of amphotericin B (0.75 mg/kg/d) or fluconazole (50 mg/kg/d).  
The number of Candida cfu in abscesses was significantly reduced (p < 0.05) in mice 
receiving rmG-CSF prophylaxis (day –1, or day –1 through 2) compared with controls on 
day 8 of infection. Administration of rmG-CSF therapy alone (for 5 days starting on day 4 
of infection) had no influence on the number of Candida cfu in abscesses. Amphotericin B 
treatment was significantly more effective than fluconazole treatment (3.41; 95%CI, 3.17, 
3.65 vs. 3.90; 95%CI, 3.66, 4.16) log cfu/abscess; p <0.05). Therapeutic administration of 
rmG-CSF in conjunction with an antifungal agent showed a tendency towards a further 
reduction of Candida cfu in abscesses compared with antifungal treatment only.  
In conclusion, in this experimental model of intra-abdominal Candida abscesses, 
rmG-CSF administration did not have a detrimental influence on the course of infection. 
Amphotericin B treatment was most effective and additional rmG-CSF therapy did not 
antagonize the effect of antifungal treatment. In contrast, addition of rmG-CSF therapy to 
antifungal treatment might further enhance the beneficial effect of the antifungal agent.  
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Introduction 
During the past three decades, the incidence of Candida species as a cause of 
nosocomial infections has steadily increased. Colonization of the gastrointestinal tract 
with Candida is common, and gastrointestinal perforation or surgery may thus be 
complicated by abdominal candidiasis with abscess formation. The mortality rate among 
patients with abdominal candidiasis is high [4,22,23]. 
The polyene compound amphotericin B has been the mainstay of antifungal therapy 
for critically ill patients with invasive candidiasis. However, due to its severe and dose-
limiting adverse effects, alternatives to amphotericin B are being used, either alone or as 
combination therapy. The triazole antifungal agent fluconazole has proven to be equally 
effective in treating candidemia as amphotericin B [19], and has become the drug of 
choice for treatment of candidemia and disseminated C. albicans infection [1,20]. 
Furthermore, fluconazole is considered the drug of choice in patients with peritoneal 
candidiasis [5], and fluconazole prophylaxis is able to prevent abdominal candidiasis in 
high-risk surgical patients [6]. However, despite antifungal treatment, mortality remains 
high and additional therapy with agents that augment host defence, such as granulocyte 
colony-stimulating factor (G-CSF) may be of potential therapeutic benefit. 
Pretreatment with recombinant murine G-CSF (rmG-CSF) beneficially influences the 
course of acute disseminated candidiasis [11], or bacterial peritonitis [2,15] in mice. 
Combined therapy with an antifungal agent and rG-CSF has an additive effect against 
disseminated candidiasis in non-neutropenic mouse models, when compared with 
antifungal treatment alone [9,12]. However, recent findings from a randomized, double 
blind study have suggested that patients with intra-abdominal candidiasis treated with 
recombinant human G-CSF may have had a less favorable outcome compared to patients 
treated with fluconazole alone [14]. One of the explanations for the observed trend 
towards worse outcome of G-CSF treatment in intra-abdominal candidiasis may be that G-
CSF down-regulates tumour necrosis factor-α production [7,11,15]. Previous research by 
our group has shown that the clearance of intra-abdominal abscesses caused by C. 
albicans is delayed in tumour necrosis factor-α (TNF) and lymphotoxin-α deficient mice, 
primarily by inducing a T helper (Th) 2 response [25].  
To explore whether G-CSF application may indeed have detrimental consequences in 
intra-abdominal candidiasis, we assessed the effect of immunomodulation with rmG-CSF 
in the presence or absence of amphotericin B or fluconazole on intra-abdominal abscesses 
caused by C. albicans in mice. 
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Materials and methods 
Animals 
Female, 6-8 weeks old CBA mice were allowed to acclimatize to laboratory 
conditions for one week prior to infection. The animals were housed under specific 
pathogen-free conditions and were fed standard laboratory chow (Hope Farms, Woerden, 
The Netherlands) and water ad libitum. The ethics committee on animal experiments of 
the University Medical Centre Nijmegen had approved the experiments. 
 
Compounds 
Amphotericin B was obtained as Fungizone (Bristol-Myers Squibb, Woerden, The 
Netherlands), containing 50 mg of amphotericin B, 41 mg of sodium deoxycholate and 
20.2 mg of sodium phosphate per vial, and was reconstituted with 10 ml of distilled water 
to obtain a standard solution of 5 mg/ml. Further dilutions were prepared in pyrogen-free 
dextrose 5%.  
Fluconazole was purchased from Pfizer Nederland, as a stock solution containing 2 
mg/ml. Recombinant murine G-CSF, provided by Amgen (Thousand Oaks, CA) was 
diluted in pyrogen-free saline to obtain a final concentration of 10 µg/ml. 
 
Minimum inhibitory concentrations (MICs) 
MICs were determined according to the M27-A microbroth dilution method as 
described by the National Committee for Clinical Laboratory Standards [16]. Briefly, C. 
albicans strain UC820 was cultured for 24 h at 35°C and resuspended in 0.9 % NaCl. The 
transmission was measured (530 nm) and was set between 75 % and 77 % (1-5 x 106 
CFU/ml). The suspension was further diluted with distilled water (1:10) and RPMI-1640 
containing 0.165 M 3-N-morpholinepropanesulfonic acid (MOPS; 1:100; pH, 7.0), to 
obtain a final suspension of 1-5 x 103 CFU/ml. 100 µl of the suspension were incubated 
for 48 h at 35°C in the presence or absence of the antifungal agents in various 
concentrations. The MIC of amphotericin B was defined as the lowest concentration of 
amphotericin B which resulted in an optically clear tube, and the MIC of fluconazole as 
the lowest concentration of fluconazole which resulted in a turbidity reduction of 50 % 
compared with that of the growth control as determined spectrophotometrically. 
 
Abdominal abscess induction 
C. albicans strain UC820 was inoculated into 100 ml of Sabouraud broth and cultured 
for 24h at 37°C. After three washes with pyrogen-free saline by centrifugation at 1500 x g, 
the number of yeast cells was counted in a hemacytometer; occasional strings of two or 
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more yeast cells were counted as 1 cfu of C. albicans. Pyrogen-free saline was used to 
dilute the suspension to the requested concentration. The viability of the yeast was at least 
98 %, as determined by plating serial dilutions on Sabouraud dextrose agar plates.  
Mouse feces were ground in a tissue grinder and suspended in 0.9 % pyrogen-free 
saline to produce a 5 % w/v mixture, and sterilized in a steam autoclave (15 min, 2 bar, 
120°C). The sterility of the preparation was confirmed by plating aliquots on blood agar 
plates. To induce abdominal abscess formation, mice received an intraperitoneal injection 
of 100 µl of sterile fecal suspension containing 5 x 105 live C. albicans cfu. 
 
Treatment regimens 
Antifungal treatment started on day 3 of infection, using doses of fluconazole (50 
mg/kg/d) or amphotericin B (0.75 mg/kg/d) that had proven to be equally effective in 
reducing the number of cfu in the kidneys in a series of pilot experiments of disseminated 
candidiasis (data not shown). Amphotericin B, fluconazole, or a combination of both 
agents was administered for 5 days. Amphotericin B was given as a subcutaneous (s.c.) 
injection once daily. Fluconazole was administered orally every 12 h (q12 h) via gavage, 
at a dosage of 25 mg/kg/dose. Control animals received 100 µl of sterile pyrogen-free 
dextrose 5 % s.c., once daily.  
In another set of experiments, the effect of rmG-CSF on Candida outgrowth from 
intra-abdominal abscesses was assessed. rmG-CSF was administered daily as a s.c. 
injection of 1000 ng/mouse (50 µg/kg) in 100 µl pyrogen-free saline. Injections of rmG-
CSF were given according to one of the following three schedules: regimen A rmG-CSF 
prophylaxis was given once 24 h prior to infection, regimen B prolonged rmG-CSF 
prophylaxis was administered once daily for 4 days from day -1 through day 2 of 
infection, or regimen C rmG-CSF therapy was given once daily for 5 days commencing on 
day 4 of infection. For assessment of antifungal treatment combined with rmG-CSF on the 
number of Candida cfu in abscesses, rmG-CSF was administered according to regimen A, 
or C starting on day 3 of infection, either alone or in combination with amphotericin B or 
fluconazole, using the same doses and dosing schedules as described above. 
 
Outcome assessments 
The number of circulating granulocytes was determined in blood obtained from the 
retroorbital plexus from subgroups of mice prior to, or at different points in time during 
infection. On different days of infection, subgroups of animals were anesthetized with 
ether and bled from the retroorbital plexus for measurement of circulating TNFα, 
interleukin-1 alpha (IL-1α), IL-6, interferon gamma (IFNγ) and IL-10 concentrations. 
Thereafter, these mice were sacrificed and the abdominal cavity was explored for the 
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presence and number of abscesses ≥ 1 mm. All abscesses ≥ 1 mm were removed, 
measured, rinsed with 70 % ethanol, and subsequently with saline to remove external 
microorganisms.  
Since it was hypothesized that rmG-CSF might alter the containment of Candida 
within the abscesses and lead to spread of the infection throughout the peritoneal cavity 
with subsequent haematogenous dissemination, we removed a 10 x 10 mm sample of the 
peritoneum for assessment of peritonitis, and the left kidney for assessment of Candida 
dissemination. The tissues were homogenized in sterile saline in a tissue grinder and 
Candida blastoconidia were enumerated by plating serial dilutions (abscesses, kidneys) or 
the complete homogenate (peritoneum) on Sabouraud dextrose agar plates, as described 
previously [13]. The cfu were counted after 24 h of incubation at 37°C, and expressed as 
log cfu/organ. Bacterial co-infection of the abscesses was evaluated by plating aliquots on 
blood agar. Cultures yielded no aerobic or anaerobic bacteria.  
For histology, tissue samples were fixed in buffered formalin (4 %), and embedded in 
paraffin. Sections were stained with periodic acid-Schiff and hematoxylin-eosin and 
examined microscopically. 
 
Stimulation of splenic lymphocytes 
To determine the effect of rmG-CSF on Th cell responses, spleens of groups of 5 mice 
that received either rmG-CSF therapy (1000 ng once daily for 5 days) or control vehicle, 
were removed on day 8 of infection. Spleen cells were obtained by gently squeezing 
spleens in a sterile 200 µm filter chamber. Microscopic examination of Giemsa stained 
cytospin preparations showed that splenocytes consisted for 95 % of lymphocytes, 2 % 
monocytes and 3 % granulocytes. Splenocytes were washed and resuspended in RPMI-
dm, counted in a Bürker counting chamber, and the number was adjusted to 5 x 106/ml. 1 
ml of the cell suspension was stimulated with 1 x 107 heat killed C. albicans UC820 
blastoconidia (E:T ratio, 2:1). Measurement of IFNγ and IL-10 concentrations was 
performed in supernatants collected after 48 h of incubation at 37 °C in 5 % CO2 in 24-
well plates (Greiner, Alphen a/d Rijn, The Netherlands).  
 
Cytokine assays 
The concentrations of TNFα and IL-1α were determined using specific 
radioimmunoassays, as described previously [17]. The detection limit using a 100 µl 
sample was 40 pg/ml for TNFα and 20 pg/ml for IL-1α. IL-10, IFNγ and IL-6 
concentrations were determined by a commercially available ELISA kit (Biosource 
Europe), according to the guidelines of the manufacturer. The detection limits were 8, 1.5, 
or 150 pg/ml, respectively. 
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Statistical analysis  
Values were expressed as means ± standard deviation (sd) or, in case of logarithmic 
data, as means and the 95 % confidence intervals. The differences between 2 groups were 
analyzed by the Mann-Whitney U test. For these comparisons the level of significance was 
set at p < 0.05. For comparison of 3 or more groups, the data were analyzed using the 
Kruskal-Wallis one-way ANOVA. For post-test comparisons, the Bonferroni t method 
was used. To ascertain reproducibility, most experiments were performed at least twice, 
and the data represent the average results of all experiments performed. 
 
Results 
In vitro susceptibilities and pharmacokinetics 
The MIC of C. albicans strain UC820 was 0.25 mg/L for both amphotericin B and 
fluconazole. A dose of up to 1.5 mg/kg/d amphotericin B was well tolerated. No 
abnormalities of renal and hepatic function were detected after five days of amphotericin 
B administration, as measured by serum urea, creatinine, aspartate aminotransferase and 
alanine aminotransferase concentrations compared to mice receiving control vehicle (data 
not shown). Peak plasma concentrations of fluconazole (25 mg/kg) given by gavage were 
reached 0.5 h after administration (25.57 ± 1.36 mg/L), and trough concentrations 
measured before the next dose (12 h after administration) amounted 6.82 ± 0.21 mg/L. 
Thus, for fluconazole, time above the MIC in the circulation was 100 % of the dosing 
interval. 
 
Intra-abdominal abscesses and antifungal therapy 
All animals survived the acute phase of infection and consistently produced abscesses, 
which could be detected from day 3 of infection. No differences in the number of 
abscesses were observed between any groups on any day of infection (Table 1). On day 8 
of infection, quantification of yeast cells recovered from intra-abdominal abscesses from 
amphotericin B-treated mice showed a significantly reduced outgrowth of C. albicans cfu 
compared to controls or fluconazole-treated mice (p < 0.05, Table 1). Fluconazole 
treatment did not reduce the number of cfu in the abscesses compared to controls. 
Combination therapy of amphotericin B with fluconazole did not further reduce outgrowth 
from abscesses compared to amphotericin B treatment alone. Seven days after the 
termination of antifungal treatment, on day 14 of infection, no differences in the number 
of Candida cfu in the abscesses were observed (Table 1). 
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Immunomodulation with rmG-CSF 
At the time of intraperitoneal infection, the mean number of granulocytes in mice that 
received rm-GCSF 24 h earlier was 1.6 ± 0.2 x 109/L, whereas in untreated mice the 
number amounted 0.8 ± 0.1 x 109/L (p < 0.05). On day 3 of infection, the circulating 
numbers of granulocytes were unchanged in control mice (0.8 ± 0.1 x 109/L), whereas the 
numbers of granulocytes in mice that had received rmG-CSF prophylaxis (2.2 ± 0.6 x 
109/L; p < 0.05), or prolonged rmG-CSF prophylaxis (2.4 ± 1.2 x 109/L; p < 0.05) were 
higher compared to those in controls. 
On the third day of infection, mice that had received rmG-CSF prophylaxis had 
significantly fewer Candida cfu in their abscesses than untreated mice did (p < 0.05, Table 
2). Both prophylaxis groups showed a reduced outgrowth of Candida cfu compared to 
controls on day 9 (p < 0.05, Table 2). Therapy with rmG-CSF that started on day 4 of 
infection did not influence the numbers of cfu in the abscesses on either day of infection 
compared to controls. The number of abscesses did not differ between the groups on any 
day of infection (Table 2). 
Since administration of rmG-CSF might alter the containment of Candida cfu in the 
abscesses, the amount of peritonitis was determined. Although the amount of Candida in 
the peritoneum was around the detection limit, i.e. was negligible, mice that received 
prolonged rmG-CSF prophylaxis had a significantly larger number of Candida cfu/cm2 
peritoneum than did controls (day 3: 82 ± 27 vs. 37 ± 22, p < 0.01; day 9: 9 ± 6 vs. 2 ± 2 
cfu/cm2, p < 0.05; data are means ± sd of at least 10 mice per group, the experiment was 
performed thrice).  
In addition, it was assessed whether rmG-CSF increases haematogenous dissemination 
of Candida. Again, the number of Candida cfu was around the detection limit at any point 
in time, and no differences in the number of C. albicans cfu, i.e. dissemination of 
Candida, in the kidneys were observed between groups (data not shown). 
 
Stimulation of splenic lymphocytes 
To assess whether rmG-CSF induces a Th1 or a Th2 type immune response, 5 x 106 
splenic lymphocytes obtained on day 9 of infection from untreated mice and mice that 
received rmG-CSF therapy were stimulated with 1 x 107 heat killed C. albicans cfu in 
vitro. Lymphocytes of mice that were treated with rmG-CSF produced significantly more 
IL-10 (901 ± 304 pg/ml) than control lymphocytes (532 ± 263; p < 0.05). No significant 
differences in IFNγ production between rmG-CSF-treated mice (560 ± 390 pg/ml) and 
controls (710 ± 475 pg/ml) was observed. The IL-10/IFNγ ratio was 2-fold higher for mice 
treated with rmG-CSF (1.9 ± 0.58) compared to the control group (1.0 ± 0.54; p < 0.05). 
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Immunomodulation combined with antifungal agents 
On day 8 of infection, amphotericin B treatment significantly reduced the number of 
cfu compared to controls (Fig. 1; p < 0.05). Combination treatment of rmG-CSF therapy 
with fluconazole or amphotericin B was slightly more effective in reducing the number of 
cfu in abscesses, although the differences between mice treated with an antifungal agent 
alone and mice treated with the agent in combination with rmG-CSF therapy were not 
significant (Fig. 1B; p > 0.05).  
Figure 1. Effect of amphotericin B (AMB) or fluconazole (FCZ) combined with rmG-CSF on 
outgrowth of C. albicans in intra-abdominal abscesses per mouse on day 8 of infection. (A) mice 
received rmG-CSF on day -1 of infection. (B) mice received daily rmG-CSF on day 3 through 7 of 
infection. Horizontal bars indicate the means. a p < 0.05 compared with control mice. b p < 0.01 
compared with control mice. The data are obtained from one experiment with 4 animals per group. 
 
Histopathology of the abscesses on day 8 of infection showed that treatment with 
rmG-CSF either alone or in conjunction with antifungal treatment increased the number of 
granulocytes present in the abscesses. This was observed for both prophylactic (not 
shown) and to a larger extent for therapeutically administered rmG-CSF (Fig. 2). On day 
15 of infection, no differences between groups were observed, neither by histopathological 
evaluation, nor in outgrowth (data not shown), although the combination of amphotericin 
B with rmG-CSF therapy (3.02; 95%CI, 2.43, 3.61 log cfu/abscesses) showed a tendency 
to reduce the outgrowth of Candida cfu from abscesses most compared to controls (3.39; 
95%CI, 2.92 to 3.86); p > 0.05). No difference in the numbers of abscesses was observed 
between the groups at any point in time. 
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Mice that received rmG-CSF prophylaxis had significantly higher circulating IL-10 
concentrations than controls (45.8 ± 33.6 pg/ml for rmG-CSF prophylaxis vs. 16.8 ± 1.5 
for controls; p < 0.05) on day 3 of infection. No further differences in the concentrations 
of circulating cytokines on any day of infection were detected (data not shown).  
 
 
 
Figure 2 (for coulour printing, see cover). Histopathology of intra-abdominal Candida abscesses 
(x 400) in untreated mice and mice treated with rmG-CSF therapy (days 3 through 7), an 
antifungal agent or combination therapy on day 8 of infection. (A) Control mice showed an 
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inflammatory response to yeast cells with a low number of granulocytes bordered by a strong 
histiocytic response. (B) Mice treated with rmG-CSF had larger abscesses with an increased 
amount of granulocytes on a necrotic background. (C) Abscesses of amphotericin B-treated mice 
showed a necrotic area with disintegrating granulocytes. (D) The response of mice treated with 
rmG-CSF in combination with amphotericin B showed tissue necrosis, a histiocytic response, 
micro-abscess formation, and an increased number of granulocytes. (E) Abscesses of fluconazole 
treated mice revealed yeast cells in an area of necrosis with many granulocytes. (F) Abscesses of 
mice treated with rmG-CSF in combination with fluconazole had similar histopathologic features 
as those of mice treated with fluconazole alone, except for an increased number of granulocytes. 
 
Discussion 
The results of the present study indicate that modulation of host defence with rmG-
CSF prophylaxis significantly reduces the number of Candida cfu in intra-abdominal 
abscesses, whereas rmG-CSF therapy (administered on days 4 through 8 of infection) had 
neither a beneficial nor an adverse effect. Antifungal treatment of intra-abdominal 
Candida abscesses with amphotericin B was significantly more effective than treatment 
with fluconazole. Addition of rmG-CSF therapy to conventional antifungal treatment did 
not antagonize the individual effect of the antifungal agents. In contrast, it showed a trend 
towards further reduction of Candida cfu in abscesses compared to antifungal treatment 
alone. 
 
After injection of a sterile fecal suspension containing viable Candida blastoconidia, 
abscesses developed following a period of peritonitis. Administration of rmG-CSF during 
either of these periods had different effects on outgrowth from abscesses; rmG-CSF 
prophylaxis significantly reduced the amount of cfu in abscesses compared to that in 
abscesses of control mice, whereas administration rmG-CSF therapy induced a slight 
increase in the amount of cfu in abscesses compared with that in abscesses of control 
mice. Mice that had received rmG-CSF prophylaxis had large numbers of rmG-CSF-
primed polymorphonuclear granulocytes (PMN) present at the time of infection and thus 
an enhanced capacity to clear the injected Candida blastoconidia from their abdominal 
cavities compared to controls, as was demonstrated by a reduced outgrowth from 
abscesses from these mice.  
Although mice that had received prolonged rmG-GCSF prophylaxis showed an 
increased severity of diffuse peritonitis, the data were around the detection limit and do 
not seem to be of biological relevance, since it was not accompanied with an increased 
haematogenous dissemination of Candida into the kidneys. At the time of rmG-CSF 
therapy, which commenced not earlier than on day 3 of infection, abscesses were already 
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well-established, and at this point in time inflammatory cells other than granulocytes, such 
as macrophages and lymphocytes, gradually play a central role in host defence against 
Candida abscesses. G-CSF inhibits the TNF production by macrophages and monocytes 
[7,24], and has been shown to induce a Th2-type cytokine pattern via attenuation of 
monokine release [3,8]. Furthermore, we have previously shown that TNF is important for 
the clearance of Candida from intra-abdominal abscesses, primarily through induction of 
Th1 responses and enhancement of the extracellular killing capacity of granulocytes [25]. 
Hence, therapeutic administration of rmG-CSF was expected to have detrimental effects in 
this model of intra-abdominal Candida abscesses. However, rmG-CSF therapy had no 
adverse influence on the course of infection. Although the IL-10/IFNγ ratios of mice 
treated with rm-GCSF were significantly increased compared with controls, this may not 
have been of biological relevance. G-CSF not only increases the number of PMN, it also 
augments the expression of adhesion molecules, recruitment, and capacity to kill Candida 
blastoconidia [26-28]. These effects of G-CSF on anticandidal activity have probably 
compensated for the anti-inflammatory effect of G-CSF through its effect on macrophages 
and T-cells. 
 
Intra-abdominal abscesses are difficult to treat, and therapy consists primarily of 
drainage of the infected cavity with or without antimicrobial treatment. To date, no 
guidelines for the use of antifungal agents for treatment of intra-abdominal candidiasis 
exist. In an international conference of investigators with extensive experience in the 
treatment of candidal infections, 60 % of the investigators would treat patients with 
peritoneal candidiasis with fluconazole alone and 5 % with amphotericin B lipid 
formulation [5]. In our model, fluconazole had no beneficial influence on the course of 
experimental intra-abdominal Candida abscesses in mice, whereas amphotericin B 
improved clearance of Candida blastoconidia from abscesses. This is in contradiction with 
the study of Sawyer et al., which showed that fluconazole was as effective as amphotericin 
B in reducing the number of Candida recovered from experimental intra-abdominal 
abscesses [21]. In that study however, fluconazole therapy was started at the time of 
infection, and thus represents the effect of fluconazole on Candida peritonitis rather than 
on well-established Candida abscesses. Indeed, fluconazole prophylaxis has proven to 
prevent development of abdominal candidiasis in high-risk surgical patients [6].  
Simultaneous administration of combination therapy of fluconazole with amphotericin 
B was not as effective as amphotericin B treatment alone in reducing the number of cfu in 
abscesses in our experiments.  
    Chapter 8 
     
 155
Since combination therapy of an antifungal agent with G-CSF has proven to be more 
efficacious than antifungal treatment alone against disseminated candidiasis [9,12] it was 
hypothesized that combination of rmG-CSF therapy with antifungal agents may have a 
synergistic effect, despite the observation that therapy with rmG-CSF alone was not 
effective in our model of intra-abdominal abscesses. Addition of rmG-CSF therapy to 
either amphotericin B or fluconazole did not significantly improve the outcome, although 
there was a slight tendency towards further reducing the number of Candida cfu per 
abscess. Both amphotericin B and fluconazole accumulate within PMN [18], and their 
concentration might have been increased by G-CSF, which has been shown to increase the 
intracellular concentration of antibiotics [10]. In addition, histopathological examination 
of abscesses obtained from mice treated with rmG-CSF showed a larger number of 
granulocytes than in control mice. Serving as secondary transport systems for 
amphotericin B or fluconazole, these cells might have contributed to achieving higher 
drug concentrations in the abscesses. In our experiments however, these putative effects 
have not led to significant synergistic effects of rmG-CSF and antifungal agents.  
In conclusion, amphotericin B was effective in treating experimental intra-abdominal 
Candida abscesses, and concurrent administration of rG-CSF was suggested to further 
improve the outcome.  
 
Acknowledgements 
The authors thank Ineke Verschueren for the determination of cytokine concentrations 
and Geert Poelen, Theo van den Ing and Margot van den Brink for their assistance with 
the animal experiments 
Treatment of intra-abdominal C. albicans abscesses with G-CSF and antifunal agents 
     
156 
References 
1.  Anaissie, E. J., S. E. Vartivarian, D. Abi-Said, O. Uzun, H. Pinczowski, D. P. Kontoyiannis, P. Khoury, 
K. Papadakis, A. Gardner, I. I. Raad, J. Gilbreath, and G. P. Bodey. 1996. Fluconazole versus 
amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am.J.Med. 
101:170-176. 
2.  Barsig, J., D. S. Bundschuh, T. Hartung, A. Bauhofer, A. Sauer, and A. Wendel. 1996. Control of fecal 
peritoneal infection in mice by colony- stimulating factors. J.Infect.Dis. 174:790-799. 
3.  Boneberg, E. M., L. Hareng, F. Gantner, A. Wendel, and T. Hartung. 2000. Human monocytes express 
functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines 
and interferon-gamma. Blood 95:270-276. 
4.  Calandra, T., J. Bille, R. Schneider, F. Mosimann, and P. Francioli. 1989. Clinical significance of 
Candida isolated from peritoneum in surgical patients. Lancet 2:1437-1440. 
5.  Edwards, J. E., Jr., G. P. Bodey, R. A. Bowden, T. Buchner, B. E. de Pauw, S. G. Filler, M. A. 
Ghannoum, M. Glauser, R. Herbrecht, C. A. Kauffman, S. Kohno, P. Martino, F. Meunier, T. Mori, M. 
A. Pfaller, J. H. Rex, T. R. Rogers, R. H. Rubin, J. Solomkin, C. Viscoli, T. J. Walsh, and M. White. 
1997. International Conference for the Development of a Consensus on the Management and 
Prevention of Severe Candidal Infections. Clin.Infect.Dis. 25:43-59. 
6.  Eggimann, P., P. Francioli, J. Bille, R. Schneider, M. M. Wu, G. Chapuis, R. Chiolero, A. Pannatier, J. 
Schilling, S. Geroulanos, M. P. Glauser, and T. Calandra. 1999. Fluconazole prophylaxis prevents 
intra-abdominal candidiasis in high-risk surgical patients. Crit.Care Med. 27:1066-1072. 
7.  Gorgen, I., T. Hartung, M. Leist, M. Niehorster, G. Tiegs, S. Uhlig, F. Weitzel, and A. Wendel. 1992. 
Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced 
toxicity via suppression of systemic tumor necrosis factor-alpha. J.Immunol. 149:918-924. 
8.  Hartung, T., W. D. Doecke, D. Bundschuh, M. A. Foote, F. Gantner, C. Hermann, A. Lenz, S. Milwee, 
B. Rich, B. Simon, H. D. Volk, S. von Aulock, and A. Wendel. 1999. Effect of filgrastim treatment on 
inflammatory cytokines and lymphocyte functions. Clin.Pharmacol.Ther. 66:415-424. 
9.  Herbrecht, R., J. Waller, H. Koenig, P. Morier, and V. Letscher. 1996. Synergistic efficacy of 
recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated 
candidosis in non neutropenic mice. J.Mycol.Méd. 6:43-48. 
10.  Joiner, K. A., A. B. Onderdonk, J. A. Gelfand, J. G. Bartlett, and S. L. Gorbach. 1980. A quantitative 
model for subcutaneous abscess formation in mice. Br.J.Exp.Pathol. 61:97-107. 
11.  Kullberg, B. J., M. G. Netea, J. H. Curfs, M. Keuter, J. F. Meis, and J. W. van der Meer. 1998. 
Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated 
Candida albicans infection in nonneutropenic mice. J.Infect.Dis. 177:175-181. 
12.  Kullberg, B. J., M. G. Netea, A. G. Vonk, and J. W. van der Meer. 1999. Modulation of neutrophil 
function in host defense against disseminated Candida albicans infection in mice. FEMS 
Immunol.Med.Microbiol. 26:299-307. 
13.  Kullberg, B. J., J. W. van 't Wout, and R. van Furth. 1990. Role of granulocytes in increased host 
resistance to Candida albicans induced by recombinant interleukin-1. Infect.Immun. 58:3319-3324. 
14.  Kullberg, B. J., K. Vandewoude, R. Herbrecht, F. Jacobs, and P. Kujath. 1998. A double-blind, 
randomized, placebo-controlled Phase II study of filgrastim (recombinant granulocyte colony-
stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and 
candidemia in nonneutropenic patients. In: 38th Interscience Conference on Antimicrobial Agents and 
Chemotherapy; 1998; Washington, DC. Am.Soc.Microbiol.; p.479. 
15.  Lundblad, R., J. M. Nesland, and K. E. Giercksky. 1996. Granulocyte colony-stimulating factor 
improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and 
endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit.Care Med. 24:820-826. 
    Chapter 8 
     
 157
16.  National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal 
susceptibility testing of yeasts; Approved standard-second edition. NCCLS document M27-A2. Wayne, 
PA, 2002. 
17.  Netea, M. G., P. N. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. Stalenhoef, and J. 
W. van der Meer. 1996. Low-density lipoprotein receptor-deficient mice are protected against lethal 
endotoxemia and severe gram-negative infections. J.Clin.Invest. 97:1366-1372. 
18.  Pascual, A., I. Garcia, C. Conejo, and E. J. Perea. 1993. Uptake and intracellular activity of fluconazole 
in human polymorphonuclear leukocytes. Antimicrob.Agents Chemother. 37:187-190. 
19.  Rex, J. H., J. E. Bennett, A. M. Sugar, P. G. Pappas, C. M. van der Horst, J. E. Edwards, R. G. 
Washburn, W. M. Scheld, A. W. Karchmer, and A. P. Dine. 1994. A randomized trial comparing 
fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. 
N.Engl.J.Med. 331:1325-1330. 
20.  Rex, J. H., T. J. Walsh, J. D. Sobel, S. G. Filler, P. G. Pappas, W. E. Dismukes, and J. E. Edwards. 
2000. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. 
Clin.Infect.Dis. 30:662-678. 
21.  Sawyer, R. G., R. B. Adams, L. K. Rosenlof, A. K. May, and T. L. Pruett. 1995. Effectiveness of 
fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation. 
J.Med.Vet.Mycol. 33:131-136. 
22.  Sawyer, R. G., L. K. Rosenlof, R. B. Adams, A. K. May, M. D. Spengler, and T. L. Pruett. 1992. 
Peritonitis into the 1990s: changing pathogens and changing strategies in the critically ill. Am.Surg. 
58:82-87. 
23.  Solomkin, J. S., A. B. Flohr, P. G. Quie, and R. L. Simmons. 1980. The role of Candida in 
intraperitoneal infections. Surgery 88:524-530. 
24.  Terashima, T., K. Soejima, Y. Waki, H. Nakamura, S. Fujishima, Y. Suzuki, A. Ishizaka, and M. 
Kanazawa. 1995. Neutrophils activated by granulocyte colony-stimulating factor suppress tumor 
necrosis factor-alpha release from monocytes stimulated by endotoxin. Am.J.Respir.Cell Mol.Biol. 
13:69-73. 
25.  Vonk, A. G., M. G. Netea, J. H. Van Krieken, J. W. van der Meer, and B. J. Kullberg. 2002. Delayed 
clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and 
lymphotoxin-alpha- deficient mice. J Infect.Dis 186:1815-1822. 
26.  Wang, J. M., Z. G. Chen, S. Colella, M. A. Bonilla, K. Welte, C. Bordignon, and A. Mantovani. 1988. 
Chemotactic activity of recombinant human granulocyte colony- stimulating factor. Blood 72:1456-
1460. 
27.  Yamamoto, Y., T. W. Klein, H. Friedman, S. Kimura, and H. Yamaguchi. 1993. Granulocyte colony-
stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear 
cells. FEMS Immunol.Med.Microbiol. 7:15-22. 
28.  Yong, K. L. and D. C. Linch. 1992. Differential effects of granulocyte- and granulocyte-macrophage 
colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. 
Eur.J.Haematol. 49:251-259. 
  
  
 
 
 
 
 
Alieke G. Vonk, Mihai G. Netea, Nathalie E.J. Denecker, Ineke C.M.M. Verschueren,  
Jos W.M. van der Meer, Bart-Jan Kullberg 
 
Department of Medicine, Division of General Internal Medicine, 
University Medical Centre, Nijmegen, the Netherlands 
 
Journal of Antimicrobial Chemotherapy 1998; 42: 469-474 
© Oxford university press 
Modulation of the pro- and anti-inflammatory cytokine 
balance by amphotericin B 9
Cytokine modulation by amphotericin B 
     
160 
Abstract 
Amphotericin B is an antifungal drug associated with side effects such as fever and 
chills, symptoms which may be mediated by pro-inflammatory cytokines such as 
interleukin-1β (IL-1β) and tumour necrosis factor alpha (TNFα). We assessed the capacity 
of amphotericin B to modulate production of these pro-inflammatory cytokines as well as 
the anti-inflammatory IL-1 receptor antagonist (IL-1ra), induced by LPS, heat-killed 
Candida albicans, or Staphylococcus aureus.  
The results of the present study show that amphotericin B slightly increased the 
production of pro-inflammatory cytokines by human mononuclear cells (PBMC), whereas 
the production of the anti-inflammatory cytokine IL-1ra was significantly inhibited. This 
results in a shift towards pro-inflammatory cytokine production, as indicated by a 
decreased IL-1ra/IL-1β ratio. Semi-quantitative reverse transcription-polymerase chain 
reaction (RT-PCR) indicated that levels of IL-1β and TNFα mRNA were increased.  
In conclusion, amphotericin B is able to cause a shift towards pro-inflammatory 
cytokine production by human PBMC. This may explain the side effects, such as fever 
and chills, observed after treatment of patients with amphotericin B. 
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Introduction 
The polyene compound amphotericin B is the cornerstone for antifungal therapy in 
critically ill patients with systemic fungal infections. Amphotericin B binds with a high 
affinity to ergosterol, the principal sterol of the fungal cell membrane. This binding alters 
membrane permeability with subsequent leakage of cations, eventually resulting in cell 
death [15]. Apart from this direct antifungal effect, amphotericin B can also increase the 
fungicidal properties macrophages [15,17,21]. It is conceivable that the severe and dose-
limiting adverse effects of amphotericin B, such as fever and chills, may be mediated at 
least in part through induction of pyrogenic pro-inflammatory cytokines [15]. 
Tumour necrosis factor (TNFα) and interleukin-1 (IL-1) are pro-inflammatory 
cytokines which are thought to mediate many pathophysiological events in severe 
infections, including fever, hypotension and multiple organ failure [16]. Contradictory 
data have been published regarding the capacity of amphotericin B to induce production of 
pro-inflammatory cytokines. Some authors have reported that amphotericin B can induce 
synthesis of pro-inflammatory cytokines in vitro, [4,5,7,13,24] but others have been 
unable to reproduce such findings [11,17,22]. 
There are counter-regulatory mechanisms, such as the production of anti-
inflammatory cytokines, which can block the effects of pro-inflammatory cytokines. IL-1 
receptor antagonist (IL-1ra) is the natural antagonist of IL-1β; its binding to IL-1 receptor 
blocks the effects of IL-1β stimulation. The capacity of amphotericin B to inhibit the 
production of this potent modulatory cytokine could be an important factor causing the 
above-mentioned adverse effects. An imbalance between pro-inflammatory and anti-
inflammatory cytokines, expressed as the IL-1ra/IL-1β ratio, in favour of the pro-
inflammatory cytokines, was recently found to be a key event in patients with type I 
diabetes, chronic inflammatory bowel diseases, rheumatoid arthritis and Lyme arthritis 
[3,6,18,20].  
The aim of the present study was to investigate whether amphotericin B can stimulate 
pro-inflammatory cytokine production by human peripheral blood mononuclear cells 
(PBMC) or modulate cytokine production induced by various bacterial and fungal stimuli. 
We also assessed whether the balance between pro- and anti-inflammatory cytokines is 
modulated by amphotericin B. 
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Materials and methods 
Reagents 
Amphotericin B was purchased as Fungizone (Bristol-Myers Squibb, Woerden, The 
Netherlands) containing 50 mg of amphotericin B, 41 mg of sodium deoxycholate (DOC) 
and 20.2 mg of sodium phosphate and was dissolved in sterile, pyrogen-free dextrose 5%. 
The preparation contained < 0.06 endotoxin units of lipopolysaccharide (LPS) per ml as 
checked by a limulus amoebocyte lysate assay. LPS (Escherichia coli serotype O55:B5) 
was purchased from Sigma Chemical Co. (St.Louis, MO, USA). Culture medium (RPMI 
1640 DM; ICN Biomedicals, Costa Mesa, CA, USA) was supplemented with 5% human 
serum, 1% gentamicin (50 µg/ml), 1% L-glutamine (2mM), and 1% pyruvate (1mM). 
 
Stimulation of peripheral blood mononuclear cells 
PBMC were isolated as described [9], with minor modifications. Briefly, venous 
blood, obtained from nine healthy volunteers, was drawn into 10 mL tubes containing 0.2 
mg of EDTA (Monoject, 's-Hertogenbosch, The Netherlands). The PBMC fraction was 
obtained by density centrifugation of blood (diluted 1:1 in pyrogen free saline) over 
Ficoll-Paque (Pharmacia Biotech AB, Uppsala, Sweden). PBMC were containing washed 
twice in saline and resuspended in culture medium. The cells were counted in a Coulter 
counter (Coulter Electronics, Meijdrecht, the Netherlands) and the number was adjusted to 
3.3 x 106 cells/ml.  
The capacity of amphotericin B to stimulate or modulate cytokine production was 
assessed by incubating 150µL of the PBMC suspension (5 × 105cells) for 24 h at 37 °C in 
96-well plates (Greiner, Alphen a/d Rijn, The Netherlands) with amphotericin B in various 
concentrations (0, 0.125, 0.25, 0.5, 1 and 2 mg/L), or the corresponding vehicle, with or 
without LPS (1 ng/ml). 
To investigate the capacity of amphotericin B to modulate cytokine production 
induced by other inflammatory stimuli, PBMC were incubated for 24 h at 37 °C with heat-
killed (100°C, 30 min) Staphylococcus aureus (ATCC 25923), or heat-killed Candida 
albicans (strain UC820) at 2 × 106 cfu/well, in the presence or absence of amphotericin B 
(2 µg/ml). 
 
Cytokine measurements 
After 24 h of incubation at 37 °C in 5% CO2 with the stimuli mentioned, supernatants 
were collected, and frozen (-80°C) until measurement of cytokines. The concentrations of 
TNFα, IL-1β and IL-1ra were determined by radioimmunoassay as described previously 
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[8]. Detection limits were 20 pg/ml for TNFα, 40 pg/ml for IL-1β, and 600 pg/ml for IL-
1ra. 
 
mRNA measurement 
After 4 h of incubation at 37°C in 5% CO2 with the stimuli mentioned, the 
supernatants were discarded and 100 µL of RNAsol (Cinna/Biotecx Laboratories, 
Houston, TX, USA) were added to the adherent cells in order to isolate RNA. mRNA was 
isolated by the RNAsol method, as described by the manufacturer. Semi-quantitative 
reverse transcription-polymerase chain reaction (RT-PCR) (from a 0.5 µg sample RNA) 
was performed as described before [19]. The following primers used for the PCR reactions 
were: β2m, sense, 5`-CCAGCAGAGAATGGAAAGTC-3`, and antisense, 5`-
GATGCTGCTT- ACATGTCTCG-3`; TNFα, sense, 5`-ACAAGCCTG -
TAGCCCATGTT-3`, and antisense, 5`-AAAGTAGACCTGCCCAGACT-3`; IL-1β, 
sense, 5`GGATAT-GGAGCAACAAGTGG-3`, and antisense, 5`-ATGTACCAG-
TTGGGGAACTG-3` (Eurogenetic, Seraing, Belgium). PCR was performed (26 cycles for 
β2m; 30 cycles for IL-1β and TNFα) with each cycle comprising 92°C for 30 s, 55°C for 
30 s, and 72°C for 90 s, using a Mastercycler 5330 (Eppendorf, Hamburg, Germany). PCR 
products were run on 2% agarose gels stained with ethidium bromide. The gels were 
scanned on a densitometer (GS-670, Bio-Rad, Veenendaal, The Netherlands) and analysed 
using Molecular Analyst™ software (Bio-Rad). The relative amount of TNFα and IL-1β 
mRNA in a sample was expressed as a ratio relative to the amount of mRNA for the 
housekeeping gene β2m. 
 
Statistical analysis 
Values were expressed as means ± S.E.M. Comparisons between groups were 
performed using the Kruskall-Wallis test. The Wilcoxon signed-rank test was used for 
paired values. For all comparisons the level of significance was set at P < 0.05. 
 
Results 
Modulation of cytokine production by amphotericin B 
Stimulation of PBMC with amphotericin B did not influence IL-1β production, 
whereas TNFα production was marginally increased, and IL-1ra production slightly 
decreased when compared to unstimulated cells (Table I). 
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To assess the capacity of amphotericin B to modulate the LPS-induced production of 
cytokines, cells were incubated with LPS, or LPS plus amphotericin B. Amphotericin B 
slightly increased the LPS-induced IL-1β and TNFα production, whereas IL-1ra 
production was significantly reduced at amphotericin B concentrations of > 0.25 µg/ml 
(Table I).  
 
Determination of cytokine mRNA 
The expression of IL-1β mRNA by PBMC stimulated with 2mg/L amphotericin B 
was not influenced (Figure 1A), whereas TNFα mRNA was significantly higher than that 
in unstimulated cells (P < 0.05, Figure 1B).  
The combination of amphotericin B (2 mg/L) and LPS increased IL-1β mRNA (P 
<0.05, Figure 1A) and slightly increased TNFα mRNA when compared with LPS 
stimulation alone (Figure 1B). This strongly suggests that amphotericin B exerts its action 
at a transcriptional level. 
 
 
Figure 1. (A) IL-1β and (B) TNFα mRNA expression by human mononuclear cells incubated for 
24h with dextrose, amphotericin B (AmB; 2mg/L), LPS (1 ng/mL) or LPS + amphotericin B. Data 
are mean ± S.E.M of nine values. Comparisons between groups were performed using the 
Wilcoxon signed-rank test. aP < 0.05 when compared with dextrose stimulation. bP < 0.05 when 
compared with LPS stimulation alone. 
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Because an imbalance between the pro-inflammatory IL-1β and the anti-inflammatory 
IL-1ra may play an important role in the development of the adverse effects of 
amphotericin B therapy, we calculated the IL-1ra/IL-1β ratios. The IL-1ra/IL-1β ratio was 
significantly reduced in the presence of amphotericin B (Figure 2). 
 
Figure 2. IL-1ra/IL-1β ratio 
(mean ± S.E.M.), in the 
supernatants of human mono-
nuclear cells incubated for 24 h 
with LPS (1 ng/mL) or LPS + 
amphotericin B (AmB) in 
various concentrations. Com-
parisons between groups were 
performed using the Wilcoxon 
signed-rank test. aP <0.05 when 
compared with LPS stimulation. 
 
 
In a separate experiment, we investigated whether the duration of stimulation was 
important for the effect of amphotericin B. Cells were stimulated with LPS in the presence 
or absence of 1 mg/L amphotericin B and supernatants were harvested after 2, 4, 8, 12 and 
24 h of incubation. Cytokine production increased steadily as the duration of incubation 
increased. The production of TNFα an IL-1β was marginally increased, whereas IL-1ra 
production was decreased by amphotericin B with or without LPS stimulation (data not 
shown). These effects were similar at all time points tested and did not differ from those 
obtained with 24 h incubation. 
 
Table II. Cytokine production by human PBMC after incubation with heat-killed C. albicans or   
S. aureus and 2 mg/L amphotericin B 
 TNFα (ng/mL) IL-1β (ng/mL)  IL-Ra (ng/mL) 
C. albicans 12.5 ± 7.1  6.4 ± 4.3 12.8 ± 3.8 
C. albicans + amphotericin B 11.5 ± 6.3  5.6 ± 3.4 10.3 ± 2.2 
S. aureus 11.9 ± 6.3  5.1 ± 2.8 12.9 ± 2.3 
S. aureus + amphotericin B 11.1 ± 6.2  6.5 ± 3.9 10.0 ± 3.0a 
aP < 0.05 compared with S. aureus stimulation alone (Wilcoxon signed-rank test) 
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Stimulation of PBMC with C. albicans or S. aureus 
To investigate whether amphotericin B can modulate cytokine production in response 
to inflammatory stimuli other than LPS, we assessed the cytokine production of PBMC 
induced by heat-killed C. albicans or S. aureus with or without amphotericin B (2 mg/L). 
After 24 h of incubation, no significant effect of amphotericin B on cytokine production 
induced by C. albicans was found (Table II). S. aureus-induced production of TNFα was 
not influenced by amphotericin B, whereas IL-1β was marginally increased (Table II). In 
contrast, IL-1ra production was significantly decreased by amphotericin B (P < 0.02, 
Table II). This resulted in a significantly reduced IL-1ra/IL-1β ratio (P < 0.02, Figure 3). 
Figure 3. IL-1ra/IL-1β ratio (mean ± S.E.M.) in the supernatants of PBMC incubated for 24 h with 
heat-killed S. aureus or C. albicans with (hatched bars) or without (open bars) amphotericin B 
(2mg/L). Comparisons between groups were performed using the Wilcoxon signed-rank test. aP < 
0.05. 
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Discussion 
In view of the side effects of intravenously administered amphotericin B, such as fever 
and chills, it is conceivable that the pathophysiological mechanism responsible for this 
phenomenon involves an imbalance in the production of pro-inflammatory and anti-
inflammatory cytokines. This balance was recently found to play a key role in patients 
with type I diabetes, chronic inflammatory bowel diseases, rheumatoid arthritis or Lyme 
arthritis [3,6,18,20]. 
Until now, the reports on the capacity of amphotericin B to stimulate the production of 
cytokines in vivo have been contradictory. Several investigators have reported increased 
cytokine production upon amphotericin B stimulation of mononuclear cells in vitro 
[5,7,13,14,24], whereas others have been unable to find such an effect [11,17,22]. In order 
to explain this discrepancy, it is important to stress that, in the studies reporting induction 
of cytokines by amphotericin B, the stimulation was much lower than that obtained with a 
strong stimulus such as LPS [4,5,7,24]. An explanation that may account for the reported 
differences between studies is the source of the cells used in the studies: some studies 
were performed with human PBMC [11,17,22], whereas others used murine macrophages 
[5,7,13,14,24]. 
 
It has been reported that amphotericin B affects the production of pro-inflammatory 
cytokines in vivo after administration to mice [13,14]. Together with the clinical
 
finding 
that amphotericin B causes fever accompanied by increased cytokine
 
concentrations when 
injected into humans [2,17,17,23] and the moderate effect of amphotericin B on pro-
inflammatory cytokine production by human PBMC in vitro, these findings suggest that 
pyrogens may be induced via an indirect mechanism in vivo after injection of 
amphotericin B. Interactions with plasma factors or induction of secondary mediators of 
cytokine induction could be involved. 
Several authors have reported that amphotericin B can inhibit the cytokine production 
induced by C. albicans [11,14,22]. However, in two
 
of these studies [11,14], 
 
live C. 
albicans with or without amphotericin B, or filtrates from live Candida pre-incubated with 
amphotericin B were added to cells. In both cases differential growth of the micro-
organism in the presence of the antifungal drug could have been the cause of reduced 
cytokine production. In the study of Raponi and colleagues [22], C. albicans was pre-
incubated with amphotericin B before being added to cells, and this pre-incubation might 
have affected the amounts of mannoproteins on the cell wall of the yeasts [1]. Since 
mannoprotein constituents are potent inducers of pro-inflammatory cytokines [25], it is 
probable that modification of the Candida cell wall by amphotericin B was responsible for 
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the decreased induction of cytokines. As we added heat-killed C. albicans and 
amphotericin B at the same time-point to PBMC, modulation of Candida growth by 
amphotericin B did not occur and the changes in the cell wall of the yeast may have been 
less significant. As a result, no effect of amphotericin B on C. albicans-induced cytokine 
production by PBMC was found. 
Amphotericin B did not influence the S. aureus-induced production of TNFα. 
However, it marginally increased IL-1β production and significantly reduced IL-1ra 
production, resulting in a significantly reduced IL-1ra/IL-1β ratio. Unlike the cell wall of 
Gram-negative bacteria, the cell walls of Gram-positive bacteria like S aureus do not 
contain LPS; instead they contain lipoteichoic acids (LTAs). The physiochemical 
properties of LTAs are similar to those of LPS [10,12]. Kusunoki and colleagues [12], 
showed that S. aureus LTA binds soluble CD14 and blocks binding of LPS to soluble 
CD14. The similarity between LPS and LTA may explain the resemblance of the PBMC 
response to LPS and S. aureus found in our study. 
In conclusion, amphotericin B can cause a shift towards pro-inflammatory cytokine 
production by human PBMC. This may explain the side effects, such as fever and chills, 
observed after intravenous administration of amphotericin B to patients with systemic 
mycosis.  
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To the Editor—We read with great interest the article by Rogers et al. [8] reporting 
the activation by amphotericin B of human genes encoding for the pro-inflammatory 
cytokines tumour necrosis factor (TNF) and interleukin (IL)–1β and for the anti-
inflammatory cytokine IL-1 receptor antagonist (IL-1Ra). Amphotericin B is still a major 
component of antifungal therapy, but its use is limited by severe adverse effects such as 
fever, chills, and hypotension. It has been hypothesized that these adverse effects of 
amphotericin B treatment are mediated through induction of pyrogenic pro-inflammatory 
cytokines [1-3,9]. The increase of the mRNA expression of these genes reported by 
Rogers et al. represents a strong argument that amphotericin B induces production of 
cytokines through transcriptional mechanisms, and this information may prove valuable in 
finding strategies to combat this deleterious side effect of the drug. JID 1999;180 
(October) Correspondence 1409 Recently, we also reported that amphotericin B increases 
the production of pro-inflammatory cytokines by human mononuclear cells, and this 
induction is mediated through activation of transcription of TNF and IL-1β genes [10], 
sustaining the results of Rogers et al. Our data not only corroborate the results of Rogers et 
al. that amphotericin B alone can induce TNF and IL-1β mRNA expression, but we 
extended these observations with data showing that amphotericin B potentiates 
lipopolysaccharide (LPS)–induced TNF and IL-1 mRNA expression. However, Candida 
albicans and Staphylococcus aureus–stimulated expression of cytokine genes were not 
influenced by amphotericin B [10], suggesting that induction of pro-inflammatory 
cytokines by different microbial stimuli is mediated through divergent pathways that are 
differentially modulated by amphotericin B.  
 
Rogers et al. [6] also reported that the production of the anti-inflammatory cytokine 
IL-1Ra, as well as the expression of IL-1Ra mRNA, are significantly stimulated by 
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amphotericin B [6]. As IL-1Ra can block the IL-1 receptors and antagonize the pro-
inflammatory action of IL-1, they hypothesized that this may represent a counter 
regulatory mechanism involved in the attenuation of the amphotericin B–related adverse 
effects. In contrast with the data of Rogers et al. obtained in a human monocytic cell line, 
we showed that amphotericin B under similar conditions causes a significant reduction of 
the spontaneous release of IL-1Ra by freshly isolated peripheral blood mononuclear cells 
(PBMC) of healthy volunteers [10]. Moreover, LPS and S. aureus–induced IL-1Ra 
production was also down-regulated by amphotericin B [10]. This inhibition results in a 
shift toward pro-inflammatory cytokine production, as indicated by a significantly 
decreased IL-1Ra/IL-1β ratio. This balance was recently found to play a key role in type I 
diabetes, chronic inflammatory bowel diseases, rheumatoid arthritis, and Lyme arthritis, 
and we propose that it also represents an important pathophysiologic mechanism 
mediating such adverse effects as fever and chills caused by amphotericin B treatment.  
  
The cause of the differences in IL-1Ra induction between our study and those of 
Rogers et al. remains speculative. The cell types used in the experiments constitute the 
major difference between the two studies. In our study, we used freshly isolated PBMC, 
whereas Rogers et al. used the human mononuclear cell line THP-1, on which the effects 
of amphotericin B may be divergent. It may be hypothesized that the effects of 
amphotericin B on PBMC of human volunteers may closely mimic those in human 
subjects. The importance of the cell type used in this type of experiments is also 
underlined by the contradictory data in the literature regarding the capacity of 
amphotericin B to stimulate the production of cytokines. Several investigators have 
reported increased cytokine production upon amphotericin B stimulation of mononuclear 
cells in vitro [2,5,9], whereas others have been unable to find such an effect [4,6,7]. An 
explanation that may account for these differences is the source of the cells used; some 
studies have been done with human PBMC [3,4,6,7], and others have used murine 
macrophages [2,5,9]. It is also important to underline that even in the studies reporting 
induction of cytokines by amphotericin B, the stimulation was much lower than that 
obtained with a strong stimulus such as LPS [1–3,9]. Given the strong potency of 
amphotericin B to induce chills and fever in vivo, one may wonder whether the in vitro 
findings regarding cytokines explain these side effects. 
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As it takes two to make a quarrel, so it takes two to make a disease, the microbe and 
its host [1]. 
 
The yeast Candida albicans is the primary etiologic agent of disseminated and 
invasive candidiasis. The incidence of disseminated and invasive candidiasis has 
paralleled the use of modern medical procedures that adversely affect the immune system, 
and highlights the difficulty of treating disseminated and invasive candidiasis. 
Overcoming these difficulties requires an improved understanding of host - C. albicans 
interactions. The most important aspect of these interactions is the host defence system. 
The nature and extent of the impairment of the host resistance determines the pattern of 
candidiasis. A better understanding of the mechanisms responsible for the defence against 
disseminated and invasive Candida infection is needed, in order to develop strategies 
aimed to enforce the anticandidal actions of the immune system. In this thesis, studies on 
host defence against disseminated and invasive candidiasis are described. Determination 
of the virulence attributes of C. albicans allowing commensalism or tissue invasion were 
not the subject of these studies. 
 
The contribution of phagocytes to host defence can be assessed by determining 
phagocytosis and killing of Candida blastoconidia by means of the classical 
microbiological method of colony counting. However, these assays yield divergent results 
due to various methodological variations. To determine the most precise method for 
assessment of phagocytosis and intracellular killing of Candida blastoconidia by murine 
peritoneal phagocytes, microbiological candidacidal assays, such as yeast-phagocyte 
suspensions and an adherent monolayer of phagocytes were compared (Chapter 2). We 
concluded that yeast-phagocyte suspensions are inappropriate for the assessment of 
intracellular killing of Candida blastoconidia by murine macrophages, due to adherence of 
Candida blastoconidia to the wall of the tubes or clumping of cells. In contrast, the 
adherent monolayer of phagocytes could be applied to independently study the process of 
phagocytosis and intracellular killing by both exudate peritoneal macrophages and exudate 
peritoneal PMNs. As a result, this assay was implemented in our laboratory.  
In line with previous reports, we found that resident murine peritoneal macrophages 
were unable to kill ingested C. albicans and demonstrated that exudate peritoneal 
macrophages as well as peritoneal PMNs were able to ingest and kill C. albicans 
blastoconidia. This suggests that macrophages need priming with an inflammatory 
stimulus for killing of C. albicans blastoconidia. Exudate peritoneal PMNs showed 
significantly higher killing percentages compared with exudate peritoneal macrophages.  
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Both C. albicans blastoconidia and hyphal morphologies are found in lesions and 
PMNs are the predominant effector cells in host defence against C. albicans, as described 
on page 12. Therefore, the extracellular antihyphal activity of PMNs, in addition to 
determination of their intracellular capacity to kill phagocytized Candida blastoconidia, 
should be determined to further characterize the PMN-mediated host response against C. 
albicans. To this purpose, a tetrazolium dye assay was optimized (Chapter 3). This assay 
reliably assessed fungal viability by measuring the amount of orange water-soluble 
formazan that is produced by conversion of XTT by fungal mitochondrial dehydrogenases 
in the presence of an electron-acceptor. Similar to the phagocytosis and killing assay 
described in chapter 2, the assay to quantify the extracellular damage of C. albicans 
pseudohyphae was implemented in our laboratory.  
Because previous studies have shown that recombinant Th1-type cytokines, such as 
TNF and IFNγ, enhance anticandidal PMN-activity, the influence of Th1-type cytokines 
on C. albicans antihyphal activity of PMN was studied (Chapter 3). PMN obtained from 
mice lacking the genes encoding for TNF/LT, IFNγ, IL-12, IL-18, IL-1α, or IL-1β were 
used. It was shown that PMN-mediated damage of Candida pseudohyphae, the 
predominating growth form in invasive lesions of candidiasis, is significantly reduced in 
absence of endogenous TNF/LT, IFNγ, or IL-1α, whereas the PMN-mediated damage 
appeared to be unaltered or even slightly improved in mice deficient in endogenous IL-12 
and IL-18, respectively.  
Although the intracellular killing of C. albicans blastoconidia by TNF/LT-/- PMNs 
appeared to be normal [2], the results of Chapter 3 showed that the extracellular 
pseudohyphal damage by TNF/LT-/- PMNs was decreased. Therefore, it is concluded that 
for full characterisation of the PMN-mediated host response against C. albicans both 
intracellular and extracellular killing should indeed be determined. 
 
Disseminated candidiasis 
Exogenous administration of recombinant human IL-1α or IL-1β in disseminated 
murine candidiasis has indicated a protective role for IL-1 in disseminated C. albicans 
infection. The mechanisms for this beneficial effect have not fully been elucidated. 
Interestingly, we found that IL-1α and not IL-1β was important for PMN-mediated 
damage of Candida pseudohyphae (Chapter 3). To gain further insight into the 
mechanisms through which both endogenous molecules confer protection against infection 
with C. albicans, IL-1α-/-, IL-1β-/-, IL-1α-/-β-/- and control mice were subjected to 
experimental C. albicans infection (Chapter 4). The results of the present study show that 
endogenous IL-1 is required for host defence against disseminated C. albicans infection. 
IL-1-deficient mice showed an increased mortality, associated with an increased 
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outgrowth of C. albicans in the kidneys. Moreover, a functional difference between IL-1α 
and IL-1β was observed again. IL-1β, both by itself and by inducing the production of KC, 
proved to be important for recruitment of granulocytes to the site of infection, and IL-1β 
was important for the generation of superoxide production. IL-1α was essential for the 
capacity of granulocytes to damage Candida pseudohyphae and both IL-1α and IL-1β 
were required for the induction of protective Th1 responses.  
The IL-1-receptor type I has been shown to be the only IL-1 receptor that leads to 
signal transduction after engagement of IL-1α or IL-1β. However, the results of Chapter 
4 show that IL-1α and IL-1β are able to induce different responses. A similar result was 
obtained from studying the pathogenesis of rheumatoid arthritis, where IL-1β has been 
shown to be the pivotal cytokine in bone and cartilage destruction and not IL-1α [3].  
Future studies into the mechanism of transduction of the IL-1 signal may be needed to 
elucidate the different results induced by IL-1α or IL-1β.  
Histopathological examination of the kidneys of IL-1α-/- mice suggested that these 
mice had an increased number of Candida cfu in the collecting ducts of their kidneys 
compared with IL-1β-/- and control mice. It cannot be excluded that IL-1α is important for 
the production of a candidacidal substance that is excreted in the urine. This hypothesis 
may be tested in the future.  
 
Administration of recombinant IL-18 protects mice against disseminated C. albicans 
infection [4], and administration of IL-12 may have either protective or deleterious effects 
during disseminated candidiasis. Thus, it is apparent that IL-18 and IL-12 play a 
significant role in the host defence against disseminated candidiasis, but a clear 
characterization of their modulating effects is still missing. To clarify the effects of 
endogenous IL-18 and IL-12 in host defence against candidiasis, IL-18-/-, IL-12-/-, and 
control mice were intravenously infected with C. albicans (Chapter 5). IL-18-/- mice, but 
not IL-12-/- mice, displayed an increased mortality due to C. albicans infection, 
accompanied by a decreased clearance of the yeasts from the kidneys late during the 
course of infection. Furthermore, histopathology of the organs, combined with phagocyte 
recruitment experiments, showed a decreased influx of monocytes at the site of Candida 
infection, mainly in the IL-18-/- mice. Whereas production of the chemokine KC was 
decreased in both IL-18-/- and IL-12-/- mice, MIP-2 production was deficient only in IL-18-
/- animals, which may explain the differences in monocyte recruitment. Because IL-18 and 
IL-12 are strong stimuli of IFN-γ production, and IFN-γ plays a crucial role in the defence 
against infection with Candida albicans, production of IFN-γ was determined. Although 
IFN-γ production was reduced in IL-12-/- mice, this reduction was even more pronounced 
in IL-18-/- mice. In conclusion, the anticandidal effects of endogenous IL-18 are mediated 
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late during Candida infection by assuring a proper IFN-γ response and promoting the 
infiltration of the site of infection by monocytes. In addition, the results of Chapter 3 and 
other studies from our group [4] did not show an effect of IL-18 on PMN function, 
explaining why there was no effect early during the course of disseminated candidiasis. 
 
Lipoproteins have also been shown to modulate host defence against candidiasis. In 
Chapter 6, the immunomodulating activity of increased VLDL levels and apolipoprotein 
E in disseminated candidiasis was investigated. ApoE -/- and control mice were used in 
the experiments. ApoE -/- mice exhibited a susceptibility to acute disseminated candidiasis 
that exceeded that of ApoE +/+ mice; mortality due to candidemia was significantly higher 
in ApoE -/- mice, and outgrowth of C. albicans blastoconidia from the kidneys became 
elevated in ApoE -/- mice. These data indicate that lipoproteins play a significant role in 
host defence against candidiasis.  
The increased susceptibility of ApoE -/- mice appeared to be the result of an increased 
growth of C. albicans in plasma due to lipids serving as nutrients, as well as the 
neutralization of candidacidal factors by lipoproteins. No neutralizing effect was observed 
for ApoE itself. However, the candidacidal factors have not been identified. Future studies 
are needed to extract these factors from serum (Chapter 6) or urine (as suggested to be 
induced by IL-1α, Chapter 4). 
 
Invasive candidiasis 
Candida albicans has also been shown to cause invasive candidiasis, i.e. C. albicans 
peritonitis and formation of C. albicans abscesses. TNF and LT play a major role in host 
defence against disseminated candidiasis. Furthermore, evidence exists that the systemic 
use of monoclonal antibodies against TNF for treatment of patients with an inflammatory 
bowel disease might increase the risk of invasive fungal infections. The mechanisms 
through which neutralization of endogenous TNF increases the susceptibility to fungal 
infections are incompletely understood. Therefore, the role of endogenous TNF and LT in 
a model of intra-abdominal Candida abscesses in TNF-/-LT-/- mice and their wild-type 
littermates was investigated (Chapter 7). The main conclusion of this study is that TNF 
and LT are necessary for host defence against intra-abdominal Candida abscesses. Two 
factors contributed to the reduced host resistance of TNF-/-LT-/- mice. First, TNF-/-LT-/- 
granulocytes were significantly impaired in their capacity to damage C. albicans 
pseudohyphae extracellularly. Secondly, TNF-/-LT-/- mice had a delayed Th1 response, as 
was shown by the significantly increased IL-10/IFNγ ratio during the first week of 
infection. This delayed Th1 response is likely to lead to a deficient stimulation of effector 
cells, resulting in a significantly increased fungal burden in the abscesses. Our data, as 
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well as those from others, indicate that TNF and LT are not essential to abscess and 
granuloma formation. TNF and LT play a major role in the subsequent stage of infection, 
i.e. the containment and clearance of abscesses through killing of micro-organisms.  
In general, abdominal candidiasis and abscesses are difficult to treat with 
antimicrobial drugs. Despite antifungal treatment, mortality remains high and additional 
therapy with G-CSF that augments host defence may be of potential therapeutic benefit. 
However, treatment with G-CSF might also be detrimental to host defence, as G-CSF has 
been shown to down-regulate TNF production, which may worsen outcome of intra-
abdominal Candida abscesses, as evidenced by the results of Chapter 7. Therefore, the 
influence of antifungal treatment with or without G-CSF administration in a model of 
intra-abdominal Candida abscesses was investigated (Chapter 8). The results indicated 
that modulation of host defence with rmG-CSF prophylaxis significantly reduces the 
number of Candida cfu in intra-abdominal abscesses, whereas rmG-CSF therapy 
(administered on days 4 through 8 of infection) had neither a beneficial nor an adverse 
effect. Antifungal treatment of intra-abdominal Candida abscesses with amphotericin B 
was significantly more effective than treatment with fluconazole. Addition of rmG-CSF 
therapy to conventional antifungal treatment did not antagonize the individual effect of the 
antifungal agents. In conclusion, amphotericin B was effective in treating experimental 
intra-abdominal Candida abscesses, and concurrent administration of rG-CSF was 
suggested to further improve the outcome. 
 
Interestingly, fluconazole was not effective in treating intra-abdominal abscesses 
induced by a fluconazole-susceptible C. albicans strain. The plasma concentrations of 
fluconazole were adequate (trough plasma concentration of 24 times the MIC). Thus, there 
remain two possible explanations for the fact that fluconazole was not as effective as 
amphotericin B in treating intra-abdominal Candida abscesses as it was in treating 
candidemia. First, fluconazole may not penetrate into abscesses. Second, within pus 
fluconazole might loose its biological activity. Because Joiner et al. showed that most 
antibiotic agents freely diffuse into abscesses despite the lack of fenestrated vascular 
supply and the presence of a collagen wall [5], it is tempting to assume that fluconazole is 
inactivated by pus of Candida abscesses. This assumption may be tested by future 
investigations of the penetration of fluconazole into abscess fluid and the influence of 
abscess fluid on the antifungal activity of fluconazole. 
 
Amphotericin B derives its beneficial effect mainly from direct candidacidal action. In 
addition, amphotericin B reportedly enhances host defence mechanisms by modulating the 
production of pro-inflammatory cytokines. The latter phenomenon may also be associated 
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with side-effects such as fever and chills. However, contradictory data have been 
published regarding the capacity of amphotericin B to induce production of pro-
inflammatory cytokines. We investigated whether amphotericin B stimulates pro-
inflammatory cytokine production by human PBMC or modulates cytokine production 
induced by different bacterial and fungal stimuli (Chapter 9). Amphotericin B alone 
induced TNF and IL-1β mRNA expression, and amphotericin B enhanced the 
lipopolysaccharide (LPS)–induced TNF and IL-1β mRNA expression. However, Candida 
albicans and Staphylococcus aureus–stimulated expression of pro-inflammatory cytokine 
genes were not enhanced by amphotericin B. In contrast, amphotericin B reduced the 
amount of IL-1ra released upon stimulation with LPS and heat-killed S. aureus, as 
reflected by significantly decreased IL-1ra/IL-1β ratios.  
These data suggest that induction of cytokine production by different microbial 
stimuli is mediated through divergent pathways that are differentially modulated by 
amphotericin B. Such a pathway may be the TLR-dependent signal transduction. C. 
albicans possibly suppresses the pro-inflammatory response induced by amphotericin B 
by stimulating the TLR2-mediated production of IL-10 [6]. 
Given the moderate effect of amphotericin B on pro-inflammatory cytokine 
production by human PBMC in vitro and the strong potency of amphotericin B to induce 
fever and chills in vivo, these findings suggest that pyrogens may be induced via an 
indirect mechanism in vivo after injection of amphotericin B. Interactions with plasma 
factors or induction of secondary mediators of cytokine induction could be involved. 
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De gist Candida albicans is de belangrijkste veroorzaker van gedissemineerde en 
invasieve infecties door Candida (candidiasis). De incidentie van gedissemineerde en 
invasieve candidiasis loopt parallel met het gebruik van moderne medische procedures die 
het immuunsysteem ondermijnen. Dit illustreert tevens dat de behandeling ervan 
gecompliceerd is. Verruiming van inzicht in de interacties tussen de gastheer en C. 
albicans zou deze situatie kunnen verbeteren. Het belangrijkste aspect van deze interacties 
is de gastheerweerstand. Het onderliggende defect in de gastheerweerstand bepaalt 
namelijk zowel de wijze waarop candidiasis zich manifesteert als de ernst ervan. Om in de 
toekomst behandelmethoden te ontwikkelen die erop gericht zijn de gastheerweerstand 
tegen gedissemineerde en invasieve candidiasis te versterken, is een beter inzicht in de 
afweermechanismen tegen C. albicans noodzakelijk. In dit proefschrift wordt onderzoek 
naar de afweermechanismen tegen gedissemineerde en invasieve candidiasis beschreven. 
Onderzoek naar virulentiefactoren die bepalen of C. albicans als onschuldige bewoner 
(commensaal) aanwezig zal zijn of tot invasieve groei overgaat zijn daarbij buiten 
beschouwing gelaten.  
 
De bijdrage van fagocyten (witte bloedcellen die micro-organsimen kunnen opnemen 
en verteren) aan de gastheerweerstand wordt doorgaans vastgesteld door het bepalen van 
fagocytose en intracellulair doden van Candida blastoconidia. Dit geschiedt gewoonlijk 
door middel van klassieke microbiologische methoden waarbij het aantal Candida 
kolonies wordt gekwantificeerd. Omdat deze bepalingen methodologisch verschillen, 
variëren de resultaten. In Hoofdstuk 2 zijn enkele van deze bepalingen die gebruik maken 
van gist-fagocyt suspensies en een adherente cellaag van fagocyten met elkaar vergeleken. 
Het doel van deze vergelijking was om de meest nauwgezette methode vast te stellen om 
het fagocyteren en doden van Candida blastoconidia door fagocyten te bepalen. Dit 
onderzoek heeft aangetoond dat gist-fagocyt suspensies ongeschikt zijn voor correcte 
determinatie van het intracellulair doden van Candida blastoconidia door macrofagen 
afkomstig van muizen. Candida blastoconidia blijken namelijk samen te klonteren of aan 
de wand van testbuizen te kleven. De adherente cellaag van fagocyten bleek daarentegen 
juist wel geschikt om zowel de fagocytose als het doden van de gefagocyteerde Candida 
blastoconidia door exsudaat macrofagen en granulocyten (PMNs) te kwantificeren. Deze 
bepaling is in ons laboratorium in gebruik genomen.  
In overeenstemming met voorgaand onderzoek heeft deze studie aangetoond dat 
residente peritoneal macrofagen niet in staat zijn gefagocyteerde Candida blastoconidia te 
doden. Exsudaat peritoneaal macrofagen doodden gefagocyteerde Candida blastoconidia 
echter wel. Dit suggereert dat macrofagen eerst aan een inflammatoire stimulus moeten 
zijn blootgesteld, c.q. zijn geactiveerd, alvorens zij tot het doden van gefagocyteerde 
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Candida blastoconidia over kunnen gaan. Bovendien doden exsudaat PMNs een groter 
aantal gefagocyteerde Candida blastoconidia dan exsudaat macrofagen.  
Zowel Candida blastoconidia als (pseudo)hyfen zijn aanwezig in een infectiehaard. 
PMNs zijn de belangrijkste cellen in de afweer tegen Candida infecties, zoals beschreven 
op pagina 12. Om de PMN-gemedieerde gastheerweerstand volledig te karakteriseren zou 
derhalve naast de fagocytose en het intracellulair doden van Candida blastoconidia door 
PMNs, tevens de extracellulaire beschadiging van (pseudo)hyfen door PMNs moeten 
worden onderzocht. Hiervoor kan een XTT-assay gebruikt worden. In aanwezigheid van 
een electron-acceptor kunnen mitochondriale dehydrogenases van levende (pseudo)hyfen 
het substraat XTT omzetten in een oranje kleurstof. De hoeveelheid geproduceerde 
kleurstof is meetbaar en een maat voor de biomassa. Deze tetrazolium kleuring werd 
geoptimaliseerd en bleek de biomassa reproduceerbaar en betrouwbaar vast te kunnen 
stellen (Hoofdstuk 3). Ook deze bepaling werd in ons laboratorium in gebruik genomen.  
 
Cytokinen zijn signaaleiwitten die van nature in het lichaam voorkomen en tijdens 
infectie mede de communicatie tussen de verschillende cellen van het afweersysteem 
verzorgen. Voorgaand onderzoek heeft uitgewezen dat recombinante type Th1 cytokinen, 
zoals TNFα en IFNγ, de anti-Candida werking van PMNs potentieren. Om deze reden 
werd de invloed van Th1 cytokinen op het vermogen van PMNs om Candida 
(pseudo)hyfen te beschadigen bestudeerd (Hoofdstuk 3). Hierbij werd gebruik gemaakt 
van PMNs afkomstig van muizen waarin de genen waren verwijderd coderend voor de 
cytokinen TNF/LT, IFNγ, IL-12, IL-18, IL-1α, of IL-1β. De resultaten toonden aan dat de 
PMN-gemedieerde beschadiging van Candida (pseudo)hyfen, de overheersende 
morfologie in invasieve candidiasis lesies, significant was gereduceerd in afwezigheid van 
endogeen TNF/LT, IFNγ, of IL-1α. De PMN-gemedieerde beschadiging van Candida 
(pseudo)hyfen was onveranderd tot licht verbeterd in afwezigheid van endogeen IL-12 of 
IL-18.  
Terwijl de capaciteit van TNF/LT-/- PMNs om Candida blastoconidia intracellulair te 
doden normaal bleek te zijn [1], wijzen de resultaten van Hoofdstuk 3 uit dat de 
extracellulaire beschadiging van (pseudo)hyfen door TNF/LT-/- PMNs significant was 
afgenomen. Het is daarom gerechtvaardigd te concluderen dat voor volledige 
karakterisering van de PMN-gemedieerde gastheerweerstand tegen C. albicans zowel het 
intra- als extracellulaire doden van Candida groeivormen zou moeten worden bepaald. 
 
Gedissemineerde candidiasis 
Uit voorgaand onderzoek is gebleken dat toediening van recombinant humaan IL-1α 
of IL-1β een beschermend effect heeft op muizen met gedissemineerde candidiasis. De 
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mechanismen die aan dit positieve effect ten grondslag liggen zijn echter nog niet volledig 
opgehelderd. Daarnaast leerde Hoofdstuk 3 ons dat IL-1α en niet IL-1β van belang was 
voor de PMN-gemedieerde beschadiging van Candida (pseudo)hyphae. Om meer inzicht 
te verkrijgen in de mechanismen waardoor endogeen IL-1α en IL-1β beschermen tegen 
gedissemineerde candidiasis werden IL-1α-/-, IL-1β-/-, IL-1α-/-β-/- en immunocompetente 
muizen intraveneus geïnfecteerd met C. albicans (Hoofdstuk 4). Uit deze studie blijkt dat 
endogeen IL-1 noodzakelijk is voor de gastheerweerstand tegen een gedissemineerde C. 
albicans infectie. De mortaliteit onder IL-1-deficiente muizen was toegenomen en ging 
gepaard met een groter aantal C. albicans kolonies in de nieren. Bovendien werd wederom 
een functioneel verschil tussen IL-1α en IL-1β waargenomen. IL-1β was van belang voor 
de influx van PMNs naar de plaats van infectie, zowel direct als indirect doordat het de 
productie van chemokine KC induceert. IL-1β was ook nodig voor de generatie van 
superoxide door PMNs. IL-1α was cruciaal voor de capaciteit van PMNs om Candida 
(pseudo)hyfen te beschadigen. Zowel IL-1α als IL-1β was noodzakelijk voor de inductie 
van een beschermende Th1 respons.  
De IL-1-receptor type I is de enige IL-1 receptor die tot signaaltransductie leidt nadat 
IL-1α of IL-1β aan de receptor zijn gebonden. Echter, de resultaten van Hoofdstuk 4 
hebben aangetoond dat IL-1α en IL-1β in staat zijn verschillende reacties te induceren. 
Een overeenkomstig resultaat werd gevonden bij bestudering van de pathogenese van 
rheumatoide arthritis [2]. IL-1β heeft hierbij een centrale plaats in de destructie van bot en 
kraakbeen, en niet IL-1α. Verder onderzoek naar de mechanismen die betrokken zijn bij 
de IL-1 signaaltransductie kan nodig zijn om het verschillende effect van IL-1α en IL-1β 
te kunnen verklaren.  
Histopathologie van de nieren van IL-1α-/- muizen suggereerde dat deze muizen een 
groter aantal Candida kolonies in de verzamelbuizen hadden in vergelijking met 
immunocompetente en IL-1β-/- muizen. Dat endogeen IL-1α van belang is voor de 
productie van een candidacide factor die in de urine wordt uitgescheidenis is een 
interessante hypothese die de moeite van nader onderzoek waard is.  
 
Administratie van recombinant IL-18 beschermt muizen tegen gedissemineerde C. 
albicans infectie [3] en toediening van IL-12 kan zowel een beschermend als een nadelig 
effect hebben op het beloop van gedissemineerde candidiasis. IL-18 en IL-12 spelen dus 
een significante rol in de gastheerweerstand tegen gedissemineerde candidiasis, maar een 
goede karakterisatie van hun modulerend effect ontbreekt nog. Om de effecten van 
endogeen IL-18 en IL-12 op de gastheerweerstand tegen candidiasis op te helderen werden 
IL-18-/-, IL-12-/-, en immunocompetente muizen intraveneus met C. albicans geinfecteerd 
(Hoofdstuk 5). Alleen onder de IL-18-/- muizen was de mortaliteit toegenomen. Dit ging 
    Chapter 11 
     
189 
gepaard met een verminderde klaring van C. albicans uit de nieren, laat tijdens het beloop 
van infectie. Bovendien bleek uit histopathologisch onderzoek van de nieren en uit 
fagocyten-influx experimenten dat de influx van monocyten naar de plaats van de Candida 
infectie verminderd was, voornamelijk in de IL-18-/- muizen. Terwijl de productie van KC 
was afgenomen in IL-18-/- en IL-12-/- muizen, was de productie van chemokine MIP-2 
alleen verminderd in IL-18-/- muizen. Dit verklaart mogelijk het verschil in de influx van 
monocyten tussen IL-12-/- en IL-18-/- muizen. Omdat IL-18 en IL-12 de productie van 
IFNγ stimuleren, en IFNγ een cruciale rol in de afweer tegen infectie met C. albicans 
speelt, werd tevens de productie van IFNγ bepaald. Hoewel de IFNγ productie 
gereduceerd was in IL-12-/- muizen, was deze reductie meer uitgesproken in IL-18-/- 
muizen. Concluderend: het anti-Candida effect van endogeen IL-18 vindt pas laat plaats 
gedurende Candida infectie en IL-18 verzekert zowel de IFNγ respons als de influx van 
monocyten naar de plaats van infectie. De resultaten van Hoofdstuk 3, en overig 
onderzoek [3], hebben geen invloed van IL-18 op de PMN-funktie aangetoond. Dit levert 
een aanvullende verklaring waarom IL-18 geen vroeg effect sorteert in het beloop van 
gedissemineerde candidiasis. 
  
Lipoproteinen zoals LDL kunnen de gastheerweerstand tegen candidiasis moduleren. 
In Hoofdstuk 6 wordt het onderzoek naar de immunomodulerende werking van 
verhoogde VLDL concentraties en apolipoproteine E tijdens gedissemineerde candidiasis 
beschreven. In deze experimenten werden ApoE -/- and immunocompetente (ApoE +/+) 
muizen gebruikt. ApoE -/- muizen waren gevoeliger voor acute gedissemineerde 
candidiasis dan ApoE +/+ muizen. Dit uitte zich in een verhoogde sterfte onder ApoE -/- 
muizen en een groter aantal C. albicans blastoconidia in de nieren van ApoE -/- muizen. 
Lipoproteinen spelen dus een belangrijke modulerende rol in de afweer tegen candidiasis.  
De verhoogde gevoeligheid van ApoE -/- muizen was het resultaat van toegenomen C. 
albicans groei in plasma. Enerzijds kan de toegenomen groei worden verklaard doordat de 
lipiden dienst doen als nutrienten, anderzijds kunnen de lipoproteinen candidacide 
factoren in het plasma neutraliseren. ApoE zelf had geen neutraliserend effect op 
candidacide plasma factoren. Echter, deze candidacide factoren zijn niet geïdentificeerd. 
In de toekomst zouden deze factoren uit plasma (Hoofdstuk 6) of urine (mogelijk 
geinduceerd door IL-1α zoals gesuggereerd in Hoofdstuk 4) kunnen worden geisoleerd. 
 
Invasieve candidiasis 
Naast gedissemineerde candidiasis kan Candida albicans tevens invasieve candidiasis 
veroorzaken, waarmee in dit proefschrift C. albicans peritonitis en intraperitoneale C. 
albicans abcessen wordt bedoeld. TNF en LT spelen een centrale rol in de 
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gastheerweerstand tegen gedissemineerde candidiasis. Volgens recent onderzoek kan de 
systemische toediening van monoclonale anti-TNF-antilichamen ter behandeling van 
patienten met een inflammatoire darmaandoening het risico op invasieve fungale infecties 
vergroten. De mechanismen waardoor de neutralisatie van endogeen TNF de vatbaarheid 
voor fungale infecties verhoogd zijn nog niet volledig opgehelderd. Daarom werd de rol 
van endogeen TNF en LT in een model van intra-abdominale Candida abcessen 
bestudeerd (Hoofdstuk 7). Hierbij werd gebruik gemaakt van TNF-/-LT-/- en 
immunocompetente muizen. De hoofdconlcusie van dit onderzoek luidt dat TNF en LT 
noodzakelijk zijn voor de gastheerweerstand tegen intra-abdominale Candida abcessen. 
Twee factoren dragen bij aan de verminderde gastheerweerstand van TNF-/-LT-/- muizen. 
Ten eerste, TNF-/-LT-/- PMNs hebben een significant verminderde capaciteit om C. 
albicans pseudohyphen extracellulair te beschadigen. Ten tweede, TNF-/-LT-/- muizen 
hebben een vertraagde Th1 respons, zoals aangetoond door de significant verlaagde IL-
10/IFNγ ratio gedurende de eerste week van infectie. De vertraagde Th1 respons leidt 
hoogstwaarschijnlijk tot onvoldoende stimulatie van effector cellen, waardoor de 
hoeveelheid Candida in abcessen significant toeneemt. Zowel uit onze gegevens, als uit 
die van anderen, kan geconcludeerd worden dat TNF en LT niet essentieel zijn voor het 
proces van abces- en granuloomvorming. TNF en LT spelen daarentegen wel een hoofdrol 
bij de expansiebeperking en klaring van C. albicans door het doden van de 
microorganismen. 
Over het algemeen zijn abdominale candidiasis en abcessen moeilijk te behandelen 
met antifungale middelen. Ondanks antifungale therapie blijft de mortaliteit aanzienlijk 
hoog. Additionele behandeling met een middel zoals G-CSF dat de gastheerweerstand 
versterkt zou een potentieel gunstig effect op de behandeling kunnen uitoefenen. Echter, 
behandeling met G-CSF zou tevens een ongunstig effect op de gastheerweerstand kunnen 
hebben. Voorgaand onderzoek heeft namelijk aangetoond dat G-CSF de TNF productie 
kan verminderen en, zoals beschreven in Hoofdstuk 7, een verminderde TNF productie 
heeft een nadelige invloed op het beloop van intra-abdominale Candida abcessen. Om 
deze redenen werd de invloed van antifungale therapie al dan niet in combinatie met G-
CSF behandeling bestudeerd in het model van intra-abdominale Candida abcessen 
(Hoofdstuk 8). De resultaten tonen aan dat modulatie van de gastheerweerstand door 
profylactisch toegediend G-CSF het aantal Candida cfu in de abcessen significant 
reduceert. Daarentegen heeft G-CSF therapie alleen (toegediend op dag 4 t/m 8 van 
infectie) noch een gunstig nog een ongunstig effect. Antifungale behandeling van intra-
abdominale Candida abcessen met amfotericine B was significant effectiever dan 
fluconazol behandeling. Toevoeging van rmG-CSF therapie aan conventionale antifungale 
therapie antagoneerde niet het effect van behandeling met een antifungaal middel alleen. 
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Concluderend, experimentele intra-abdominale Candida abcessen kunnen effectief worden 
behandeld met amfotericine B, en simultane administratie van rmG-CSF kan leiden tot een 
beter resultaat. 
 
Het was opvallend dat behandeling met fluconazol niet effectief was tegen intra-
abdominale Candida abcessen. De C. albicans stam was gevoelig voor fluconazol en de 
plasma concentraties van fluconazol waren adequaat (dalconcentratie plasma 24 x MIC). 
Bovendien was fluconazol even effectief als amfotericine B ter behandeling van 
candidaemie. Er resteren dus twee denkbare verklaringen voor de ineffectiviteit van 
fluconazol behandeling van intra-abdominale Candida abcessen. Ten eerste, fluconazol 
penetreert mogelijk niet in abcessen. Ten tweede, het is mogelijk dat fluconazol 
biologische activiteit verliest in pus. Omdat Joiner en anderen hebben aangetoond dat, 
ondanks de afwezigheid van gefenestreerde vascularisatie en de aanwezigheid van een 
collageen kapsel, de meeste antibiotica eenvoudig in abcessen penetreren [4], is het 
aanlokkelijk om aan te nemen dat fluconazol door de inhoud van Candida abcessen wordt 
geinactiveerd. Deze hypothese dient in toekomstige studies te worden getoetst. 
 
Amfotericine B dankt het gunstige effect voornamelijk aan een direct candicide 
werking. Daarnaast is beschreven dat amfotericine B mogelijk de gastheerweerstand 
versterkt door de produktie van pro-inflammatoire cytokinen te induceren. Dit laatste 
fenomeen is mogelijk geassocieerd met het optreden van bijwerkingen als koorts en koude 
rillingen. Er zijn echter tegenstrijdige gegevens gepubliceerd met betrekking tot de 
capaciteit van amfotericine B om de produktie van pro-inflammatoire cytokinen te 
induceren. In Hoofdstuk 9 is het onderzoek beschreven naar de inducerende en 
modulerende werking van amfotericine B op de produktie van pro-inflammatoire 
cytokinen door humane mononucleaire cellen die geisoleerd zijn uit perifeer bloed 
(PBMC). Amfotericine B induceerde de expressie van TNF en IL-1β mRNA, en 
amfotericin B versterkte de lipopolysaccharide (LPS)–geïnduceerde TNF and IL-1β 
mRNA expressie. De door Candida albicans en Staphylococcus aureus–gestimuleerde 
expressie van genen die coderen voor de pro-inflammatoire cytokinen werd niet versterkt 
door amfotericine B. Daarentegen reduceerde amfotericine B de hoeveelheid IL-1ra in 
respons op LPS en hitte-gedode S. aureus bacteriën, zoals blijkt uit de significant 
gereduceerde IL-1ra/IL-1β ratio’s.  
Deze data suggereren dat de inductie van de cytokineproduktie door diverse 
microbiële stimuli via verschillende wegen wordt gemedieerd waardoor amfotericine B 
een verschillend effect sorteert. Een mogelijk voorbeeld is de TLR-gemedieerde signaal 
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transductie. C. albicans onderdrukt waarschijnlijk de amfotericine B-geïnduceerde pro-
inflammatoire cytokinen respons door de TLR2-gemedieerde productie van IL-10 [5]. 
Omdat amfotericine B in vitro een geringe invloed heeft op de produktie van pro-
inflammatoire cytokinen, en in vivo juist een hoge potentie heeft om koorts en koude 
rillingen te veroorzaken, kan gesuggereerd worden dat in vivo pyrogenen mogelijk via een 
indirect mechanisme na toediening van amfotericine B worden geproduceerd. Interacties 
met plasmafactoren of induktie van secondaire mediatoren van de cytokine produktie 
vormen daarbij een mogelijkheid. 
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Het schrijven van een proefschrift is nooit een doel op zich voor mij geweest. In feite 
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onderzoek te doen en dat later als arts voort te zetten. Voornamelijk in die eerste periode 
heb je me intensief begeleid en zelfs nu nog voorzie je me zo nu en dan van advies 
waardoor ik aardig op koers blijf. Dank dat ik, ondanks alle drukte, altijd welkom ben met 
typische Vonk-zaken. 
 
De goede basis voor dit proefschrift werd gelegd in de tijd dat ik als student 
onderzoek op het laboratorium van algemene interne geneeskunde deed. Ik ben niet 
vergeten dat Liesbeth de methode om PBMC’s te isoleren met de hand voor me opschreef. 
Zoiets had ik nog niet eerder meegemaakt en dat was duidelijk het begin van een 
hardnekkige labaffiniteit. Trees en Liesbeth, bedankt dat jullie me als het ware 
labtechnisch hebben leren lopen. Ik denk dat ik later door het klimmen met Natasja ook op 
de onderzoeksladder omhoog ben geklommen. Natasja bedankt voor je kameraadschap. 
 
Een van de voornaamste lessen van deze onderzoeksperiode is dat een negatieve 
bevinding helemaal zo gek nog niet is, maar dat dit soms wel veel doorzettingsvermogen 
vraagt. Ineke, ik ben erg blij dat ik met je heb kunnen samenwerken. Voor mijn gevoel 
liep het als een goed geoliede machine. Ik heb enorm met je gelachen en de fijne 
praktische kneepjes van je geleerd. Ik bewonder je inzet. Je hebt er zonder twijfel aan 
bijgedragen dat mijn doorzettingsvermogen groter werd dan ik voor mogelijk hield.  
 
De aanwezigheid van Johanna, Magda, Anneke, Helga, Heidi, en Berry waren 
eveneens onontbeerlijk voor deze onvergetelijke periode. Goed werk. Goed gesprek. 
Dank. Pierre, bedankt dat je probeerde mij van stof tot nadenken te voorzien.  
Chantal, dank voor alle pdf’s die je me toestuurde als ik erom vroeg. In jouw buurt loop ik 
het risico op een lachbui, heerlijk, dank je. Meer! 
Dr. Freek van Loon bedankt voor het commentaar op mijn veel te klein geschreven tekst. 
Marcel van Deuren bedankt voor Farzin.  
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Verreweg de meeste tijd heb ik doorgebracht op het dierenlab. Ik dank Debby, Kay, 
Geert, Theo, Maichel, Margot, Monique, Hennie, Helma en Bianca voor het aanleren van 
de benodigde technieken, jullie vakkundigheid en hulp bij mijn experimenten. Jullie waren 
altijd bereid om mee te denken, muizen te injecteren of materiaal op plaat te zetten. Dit 
allemaal volgens complexe schema’s op soms onmogelijke tijden. Dat “waar Vonk werkt, 
soms ook vuur is” zullen we maar niet meer letterlijk nemen, niet Kay? Dank allemaal 
voor al het plezier!  
 
Cathrien Wieland, Yvonne Jonkers, Monique Joosten en Marieke Versteegen, bedankt 
voor de prettige samenwerking en de feedback die ik als begeleider van jullie heb 
ontvangen. Cathrien, ik vond het geweldig dat je als student binnen een mum van tijd met 
me in discussie kon treden. Onze bijzonder goede samenwerking heeft geresulteerd in een 
alom gehekelde fagocytose- en killingassay. Ik ben er trots op dat je onderzoek bent gaan 
doen. Nog is het jou niet welletjes….. 
Naast het Candida-onderzoek heb ik tevens mogen proeven van onderzoek op andere 
gebieden. Ik dank Lorna Stearne, Inge Gyssens (UMC Rotterdam) en Maaike Dooper 
(Nuimico Research B.V., Wageningen) voor de plezierige samenwerking.  
 
Toch is er ook een dip. Geen saus, maar Anna. Anna, dank dat je tijdens mijn 
ziekteproces een geweldige steun bent geweest. Ook als ik helemaal stuk zat gaf je me stof 
tot nadenken. Simpele puzzels. Lastige puzzels. Soms loste je ze aan de rand van mijn bed 
zelf maar even op. Ik lag er gewoon. Jij zat er gewoon.  
Ik heb bijzonder genoten van de manier waarop we gepassioneerd over ons onderzoek 
en andere onderwerpen hebben gediscussieerd en van onze akties als A-team. Het spijt me 
dat ik dit niet in een formule kan uitdrukken, maar dat is immers jouw taak. Ik denk dat ik 
nu mijn vingers moet houden. Bedankt. 
Gelukkig was er een man om het A-team op noodzakelijke momenten met beide 
benen op de grond te houden en ons, met gevaar voor eigen leven, voor serieus 
overgewicht te behoeden door regelmatig onze koekjes op te eten (ik schrijf dit uiteraard 
zonder toestemming van Anna). Reinout, bedankt voor de nodige humor en je uitstekende 
kamergenootschap. 
 
Mihai Netea, mijn onnavolgbare copromotor, ik heb geprobeerd iets van jouw 
creatieve manier van kijken naar alles om me heen eigen te maken. Ergens een experiment 
in te zien. Wel, ik denk dat ik nog maar een rondje op de motor maak. Drie waarschijnlijk. 
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Tenslotte dank ik mijn directe begeleider en promotor Bart-Jan Kullberg. BJ, je hebt 
me geleerd kritischer dan kritisch onderzoek te doen. Je verfijnde steeds mijn schrijfwerk 
en tot op heden is het me niet gelukt iets zonder commentaar terug te krijgen. Met humor 
en geduld heb je Candida in RPMI laten groeien. Dat zal ik waarschijnlijk zelfs wel 
missen. De rest heb je inmiddels per mail ontvangen, denk ik. Ik dank je voor alles. 
Antoinette, bedankt dat ik vaak beslag op je tijd heb mogen leggen. 
 
Rene, Patrick, Peter, Maarten en Toine, dank voor eindeloze kilometers motorplezier, 
gesprekken, films, en pure pret. Jullie hebben me letterlijk en figuurlijk wel eens uit de 
greppel moeten halen. Chanou, Milka en Brita jullie waren er altijd voor mij. Kamran, 
mijn onvervangbare oudere broer, dank voor je altijd aanmoedigende aandacht. 
 
Mijn familie dank ik voor hun onvoorwaardelijke liefde en steun. Pap, zonder de 
orgametrilpraat 24/7 zou ik dit niet hebben kunnen schrijven. Lieve Farzin, zonder jou was 
dit simpelweg niet mogelijk geweest. Dank je voor je grenzeloze vertrouwen en geloof in 
mij.  
ﻪﮐﻴﻠﺁ ‘  ﻦﻤ نﻴﺰﺮﻓﺮﺎﺧﺗﻓا ﻮﺗ ﻪﺒ نﻤ ﻮ ﻢﺮاﺪ ﺖﺗﺴﻮﺪﻢﻨﮐﻰﻡ  
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List of abbreviations 
 
 
 
AmB  Amphotericin B 
CFU  Colony forming unit 
G-CSF Granulocyte colony stimulating factor 
GM-CSF Granulocyte macrophage colony stimulating factor 
IFNγ  Interferon-γ 
IL   Interleukin 
IL-1ra Interleukin-1 receptor antagonist 
KC   Keratinocyte-derived chemokine  
LTα  Lymphotoxin-α 
LPS  Lipopolysaccharide 
MBL  Mannose binding lectin 
MCP-1 Monocyte chemotactic protein 1 
MIP-2 Macrophage inflammatory protein 2 
MPO Myeloperoxidase 
NK  Natural killer (cell) 
NO   Nitric oxide 
ONOO Peroxinitrate 
PBMC Peripheral blood mononuclear cells 
PBS  Phosphate buffered saline 
PMN(s) Polymorphonuclear granulocyte(s) 
RPMI Acronym of Roswell Park Memorial Institute; cell culture 
   medium 
SCID Severe combined immunodeficiency (T- and B-cell defect) 
Th   T helper cell 
TLR  Toll like receptor 
TNFα Tumour-necrosis factor-α 
TPN  Total parenteral nutrition 
Treg  T regulatory cell 
XTT  tetrazolium dye: 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)- 
   2H-tetrazolium-5-carboxanilide 
